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Abstract 
Shewanella oneidensis exhibits a diverse respiratory system, able to use over 20 
terminal electron acceptors, including solid metal oxides. CymA is located in the inner 
membrane, facing the periplasmic space, and it is responsible for the re-oxidation of 
the quinol/quinone pool. A plethora of proteins re-oxidise CymA, such as the 
periplasmic fumarate reductase FccA. This thesis investigates the nature of the 
interaction between CymA and FccA with a variety of biochemical and biophysical 
techniques.  
Chapter 3 describes a new approach in purifying recombinant form of CymA as a 
pure monodispersed solution that was developed with the reconstruction of the 
expression vector. The purity was >90% with a yield of 2 mg L-1 of culture. The 
biochemical and electrocatalytic properties of the recombinant CymA remained 
unaltered.  
Chapter 4 presents for the first time the purification of a soluble version of CymA, 
CymAsol [CymA-Δ(1-31)], at >95% purity, but with a lower yield of 0.3 mg L-1 of culture 
due to limitations from the TEV proteolytic cleavage reaction for tag removal. 
Nonetheless, the first crystallisation attempt was achieved with CymAsol. In total, 
2,016 conditions were assayed, from which PEG 3350 seemed to promote atypical 
protein precipitation, although no crystals were formed.  
Chapter 5 presents a systematic investigation of the CymA: FccA interaction, where 
no strong interaction was observed with cyclic voltammetry using a CymA-containing 
tethered bilayer lipid membrane system, or with QCM-D using a CymA-containing 
solid supported bilayer lipid membrane system. Dissolved oxygen alone was the only 
condition that replicated the previously published electrocatalytic data under the 
same system. This was further validated with isothermal titration calorimetry with 
CymAsol, while, in a separate experiment, it was shown that CymA is necessary for 
the FccA-specific fumarate reduction in vitro with an initial rate of 3.3 (±0.3, n=3) µM 
NADH oxidised min-1. Lastly, QCM-D showed that CymAsol binds to a positively 
charged lipid bilayer, while the MBP-tag of the whole construct binds to a negatively 
charged lipid bilayer. Thus, the new evidence presented herein points towards a 
transient nature of weak interaction between CymA and FccA.  
The contributions of this work are in advancing the understanding of the anaerobic 
respiratory system of S. oneidensis. 
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Chapter 1 - Introduction 
1.1 The family of dissimilatory metal reducing bacteria with 
an evolutionary perspective 
The atmosphere of earth was completely anoxic until 2.4 – 2.3 billions of years 
(Ga) ago, according to sulphur isotope fractionation studies (2). Laser-Raman 
spectroscopy of the oldest fossil on geological record (an Apex chert found in 
north-western Western Australia (3)) has provided conclusive evidence for the 
presence of microbial life at about 3.5 Ga ago (4). Laser-Raman spectroscopy 
is able to analyse the chemical composition of fossils, which allows the 
differentiation between biotic and abiotic features that share the same 
morphology. Thus, there has been a significant period of anoxic life before the 
evolution of the first oxygenic photosynthetic organisms. The appearance of 
photosynthesis led to a period (about 2.5 – 2.3 Ga ago) where the oxygen 
level was fluctuating before it became stable (5). The phylum of cyanobacteria 
is believed to have played an important role in the final oxygenation of Earth 
(2).   
During the anoxic period, the atmosphere of earth was reducing with the 
presence of hydrogen, whose level was later decreased by the evolution of 
methanogens (by conversion of H2 and CO2 to CH4) and by natural escape to 
the outer space (6). The earliest forms of microbial respiration may have been 
based on hydrogen as the electron donor and Fe(III) as the electron acceptor 
(7, 8). Phylogenetic analysis of 16S ribosomal RNA (rRNA) sequences has 
been employed to identify all relatives to the last common ancestor (7). 
Consequently, all identified microbes by the phylogenetic analysis were 
capable of Fe(III)-reduction in cultures. It was also showed that Thermotoga 
maritima, which was previously thought to be a fermentative organism, was 
able to conserve energy for growth through Fe(III)-reduction in culture 
experiments (7). T. maritima is one of the most ancient ancestors in existence, 
although the importance of this observation lies on the fact that anaerobic iron 
respiration can generate sufficient energy for growth. Thus, all evidence from 
geochemical and phylogenetic studies point towards an ancient respiratory 
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system of Fe(III)-reduction whose remnants survive today in a group of 
bacteria called dissimilatory metal reducing bacteria (DMRB).   
Although DMRB have a long history on this planet, they were only identified 
just over two decades ago with the isolation of Shewanella oneidensis MR-1 
from the sediment of Lake Oneida in New York (9) and Geobacter 
metallireducens from the sand sediment of Potomac River in Washington D. 
C. (10). Other DMRB that have been identified to date include those in the 
genera of Clostridium (11), Aeromonas (12), Rhodoferax (13) and 
Desulfobulbus (14). Today, those microbes are primarily found in aquatic 
anoxic niches around the world and they are implicated in the geochemical 
iron cycle of anoxic environments (15).  
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1.2  Background on Shewanella oneidensis 
1.2.1 Shewanella oneidensis as a dissimilatory metal reducing 
bacterium with unique characteristics 
The genus Shewanella has being studied since 1931 (16), while its ability for 
dissimilatory metal reduction was uncovered in ca. 1988 with the isolation of 
the MR-1 strain (9). The species of the genus Shewanella exhibit diverse 
physiology and habitants. Thus, the taxonomy of different species within the 
genus is primarily based on 16S rRNA sequencing. Shewanella species often 
have a symbiotic relationship with fermentative microorganisms in energy-rich 
niches and/or in environments where the redox conditions can change rapidly. 
Interestingly, some Shewanella isolates from sea-ice niches found in 
Antarctica are psychro- (tolerant to cold) and piezo-tolerant (tolerant to high 
pressure). Shewanella species have also been described as an opportunistic 
pathogen of humans (17), or responsible for fish spoilage (18). Shewanella 
oneidensis MR-1 is a strain of this genus based on 16S rRNA sequencing. 
This species was re-classified three times and re-named once, until it was 
assigned its current name of Shewanella oneidensis. Firstly, it was placed 
under the genus of Achromobacter (16), which was later re-classified as a 
species of the genus Pseudomonas (19), then of Alteromonas (20) and lastly 
of Shewanella (21). Much later, in the light of 16S rRNA sequencing data, it 
was renamed from Shewanella putrefaciens to Shewanella oneidensis (22).         
S. oneidensis is a Gram-negative, motile, facultative anaerobic γ-
proteobacterium with bacillus morphology (22). One of the most intriguing 
aspects of S. oneidensis, though, is its metabolic versatility. It is able to respire 
through a plethora of terminal electron acceptors (TEAs) (23), such as 
molecular oxygen, fumarate, nitrite, nitrate, DMSO, TMAO, along with a 
variety of  metal oxides and chelates of metals, such as Fe3+ (24, 25), Mn3+ 
(24), Mn4+ (24), U6+ (25, 26), Cr6+ (25-27)  and Tc6+ (25). Consequently, S. 
oneidensis has found great interest from the scientific community.  
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1.3 The anaerobic respiratory system of Shewanella 
oneidensis  
1.3.1 General overview of the pathways that comprise the 
anaerobic respiratory system 
 
Figure 1: Schematic overview of the anaerobic respiratory system of 
Shewanella oneidensis.  Electrons from the oxidation of organic matter in the 
cytoplasm are directed to the quinone molecules in the inner membrane (IM) 
via the IM NADH and/ or formate dehydrogenases with the co-current release 
of protons (H+) in the periplasm. The generated proton gradient is employed for 
the synthesis of ATP by ATP-synthase. It is maintained by the re-oxidation of 
the quinols via the IM CymA or TorC. CymA distributes the electrons either to 
periplasmic terminal reductases, or towards the outer membrane (OM) 
complexes for the extracellular reduction of metal oxides or DMSO. TorC is the 
functional homologue of CymA for the periplasmic reduction of TMAO by TorA. 
The electron flow is indicated with black arrows, while the H+ flow is indicated 
with red arrows.   
  
Scott et al (28) isolated extracts of different S. oneidensis strains, which were 
either aerobically or anaerobically grown, and assayed the activity of enzymes 
that are linked to different metabolic pathways. It was found that under oxic 
conditions, the tricarboxylic acid cycle (TCA) is active, while under anoxic 
conditions formate (or formaldehyde) is the main carbon intermediate and the 
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bacterium employs a truncated TCA and serine pathway by selecting 
enzymes from each pathway. As a result, under anoxic conditions, there is a 
net flow of electrons from the formate dehydrogenase to menaquinone, which 
is present in the inner membrane. Concurrently, the oxidation of formate 
produces protons in the periplasmic space. A net flow of electrons can also 
derive from other anaerobic metabolic pathways in the form of NADH, which 
is coupled by the inner membrane dehydrogenases. This reduces the 
menaquinone, while protons are translocated to the periplasm. The proton 
translocation and the periplasmic proton production generate a proton 
gradient (the proton motive force) that drives ATP-synthases. The electron 
flux, hence, is linked to the proton motive force. The proton motive force is 
maintained by reducing terminal electron acceptors that act as electron sinks. 
The menaquinol is re-oxidised by primarily CymA, an inner membrane 
anchored tetrahaem c-type cytochrome. CymA mediates the electrons to 
other proteins, allowing its own re-oxidation. Thus, the menaquinol and CymA 
re-oxidation that maintains the electron flux is a crucial component of the 
respiratory system. The electrons can follow one of three paths: they can be 
transported directly to (a) periplasmic terminal reductases, to (b) periplasmic 
electron shuttle proteins, or (c) directly from CymA to the outer membrane 
complexes. An overview of the pathways involved in the anaerobic respiratory 
system of S. oneidensis is schematically shown in figure 1.   
1.3.2 CymA as an inner membrane electron-distribution hub 
CymA is a quinol dehydrogenase that is localised at the inner membrane and 
it catalyses the reduction of menaquinol: 
MQH2  
𝐶𝑦𝑚𝐴
→     MQ + 2 e- + 2 H+ 
where MQH2 and MQ are the menaquinol and menaquinone respectively. 
CymA, the product of cymA gene, was successfully cloned and characterised 
as a tetrahaem c-type cytochrome with an inner membrane anchor domain 
and an approximate molecular mass of 21 kDa (29). Spectroscopically, the 
haem groups of the reduced cytochromes show three peaks at the UV-visible 
region, which are also known as α, β, and γ Soret bands. The wavelength of 
the α Soret band is often used to establish the type of cytochromes. Generally, 
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the haem group (iron protoporphyrin IX) of c-type cytochromes is covalently 
attached to the protein through thioether bonds between the vinyl groups of 
the haem and the cysteine thiol groups on a CXXCH motif. The sequence of 
cymA revealed that CymA is part of the NapC/ NrfH family of quinol 
dehydrogenases (29). From gene sequence alignment, S. oneidensis CymA 
is a homologue of Escherichia coli NapC, Desulfovibrio desulfuricans NrfH, 
Wolinella succinogenes NrfH, Haemophilus influenza NapC, Paracoccus 
denitrificans NapC, and Sulfurospirillum deleyianum NrfH (29).  
Although the crystal structure of CymA remains elusive, the crystal structure 
of NrfH was solved as an NrfH2A4 complex to a resolution of 2.3 Å from 
Desulfovibrio vulgaris (30). The entire complex (300 kDa) consists of two NrfA 
dimers each binding to one NrfH molecule (figure 2). NrfH is an α-helical 
protein with an N-terminal transmembrane (TM) α-helix and a globular 
domain. Besides the TM α-helix, a second α-helix is also believed to be 
embedded within the membrane because of its high number of hydrophobic 
residues. Furthermore, this second membrane-associated helix is implicated 
in the orientation and membrane attachment of NrfH. Truncated NrfH (31), 
NapC (32) and CymA (33) constructs, in which the N-terminal TM helix was 
removed, were all able to interact with the quinol pool in mutant 
complementation and in vitro biochemical studies in line with the suggested 
role of the second helix in membrane attachment.  
NrfH dimerises in such a way that haem I is optimally arranged to interact with 
the quinol pool (figure 3). The globular domain houses the 4 haem groups in 
a two-pair arrangement (haems 1 and 2 versus 3 and 4), facing the 
periplasmic space. Rodrigues et al (30) proposed a menaquinone (MQ) 
binding pocket, which is located between haem I and the second 
transmembrane α-helix. According to their proposed model, the hydroxyl 
groups of MQ form hydrogen bonds with the side chains of Asp89 and Lys82, 
both highly conserved amino acids. Those residues are both located on the 
second membrane-associated α-helix, which is oriented parallel to the 
membrane plane, allowing efficient interaction with the quinol pool.  
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Figure 2: Crystal structure of NrfH2A4 complex from Desulfovibrio vulgaris. A. 
Crystal structure of the whole complex at 2.3 Å resolution. Dashed lines 
represent the boundaries of the lipid bilayer membrane. The N-terminal 
transmembrane α-helices of the two NrfH molecules dimerise through a 
dimerisation motif, bringing the second membrane-associated N-terminal α-
helices perpendicular to the membrane. B. The arrangement of the haems is 
shown for the entire complex. The haem groups of NrfH molecules are labelled 
with Roman numerals, while the haem groups of two out of the four NrfA 
molecules are labelled with Arabic numerals. The haem groups are coloured by 
molecule as shown in panel A. The images were produced with PyMOL (PDB: 
2J7A).   
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Figure 3: NrfH homodimer crystal structure at 2.8 Å resolution from 
Desulfovibrio vulgaris with bound HQNO. The two NrfH molecules are 
depicted in red and blue, while the haem groups are presented as sticks. The 
primary N-terminal α-helix dimerises in such a way so to bring haem I in optimal 
orientation towards the membrane for quinone interaction through its quinone 
binding pocket, where HQNO is bound. HQNO (spheres) is an inhibitory 
quinone analogue. The image was produced with PyMOL (PDB: 2VR0).  
 
A couple of years later, Rodrigues et al (34) presented a crystal structure of 
the NrfH2A4 complex bound to a MQ-analogue, 2-heptyl-4-hydroxyquinoline-
N-oxide (HQNO), at a resolution of 2.8 Å. There was no structural difference 
between structures, but the position of HQNO, which confirmed the proposed 
binding site. Specifically, Asp89 is located at the polar region of the membrane 
and it is functionally implicated with proton shuttling. Lys82 is likely to act as 
a direct proton acceptor for quinol oxidation.  
Magneto-optical spectroscopic interrogation, along with biophysical 
characterisation of CymA from S. frigimarina and S. oneidensis suggests bis-
His ligation of the haem groups (1, 35). Dimerisation of CymA is also 
suggested by the presence of bands of higher molecular weight during CymA 
purification that contained CymA as confirmed by mass-spectroscopy of 
tryptic digestion. Dynamic light scattering and size-exclusion chromatography 
also provided evidence that corroborates the presence of a CymA dimer within 
the detergent micelles (1).  
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Although CymA is required for respiration, it was not found to be a terminal 
reductase (29). Thus, it started becoming clear that CymA must act as an 
electron mediator between the quinone pool and terminal reductases. 
Transposon mutagenesis generated a phenotypically deficient mutant in MQ 
and methyl-MQ, CMTn-1, which was unable to reduce fumarate, nitrate, Fe(III) 
and a limited ability to reduce Mn(IV), although no difference from the wild-
type was observed for TMAO reduction (36). Although CMTn-1 illustrates the 
importance of the quinone pool, it could not be rescued with MQ and methyl-
MQ complementation (37), which suggested a mutation on an upstream 
element of the pathway. Subsequent genetic investigation of the mutant 
revealed that the transposon element interrupted the cymA gene (37). A cymA 
deletion mutant (ΔcymA) exhibited the same phenotype as CMTn-1 mutant 
(37), which corroborates that CymA is an upstream element that must interact 
with the quinol pool in order to give a MQ-deficient phenotype.  
Regarding S. oneidensis respiratory system, three quinones have been 
identified as the major components of the quinone pool both by thin layer 
chromatography (36) and high-performance liquid chromatography (38); 
ubiquinone (UQ), MQ and methylmenaquinone (methyl-MQ). MQ was 
identified as a co-factor of CymA by co-purification and subsequent 
electrochemical characterisation that functionally supports the presence of the 
MQ-binding site on CymA (39). Surface-enhanced Resonance Raman 
Spectroelectrochemistry (SERR) (40), along with the available crystal 
structure of NrfH, has provided great insights into the biological importance of 
the bound MQ. It lowers the redox potential of the entry haem, facilitating the 
biological electron transfer by an increased overall driving force of a downhill 
electron transport.  
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1.3.3 Respiratory pathways involving intracellular electron 
transfer 
1.3.3.1 Nitrate ammonification by the nitrate reductase NapAB and the 
nitrite reductase NrfA 
Bacterial nitrate ammonification occurs anaerobically by a two-step process: 
First, nitrate is reduced to nitrite by the NAP system (periplasmic nitrate 
reductase). Second, nitrite is reduced to ammonia by the NRF system 
(periplasmic nitrite reductase). Generally, the NAP system consists of at least 
four proteins: NapC, which is a homologue of CymA; the catalytic heterodimer 
NapAB; and the accessory protein NapD, which is involved in the translocation 
of NapA to the periplasmic space. Regarding the NRF system, there are two 
types: the NrfHA system, which is primarily found in δ- and ε-proteobacteria; 
and the NrfABCD system, which is primarily found in γ-proteobacteria. NrfH is 
the homologue of CymA and NapC. The NrfBCD is the functional equivalent 
of NapC and CymA, re-oxidising the inner membrane MQH2. However, S. 
oneidensis possesses no NrfH or NrfBCD equivalent and no NapC. Instead, 
NrfH and NapC are functionally replaced by CymA.      
The periplasmic heterodimeric nitrate reductase NapAB consists of a large 
catalytic subunit NapA of an approximate molecular mass of 91 kDa and a 
small electron-transfer subunit NapB of an approximate molecular mass of 17 
kDa. It catalyses the reduction of nitrate to nitrite: 
  𝑁𝑂3
− + 2 𝑒− + 2 𝐻+  
𝑁𝑎𝑝𝐴𝐵
→      𝑁𝑂2
− + 𝐻2𝑂  
 
Although the crystal structure of S. oneidensis NapAB has not been solved 
yet, much information can be obtained by the solved crystal structure of the 
Rhodobacter sphaeroides NapAB at 3.2 Å resolution (41) (figure 4). This is 
the only available crystal structure of the nitrate reductase holoenzyme. The 
catalytic subunit NapA houses a [4Fe-4S] cluster and a molybdenum cofactor. 
The overall structure of NapA comprises of four domains. Domain I contains 
all the cysteines that bind the [4Fe-4S] cluster. Domains II and III have a mixed 
α/β-fold and bind two molybdopterin guanine dinucleotides (MGD). Domain IV 
shows a long N-terminal tail that crosses domains II and III, forming a β-barrel 
structure above both MGD. The catalytic site lies between the two MGD, but 
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access to it is restricted by domains II and III. The electron transfer subunit 
NapB contains two c-type haems. NapB interacts with NapA by the C- and N-
terminal tails that surround NapA. A monomeric structure of NapB from H. 
influenza shows those tails to be highly disordered when not bound to NapA 
(42) and a conformational change is implicated to be induced during the 
association of NapB with NapA (41). Haem II of NapB is brought to close 
proximity to the [4Fe-4S] cluster, while haem I is solvent-exposed for 
interacting with NapC. The overall arrangement of the cofactors of NapAB 
permits electron transfer to the catalytic site from the solvent exposed haem I 
of NapB (41).  
Functionally, NapB is not required for nitrate reduction, but it plays an 
important regulatory role that provides evolutionary advantage. S. oneidensis 
MR-1 deletion mutants of both subunits were generated by in-frame deletion 
mutagenesis, namely ΔnapA and ΔnapB (43). ΔnapB grew faster to maximum 
cell density, compared to the wild type (MR-1), when nitrate was the TEA (43). 
Furthermore, ΔnapB generated more colonies (on petri dish) within the first 7 
hours, although the final count of colonies was the same as with the wild type. 
Both mutants, though, grew as the wild type on cultures with nitrite, which 
indicates that the NAP system has no involvement with the NRF system. 
Double mutant ΔnapAΔnapB could not grow on nitrate, but it was rescued by 
gene complementation of the napA gene, confirming that NapA is essential 
for nitrate reduction (43). On a competition assay between ΔnapB and wild 
type S. oneidensis MR-1, wild type colony count increased by 6.6% after one 
day, with a further increase of 26.7% after 5 days (43). Thus, the presence of 
the napB gene provides S. oneidensis with a fitness gain. In the presence of 
CymA, electrons flow preferentially to NapB until depletion of nitrate, then the 
electron flow switches to NrfA.  
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Figure 4: Crystal structure of NapAB complex at 3.2 Å resolution from 
Rhodobacter sphaeroides. A. The much smaller NapB of 17 kDa is coloured 
in magenta, while the 91 kDa NapA is coloured by its four domains I, II, III, and 
IV in red, green, blue, and yellow respectively. B. The arrangement of the metal 
co-factors of the NapAB complex is shown, where haem I of NapB is the entry 
point of electrons. MGD: molybdopterin guanine dinucleotides. The image was 
produced with PyMOL (PDB: 1OGY). 
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The periplasmic nitrite reductase NrfA (also referred to as ccNiR), with an 
approximately molecular mass of 52.6 kDa, catalyses the reduction of nitrite 
to ammonia: 
  𝑁𝑂2
− + 6 𝑒− + 8 𝐻+  
𝑁𝑟𝑓𝐴
→     𝑁𝐻4
+ +  2 𝐻2𝑂  
 
However, this enzyme can also catalyse the two-electron reduction of 
hydroxylamine (44) and the five-electron reduction of nitric oxide to ammonia 
(45). NrfA forms a stable complex with its electron donor partner NrfH and 
exists in a homodimeric form, as resolved from all crystal structures; most 
notably, the crystal structures of NrfA from D. vulgaris at 2.30 Å resolution 
(46), D. desulfuricans at 2.30 Å resolution (47), W. succinogenes at 1.70 Å 
resolution (48) and E. coli at 2.30 Å resolution (49). Nonetheless, NrfA from 
S. oneidensis has been described not to form a stable complex with CymA, 
but to interact transiently. The crystal structure of NrfA from S. oneidensis 
exists at 2.59 Å resolution (50).  
Structurally, NrfA is highly conserved amongst those organisms and the 
solved structure from S. oneidensis is similar to that of E. coli except the region 
where it interacts with its electron donor, CymA (33). NrfA exhibits a bis-His 
haem arrangement for all haems except the catalytic haem where a lysine is 
the proximal ligand and a water molecule the distal ligand. A Ca2+ binding site 
is present near haem I at the active site. In contrast with NrfA structures from 
other organisms, S. oneidensis does not have a second Ca2+ binding site 
between haems III and IV. The presence of Ca2+ had no profound catalytic 
effect in solution assays and electrochemical experiments (50, 51). This is in 
contrast with NrfA from E. coli where ≥0.5 mM CaCl2 improved the catalytic 
cycle of the enzyme (52). The presence of MgCl2 had no effect (52), which 
confirms that Ca2+ ions are necessary, but not essential, for catalysis. 
Nonetheless, the physiological role of the Ca2+ binding sites is not yet 
completely clear.  
The nrfA gene was deleted by in-frame deletion mutagenesis, resulting in the 
ΔnrfA mutant of S. oneidensis (43). Growth cultures, comparing the optical 
density at different time points and up to 20 h, showed that the ΔnrfA mutant 
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was not able to grow at all on nitrite and its growth on nitrate was impaired 
compared to the wild type (43). The impaired growth on nitrate is explained by 
the fact that nitrite is toxic to cells and it has been shown that it results to a 
prolonged lag-phase (53). Thus, NrfA is essential for nitrite reduction. 
Interestingly, it was showed that the onset of nitrite reduction occurs on 
depletion of nitrate by measuring the amounts of nitrate and nitrite by ion 
chromatography at different time points of cultures of wild type and mutants, 
involving both the first step of nitrate reduction (ΔnapA, ΔnapB & 
ΔnapAΔnapB) and the subsequent step of nitrite reduction (ΔnrfA & 
ΔnrfAΔnapB) (43). This finding suggests that a regulatory mechanism is in 
place, allowing preferential direction of electrons that depends on the 
substrate availability.  
 
1.3.3.2 TMAO reduction by TMAO reductase TorA 
Shewanella species, being of marine origin, are capable of anaerobic 
respiration by catalysing the reduction of TMAO: 
  𝑇𝑀𝐴𝑂 + 2 𝑒− + 2 𝐻+  
𝑇𝑜𝑟𝐴
→     𝑇𝑀𝐴 + 𝐻2𝑂  
 
TMAO is a chemical found in marine fish and invertebrates, where it acts as 
an osmoprotector (54). S. oneidensis reduces TMAO through a soluble 
enzyme (TorA) with a molecular mass of about 90 kDa that is localised in the 
periplasmic space (55). TorA has a single molybdenum co-factor for catalysis, 
as seen from its crystal structure (2.5 Å resolution) from Shewanella massilia 
(56) (figure 5). TorA is encoded by torECAD operon, but unlike other 
periplasmic terminal reductases in S. oneidensis, TorA accepts electrons from 
TorC instead of CymA. TorC was identified as a TMAO-inducible band on 
Coomassie- and haem-stained SDS-PAGE gels of subcellular membranous 
fractions from S. massilia cells grown with and without TMAO (55). S. massilia 
has 96.8% 16S rRNA sequence similarity with S. oneidensis (55). 
Furthermore, the ΔcymA mutant was able to grow in the presence of TMAO 
(36). A ΔtorC mutant has not been investigated so far; it would be interesting 
to assess whether TorA can accept electrons from CymA, despite its 
specificity to accept electrons from TorC.   
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Figure 5: Crystal structure of TorA at 2.5 Å resolution from Shewanella 
massilia. A. The structure is rainbow coloured from N- to C-terminus (blue to 
red). B. The arrangement of the molybdenum co-factor at the catalytic site by 
two molybdopterin guanine dinucleotides (filled spheres).The image was 
produced with PyMOL (PDB: 1TMO). 
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1.3.3.3 Fumarate reduction by fumarate reductase FccA 
 
 
Figure 6: Crystal structure of FccA at 2.9 Å resolution from Shewanella 
oneidensis. The domain I (coloured in red) houses the four haems, which is 
involved in electron transport to the FAD that is housed in domain II (coloured 
in green). Domain II along with domains III (coloured in magenta) and IV 
(coloured in blue) are the catalytic domains of the enzyme. The image was 
produced with PyMOL (PDB: 1D4C). 
 
The periplasmic fumarate reductase FccA (previously referred to as Fcc3) is 
an FAD-containing tetrahaem c-type cytochrome that catalyses the reduction 
of fumarate to succinate under anaerobic conditions with an approximate 
molecular mass of 63.8 kDa (57): 
  𝑓𝑢𝑚𝑎𝑟𝑎𝑡𝑒 + 2 𝑒− + 𝐹𝐴𝐷𝐻2  
𝐹𝑐𝑐𝐴
→    𝑠𝑢𝑐𝑐𝑖𝑛𝑎𝑡𝑒 +  𝐹𝐴𝐷 + 2 𝐻+   
 In contrast to CymA, there is a plethora of crystal structures of various forms 
of FccA, including the FccA from S. oneidensis MR-1 (58) (figure 6). Leys et 
al (58) presented the solved crystal structures of the free FccA at 2.9 Å 
resolution, the FccA bound to fumarate at 2.8 Å resolution, and the FccA 
bound to succinate at 2.5 Å resolution. FccA consists of four domains: three 
comprising the C-terminal catalytic part of the enzyme and one N-terminal 
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tetrahaem c-type cytochrome domain. The crystal structure of FccA from 
Shewanella frigidimarina (59% sequence identity) at 1.8 Å resolution is in 
broad agreement, but it lacks the domain IV (59). Domain I houses four c-type 
haems, which are covalently bound to the protein. It shows very little 
secondary structure. Domain I is linked to the FAD pocket via an α-helical 
linker. Domain II is the FAD domain with a Rossmann fold, which is 
characteristic of the family of flavoproteins. That is, a 5-stranded parallel β-
sheet with 3 α-helices on its one side and a 3-stranded antiparallel β-sheet on 
the other. Domain III consists of 4-standed antiparallel β-sheet, which is 
surrounded by a number of α-helices. Lastly, domain IV consists of a small 3-
stranded β-sheet and 2 α-helices. 
 
Figure 7: Crystal structure of FccA at 2.9 Å resolution from Shewanella 
frigidimarina. The domain I (coloured in magenta) houses the four haems, 
which is involved in electron transport to the FAD that is housed in domain II 
(coloured in green). Domain II along with domain III (coloured in red) are the 
catalytic domains of the enzyme. The image was produced with PyMOL (PDB: 
1QJD).  
 
Domain III (58), which is also referred to as the clamp domain (59), seems 
flexible and adapts different positions upon substrate binding and subsequent 
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catalysis, as observed from the three structures mentioned previously. It 
rotates, forming an enlarged cleft between domains III and IV. The cleft 
controls access of the substrate to the active site of the protein. This is also in 
agreement with the FccA structure from S. frigidimarina (59) (figure 7). It was 
observed that fumarate and succinate are positioned above and parallel to the 
isoalloxazine ring of FAD with its two carboxyl groups interacting with residues 
Arg544, Gly547 and His503 (all of which are highly conserved) (figure 8). 
However, the second carboxyl group of fumarate is shifted compared to that 
of succinate. Mechanistically, both FccA structures from S. oneidensis and S. 
fridigimarina (58, 59) suggest an open conformation of the clamp domain 
(domain III) in the absence of substrate or product, allowing substrate entry to 
the active site. Upon binding of fumarate, the clamp domain closes, inducing 
a twist of the second carboxyl group of fumarate. The central carbon-carbon 
double bond of fumarate is reduced forming transiently a carbanion 
intermediate, which is, then, protonated by Arg401.  
 
Figure 8: Fumarate and succinate interactions at the catalytic site. A. Fumarate 
interacts through its two carboxyl groups with the conserved His503, Gly547, 
and Arg544 residues. B. The shifted carboxyl group of succinate in comparison 
to that of fumarate. The image was produced with PyMOL (PDB: 1D4D and 
1D4E). 
 
The N-terminal c-type cytochrome domain (domain I) (58) shows a 
perpendicular haem arrangement between haem I and II, while haems II and 
III show a parallel arrangement. Haems III and IV show an edge-to-edge 
arrangement with the iron atoms to be maximally separated. All four haems, 
though, are in van der Waals contact that stabilises them and allows fast 
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electron transfer. This haem arrangement is also observed for FccA from S. 
fridigimarina (59).  
FccA was of the first periplasmic proteins to be studied in connection with 
CymA (33, 60, 61). A cloned CymA lacking its N-terminal trans-membrane 
domain, CymAsol, was constructed and was shown to interact directly with 
FccA in vitro (33). Such interaction is supported by a genomic analysis that 
specifically links a 3- to 8-fold increase of the transcription levels of cymA 
under fumarate reducing conditions (62). However, another study using 
formaldehyde cross-linking failed to cross-link the CymA: FccA complex (63). 
Although four potential CymA complexes with a molecular mass of 34, 54, 95 
and 116 kDa were observed, using an antibody against CymA, the binding 
protein(s) could not be identified (63).  An independent nuclear magnetic 
resonance (NMR) study supports the formation of CymA: FccA complex with 
a KD = 398 µM, which is indicative of transient interactions between the two 
proteins (64). Thus, there is a controversy surrounding the nature of CymA: 
FccA interactions.  
 
1.3.3.4 Small tetrahaem c-type cytochrome STC 
The small Tetrahaem cytochrome, STC, was first isolated from S. frigidimarina 
and later from S. oneidensis MR-1 with a molecular mass of 11.8 kDa and 
12.2 kDa, respectively, derived from mass-spectroscopy, which is in 
agreement with the theoretical values (63, 65). STC, previously known as 
CctA, is encoded by the cctA gene (65). It must be noted that the STC protein 
from S. oneidensis MR-1 is 64% similar to that from S. frigidimarina. Deletion 
mutants lacking the cctA gene were not able to reduce iron in S. frigidimarina, 
implicating the STC in the iron reduction pathway (65). Consistent with this 
observation, in vivo formaldehyde cross-linking of S. oneidensis MR-1 cells 
that were grown with ferric citrate revealed a complex of STC with CymA by 
monoclonal antibodies against both CymA and STC (63). Nonetheless, in 
more recent genetic studies, STC was implicated to have a role in the DMSO 
reduction pathway and a minor role in the iron citrate reduction pathway, most 
likely acting as an electron carrier (66). STC was also shown by NMR to 
interact transiently with MtrA with a KD of 572 µM (64).   
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The crystal structures of STC from S. oneidensis MR-1 both at its oxidised 
and reduced form have been solved to a very high resolution of 0.97 Å (figure 
9) and 1.02 Å respectively (67). It has a protein fold of a series of α-helices 
that are connected with extended loops. Its four haems are bis-His ligated and 
are packed in pairs. The arrangement of the haems is highly conserved with 
the transport of electrons over long distances as the common function. The 
haems are closely aligned with the haems of the FccA.  
 
Figure 9: Crystal structure of STC at 0.97 Å resolution from Shewanella 
oneidensis. The polypeptide is shown in magenta, while the four haem groups 
are presented as green sticks. The image was produced with PyMOL (PDB: 
1M1Q). 
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1.3.4 Respiratory pathways involving extracellular electron 
transfer 
1.3.4.1 Reduction of metal oxides by the MtrCAB/OmcA complex 
One of the remarkable abilities of S. oneidensis, which is ubiquitous to the 
Shewanella genus, is the use of solid metals for growth. S. oneidensis reduces 
solid metals through extracellular electron transfer, which reaction is catalysed 
by the MtrCAB/OmcA complex in vivo. It must be noted that the minimal 
machinery for extracellular reduction of solid metals is the MtrCAB complex, 
which system has also been reconstituted in E. coli (68, 69). The proteins 
forming this outer-membrane complex are found at the gene cluster mtrDEF-
omcA-mtrCAB (70). MtrF, MtrD and MtrE are homologues of MtrC, MtrA and 
MtrB respectively and both complexes populate the outer-membrane. OmcA 
is a homologue of MtrC, which is a decahaem c-type cytochrome that forms 
the catalytic subunit of the complex. MtrB is a β-barrel integral outer-
membrane protein that is responsible for the localisation and stabilisation of 
the complex proteins at the outer-membrane.  MtrA is a periplasmic globular 
protein and is believed to be involved in electron relay from the inner-
membrane to the outer-membrane.  
The periplasmic globular protein MtrA is a decahaem c-type cytochrome of an 
approximate molecular mass of 40 kDa. Homology modelling suggests that it 
consists of two domains that are homologous to NrfB from E. coli (71). Such 
homology corroborates that MtrA is involved in electron relay, rather than it 
acts as a terminal reductase. Small-angle X-ray scattering was employed to 
provide structural insights of MtrA (72). It has been verified by analytical 
ultracentrifugation that MtrA exists in a monomeric state between 0.5 mg /ml 
and 4 mg /ml (72). The modelling of data derived from this study suggests a 
prolate ellipsoid shape of 10.4 nm in length and 5 nm in the widest cross-
sectional dimension (72). CymA spans about 4 nm from the inner membrane 
and the MtrA has a length of about 10 nm, which makes it possible to directly 
interact with CymA upon its association with the integral MtrB. Further 
evidence to support this hypothesis arrives from biochemical studies, where 
MtrA was shown to form a tight complex with MtrB (71). The periplasmic space 
is about 13 to 25 nm across (73, 74). However, there is not sufficient evidence 
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to conclusive describe this pathway. It is unclear how MtrA associates with 
MtrB and how deep inside the porin this association takes place. Thus, if MtrA 
does not act as a molecular wire spanning across the periplasmic space, it is 
more likely that STC may act as a molecular shuttle, or be part of the molecular 
wire. This hypothesis explains the implication of STC to iron reduction.  
Analysis of the predicted amino acid sequence revealed that MtrB 
(approximate molecular mass of 85 kDa) is similar to outer-membrane 
proteins such as OmpC (27% identical, 41% similar) from Salmonella 
typhimurium and AltE (21% identical, 53% similar) from Staphylococcus 
epidermidis (75). Briefly, OmpC is a non-specific general porin in E. coli and 
the crystal structure was solved with 2.0 Å resolution (76). It exists in a 
heterotrimeric form with a 16-standed hollow β-barrel fold. It has short 
connections at the periplasmic side and irregular loops at the extracellular 
side.    
Thus, MtrB is predicted to have a β-barrel structure embedded in the outer 
membrane, forming a pore of about 4 nm in diameter (71). Early studies 
analysing membrane fractions from wild-type and ΔmtrB mutant showed that 
MtrB is localised in the outer-membrane, where it is transported by the type-II 
sretion system (no MtrB was detected in mutants defective in type-II secretion 
system) (75, 77). This is further supported by a signal peptide found in the 
mtrB gene (75). Furthermore, MtrB does not contain any co-factors related to 
electron relay. MtrAB co-purified and showed a strong association, while the 
separation of the two proteins was not possible under non-denaturing 
conditions (71). Sedimentation equilibrium showed a stoichiometry of 1:1 
(MtrA: MtrB) and when MtrC was introduced it showed a stoichiometry of 1:1 
(MtrAB: MtrC) (71). The possible role of MtrB (i.e to stabilise the MtrCAB 
complex in the outer membrane), comes from analysis of the sedimentation 
equilibrium data: MtrC and MtrA associate with an equilibrium KD of 11 ± 4 
µM, where in the presence of MtrB (MtrAB + MtrC ↔ MtrCAB) the association 
was much stronger with a KD ≤ 0.1 µM (71).  
The decahaem c-type outer membrane-anchored cytochrome, MtrC, has an 
approximate molecular mass of 90 kDa. Structural information derives from 
the solved crystal structure of its homologue MtrF from S. oneidensis at 3.2 Å 
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resolution (78) (figure 10). MtrF is organised into four domains: domains II 
and IV house the haems, while domains I and III each consists of 7 anti-
parallel β-strands with an extended Greek-key topology. The overall fold of 
the protein is of a split β-barrel. The haems are arranged into a staggered 
cross structure, suggesting three pathways of electron relay, which explains 
the association and interaction of MtrC with the outer-membrane anchoring 
OmcA.  
 
Figure 10: Crystal structure of MtrF at 3.2 Å resolution from Shewanella 
oneidensis. A. The staggered cross arrangement of the haems, which 
suggests three possible pathways of electron relay: electron entry occurs at 
haem X, while the possible electron exit could occur through either haems II, 
VII, or V. B. The structure of MtrF is coloured by domain corresponding to the 
Latin numerals shown. The images were reproduced from (78). 
 
Based on the crystal structure of MtrF, a homology model of MtrC was 
generated and analysed (79) (figure 11). The MtrC homology model showed 
a highly similar structure of MtrC to that of MtrF. Co-immunoprecipitation and 
co-purification studies showed that two molecules of OmcA associate with one 
molecule of MtrC (80). OmcA is implicated in reducing solid minerals directly, 
as well as indirectly via the redox cycling of secreted riboflavins (80). 
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Figure 11: A homology model of MtrC of Shewanella oneidensis based on the 
structure of MtrF. The modelled structure of MtrC is coloured by domain 
corresponding to the Latin numerals shown. The figure is reproduced from (79). 
 
Further validation of the direct reduction of solid minerals comes from 
investigation of the cytochrome-hematite interface (using both whole cells and 
purified proteins) with atomic force microscopy, where it was shown that both 
OmcA and MtrC form a specific bond with hematite (81). The crystal structure 
of OmcA from S. oneidensis at 2.7 Å resolution has very recently been solved 
(82). By further investigation of the oligomeric state of OmcA with small-angle 
X-ray reflection, it was confirmed that OmcA exists as a dimer (82) (figure 
12), which explains the 2:1 OmcA: MtrCAB interaction and suggests that a 
dimer (rather than two individual molecules) binds the MtrCAB complex, 
through interactions with MtrC. The resolved OmcA structure (82) reveals that 
OmcA is organised into four domains: domains I and III form a Greek-key split 
β-barrel structure, domains II and IV houses 5 haems each. Domains I and III 
also have a disulphide bond. All haems exhibit bis-His axial ligation and, like 
MtrC, they are arranged as a staggered cross. The structure of the OmcA 
dimers in the crystal (82) suggests that the solvent-exposed haem 10 acts as 
the exit haem of electrons for the reduction of extracellular metals or small 
molecules. Interestingly, insertions and deletions of polypeptides were found 
when OmcA was aligned with MtrF and are responsible for changing the 
overall surface potential (82). Thus, it is proposed that interactions between 
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the partner proteins may be achieved by the neutralisation of the negatively 
charged propionate groups of the c-type haems (82).   
 
 
Figure 12: Crystal structure of OmcA homodimer at 2.7 Å resolution from 
Shewanella oneidensis. A. The OmcA homodimer structure coloured by 
domains: I in green, II in yellow, III in blue, and IV in red. B. The staggered cross 
haem arrangement. The figure is reproduced from (82).  
 
1.3.4.2 DMSO reduction by the DMSO reductase DmsAB 
S. oneidensis reduces DMSO through extracellular electron transfer, which 
reaction is catalysed by the outer-membrane DMSO reductase DmsAB: 
  𝐷𝑀𝑆𝑂 + 2 𝑒− + 2 𝐻+  
𝐷𝑚𝑠𝐴𝐵
→      𝐷𝑀𝑆 + 𝐻2𝑂  
 
 This is in contrast with E. coli and Rhodobacter spp. DMSO reductase 
system, which is located at the periplasm (83, 84). DmsAB consists of two 
subunits, a molybdenum containing DmsA and an iron-sulfur containing 
DmsB. DmsAB is encoded as part of the operon dmsEFABGH (85). DmsB 
was observed to be localised on the outer-membrane through the construction 
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of a DmsB construct bearing an epitope tag from human influenza type A 
virus, which was immunodetected and visualised on whole cells (85). The 
outer-membrane localisation was further verified by Western blot of cell 
fractions. Interestingly, similar levels of DmsB were observed in cells grown 
both anaerobically and aerobically. ΔdmsE mutant showed a decreased ability 
to grow on DMSO, while ΔdmsB abolished its ability to grow on DMSO (85). 
Thus, DmsE is proposed to act as a periplasmic electron shuttle, most 
probably from shuttling electrons from CymA to the outer-membrane complex. 
DmsF is an integral membrane protein, localising the outer-membrane that is 
responsible for anchoring DmsAB. Further analysis of the sequence of the 
genes, along with electrochemical interrogation of DmsE has shown that 
DmsE and MtrA share most properties. Thus, Bewley et al (86) suggest a 
functional relationship between DmsEFAB and MtrCAB.  
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1.4 Aim of this thesis 
This thesis and the work herein is focused on the study of CymA and the 
nature of its interaction with the periplasmic fumarate reductase FccA of S. 
oneidensis. The underlining basis of those studies is two-fold: firstly, to 
generate new approaches for the overexpression and purification of CymA in 
providing new tools in advancing the research field, and, secondly, to 
investigate the nature of FccA: CymA interaction. Currently, a controversy 
exists around this interaction. On the one hand, NMR data showed a transient 
nature of interaction between CymA and FccA with a KD of 0.4 mM (87), while, 
on the other hand, biophysical and electrochemical data led the authors to 
argue for the formation of stable long-lived FccA: CymA complex (88). This 
thesis directly addresses this controversy. Chapter 3 presents a re-
constructive vector and a new recombinant gene for the homologous 
overexpression for the production of CymA. Chapter 4 presents the 
heterologous expression for the production of CymAsol [Δ(1-31)-CymA (89): a 
recombinant form that lacks most of the transmembrane α-helix] and the first 
reported crystallisation attempt of CymAsol, which is instructive for the 
determination of its crystal structure in the future. Lastly, chapter 5 presents 
new evidence surrounding the FccA: CymA interaction, which they also 
address directly previously published observations as a contribution in 
resolving the controversy on whether they interact transiently or form a stable 
long-lived complex. Thus, this thesis central aim is to present evidence in 
arguing that the nature of FccA: CymA interaction is probably of a transient 
nature under our current knowledge of the system.   
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Chapter 2 – Materials & Methods 
2.1 Materials and Reagents 
All materials were used as purchased; a list of vendors for common chemicals 
that were used in this work is provided in appendix A. Milli-Q grade water with 
a resistance of 18 MΩ∙cm at 21 °C was used in the preparation of all solutions 
unless otherwise stated. Room temperature: 18 ± 3 °C. A PHM63 digital pH 
meter was used for measuring the pH of solutions, which was calibrated     
according to the manufacturer’s instructions immediately prior to any 
measurements. 
2.2 Bacterial strains, and plasmids  
The bacterial strains that were used in this work were as follows: 
• Shewanella oneidensis MR-1 
Genotype: Wild type.  
Source: kindly donated by Professor Julea Butt. 
• Escherichia coli OmniMAX2 
Genotype: F′ {proAB+ lacIq lacZΔM15 Tn10(TetR) Δ(ccdAB)} mcrA 
Δ(mrr-hsdRMS-mcrBC) φ80(lacZ)ΔM15 Δ(lacZYA-argF) U169 endA1 
recA1 supE44 thi-1 gyrA96 relA1 tonA panD. 
Source: kindly provided by Professor Lars Jeuken, but also 
commercially available by a variety of vendors, such as ThermoFisher 
Scientific (Cat. no.: C854003).   
• Escherichia coli BL21 (DE3) 
Genotype: E. coli str. B F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 
[lacI lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-12(λS). 
Source: kindly provided by Professor Lars Jeuken, but also 
commercially available by a variety of vendors, such as New England 
Biolabs (Cat. no.: C2527I). 
• Escherichia coli BL21 STAR™ (DE3)  
Genotype: F-ompT hsdSB (rB-, mB-) galdcmrne131 (DE3). 
Source: kindly donated by Dr Vincent Postis, but also commercially 
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available by a variety of vendors, such as ThermoFisher Scientific 
(Cat. no.: C601003). 
 
The plasmids that were used in this work were as follows: 
• pLS167 
A modified pBAD202/D-TOPO, by Invitrogen, vector encoding for 
CymA with C-terminal fusion of V5-epitope and a His6 tag.  
Source: kindly donated by Professor Julea Butt with permission from 
Dr Liang Shi.  
• pTH24-TEV-SH 
An expression vector encoding for TEV protease with C-terminal 
fusion of a V5-epitope and a His6 tag.  
Source: kindly donated by Dr Vincent Postis. 
• pRARE2 
A vector from Novagen that supplies tRNAs for seven rare codons 
(AUA, AGG, AGA, CUA, CCC, GGA, and CGG) for overcoming E. 
coli codon selection bias during heterologous protein expression. 
Source: kindly donated by Dr Vincent Postis. 
• pEC86 
A vector derived from pACYC184 encoding the ccmA-H gene 
cassette that expresses the System I c-type cytochrome assembly 
complex required for c-type haem maturation of co-expressed c-type 
cytochromes.  
Source: kindly donated by Professor Julea Butt. 
• pMKL1 
An expression vector for the heterologous expression of cytochromes 
encoding CymAsol with N-terminal fusion of His6 tag followed by 
maltose binding protein (MBP). A recognition site for TEV-specific 
proteolytic cleavage between the tags and the CymAsol is also 
present.  
Source: kindly donated by Professor Julea Butt with permission from 
Dr Liang Shi.   
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2.3 Growth media, and growth & expression conditions 
2.3.1 Growth media recipes 
• Lysogeny broth (LB) per 1 L: 10 g tryptone, 10 g NaCl, 5 g yeast 
extract. 
• Terrific broth (TB) per 0.9 L: 12 g tryptone, 24 g yeast extract, 4 ml 
glycerol. The medium was supplemented with 0.1 L of 0.17 M 
KH2PO4, 0.72 M K2HPO4 phosphate buffer.   
• 2xYT broth per 1 L: 16 g tryptone, 10 g yeast extract, 5 g NaCl. 
• Solid-phase medium: LB supplemented with 1.5% w/v agar. 
 
Stocks of kanamycin (in water), carbenicillin (in water), and chloramphenicol 
(in ethanol) were prepared at 50 mg/ml, 100 mg/ml, and 30 mg/ml 
respectively. The antibiotics, where indicated, were added to final 
concentrations of 50 µg/ml kanamycin, 100 µg/ml carbenicillin, and 30 µg/ml 
chloramphenicol unless otherwise stated. Antibiotic stocks were filter-
sterilized and stored at 4 °C for a maximum of 6 months.    
 
2.3.2 Growth media sterilisation 
Growth media were sterilised by autoclaving them at 121 °C for 20 min. 
Chemicals prone to degradation under autoclaving conditions (antibiotics, 
phosphate buffer, lactate, and fumarate) were sterilised by filtration with filter 
pore size of 0.22 µm prior to adding them to cooled sterile media using 
standard aseptic technique.   
 
2.3.3 Standard growth conditions 
The standard growth conditions that were used for growing bacteria for 
general purposes, such us for use in mini-preps, booster cultures, or for 
producing glycerol stocks were: 
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For Shewanella oneidensis MR-1 
Liquid cultures: 30 °C with orbital shaking at 200 rpm for 16 h. 
Solid-phase cultures: 30 °C for 24 h.  
 
For Escherichia coli strains  
Liquid cultures: 37 °C with orbital shaking at 250 rpm for 16 h.  
Solid-phase cultures: 37 °C for 16 h. 
 
2.3.4 Expression conditions of CymA† in Shewanella oneidensis 
MR-1/ pTL01 
The expression conditions for overexpressing CymA† were based on 
previously published work (1, 35).  
S. oneidensis MR-1/pTL01 was grown on solid-phase medium supplemented 
with kanamycin under standard growth conditions. A single colony was then 
used to inoculate 10 ml of LB medium containing kanamycin for small-scale 
growth under standard conditions. Subsequently, 3% v/v inoculum from the 
LB culture was used to inoculate 100 ml of 2xYT medium containing 
kanamycin for medium-scale growth under standard conditions. For 
expression, the TB cultures (1 L of medium per 2.5 L Erlenmeyer flask) 
containing kanamycin were inoculated with 3% v/v inoculum from the 2xYT 
cultures and were incubated under standard conditions until they reached mid-
exponential phase (cell density OD600 ~ 0.7 AU). Subsequently, the cells were 
induced with L-arabinose at final concentration of 1 mM and the orbital 
shaking speed was reduced to 180 rpm in order to further promote 
microaerobic conditions. The expression of CymA† was allowed to proceed 
for 18 h before harvesting the cells by centrifugation.         
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2.3.5 Expression conditions of FccA in Shewanella oneidensis 
MR-1 
The expression conditions for overexpressing native FccA were based on 
previously published work (90).  
S. oneidensis MR-1 (wild type) was grown on solid-phase medium under 
standard growth conditions. A single colony was then used to inoculate 50 ml 
of LB medium, which was incubated under standard growth conditions. 
Subsequently, 5 L Duran bottle containing LB supplemented with 25 mM 
neutralized fumarate and 50 mM DL-lactate, which was pre-equilibrated at 30 
°C  for 24 h, was inoculated with 0.5% v/v inoculum from the LB cultures. The 
cells were grown with no agitation (nearly anaerobically in order to induce the 
expression of FccA) at 30 °C for 24 h before they were harvested by 
centrifugation.      
 
2.3.6 Expression conditions of {His6-Maltose Binding Protein 
(MBP)-TEV cleavage site-CymAsol} in Escherichia coli 
BL21(DE3)/ pEC86/ pMKL1 
The expression conditions for overexpressing {His6-MBP-TEV cleavage site-
CymAsol} were modelled on previously published work (89).  
E. coli BL21(DE3)/pEC86/pMKL1 was grown on solid-phase medium that was 
supplemented with carbenicillin and chloramphenicol under standard growth 
conditions. A single colony was then used to inoculate 10 ml of LB medium 
supplemented with carbenicillin and chloramphenicol for small-scale growth 
under standard conditions. Subsequently, 3% v/v inoculum from the LB culture 
was used to inoculate 100 ml of 2xYT medium containing carbenicillin and 
chloramphenicol for medium-scale growth at 30 °C with orbital shaking at 200 
rpm for 16 h. The expression TB cultures (1 L of medium per 2.5 L Erlenmeyer 
flask) containing carbenicillin and chloramphenicol were inoculated with 3% 
v/v inoculum from the 2xYT cultures and were incubated at 30 °C with orbital 
shaking at 200 rpm until they reached the mid-exponential phase (cell density 
OD600 ~ 0.7 AU). Subsequently, the cells were induced with isopropyl β-D-1-
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thiogalactopyranoside (IPTG) at final concentration of 50 µM. The expression 
was allowed to proceed for 16 h before harvesting the cells by centrifugation.        
 
2.3.7 Expression conditions of recombinant TEV in Escherichia 
coli BL21 STAR™ (DE3)/ pRARE2/ pTH24-TEV-SH 
The expression conditions for overexpressing recombinant TEV were in 
accordance to a kindly provided protocol by Dr Vincent Postis.  
E. coli BL21 STAR™ (DE3)/pRARE2/pTH24-TEV-SH cells were grown on 
solid-phase medium supplemented with carbenicillin and chloramphenicol 
under standard conditions. A single colony was used to provide the inoculum 
for the expression culture in LB supplemented with carbenicillin and 
chloramphenicol, which was grown under standard conditions. A 30 L 
fermenter with TB medium containing carbenicillin and chloramphenicol was 
inoculated with 1% v/v inoculum. The OD600 was ~ 0.05 AU at the time of 
inoculation. The culture was incubated at 20 °C with agitation until the OD600 
reached ~ 0.6 AU, before expression was induced with IPTG at final 
concentration of 0.1 mM. The expression was allowed to proceed for 20 h 
before the cells were harvested by centrifugation. The 30 L fermenter culture 
was prepared by David Sharples operating a Fermenter Bioflow3000 by 
Newbrunswick.    
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2.4 Molecular Biology Methods 
2.4.1 Plasmid purification (mini-prep) 
Routinely, bacterial cells harbouring the target plasmid(s) for purification were 
grown in LB cultures supplemented with the necessary antibiotics under 
standard conditions. Plasmid purification was conducted using the 
ChargeSwitch® Pro Filter Plasmid Miniprep Kit (Invitrogen), following the 
provided protocol, from 4 ml of bacterial culture. Purified plasmids were stored 
at 4 °C for use within a week, or at -20 °C for long-term storage.    
  
2.4.2 DNA quantification 
DNA quantification was performed spectrophotometrically using a Shimadzu 
UV-2450 UV-VIS spectrophotometer and a quartz-crystal cuvette with 0.1 cm 
path-length. The DNA sample was diluted 50-fold with water before 
absorbance values were measured at 260 nm and 280 nm. The value that 
was used for quantification was 50 µg/ml of dsDNA = 1.0 AU absorbance at 
260 nm for a cuvette with 0.1 cm path-length. The ratio A260/A280 was used as 
a measure of sample purity and samples that exhibited purity ratio between 
1.6 and 2.0 were used in subsequent experiments.   
Quantification of DNA fragments purified from agarose gels was performed 
using the ND-1000 Nanodrop™ micro-spectrophotometer (ThermoFisher 
Scientific). 
    
2.4.3 Digestion of plasmids with NcoI and HindIII restriction 
enzymes 
Digestion of pUC57 or pLS167 plasmids was performed in thin-wall PCR 
tubes with high-fidelity restriction enzymes NcoI-HF® (20,000 units/ml by New 
England Biolabs) and HindIII-HF® (20,000 units/ml by New England Biolabs). 
The buffer that was used was NEBuffer 4 (cat. No.: B7004S) from New 
England Biolabs. Approximately 2 µg of plasmid DNA and 40 units of each 
restriction enzyme were used in a 50 µl total reaction volume. 
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The tubes were incubated at 37 °C for 3 h in a DNA Engine Dyad® peltier 
thermal cycler (Bio-Rad).  
 
2.4.4 Separation of DNA fragments by agarose gel 
electrophoresis 
Agarose gel was prepared in tris acetic acid EDTA (TAE) buffer, which 
consisted, at final concentration, of 40 mM Tris pH 8.3, 20 mM acetic acid, 
and 1 mM EDTA.  
Agarose was added to 1-2 % w/v and the suspension was heated in a 
microwave until all of the agarose was fully dissolved (approximately 1.5 min 
at maximum power in a 900W microwave). Subsequently, the solution was 
cooled under running tap water before 2 µl of SYBR® safe DNA gel stain was 
added (per 30 ml of solution) and mixed by gentle swirling. The solution was 
poured into a gel cassette with an attached comb of an Embi Tec RunOne™ 
electrophoresis cell and was left to set at room temperature for approximately 
20 min. 
Concentrated (6-fold) MassRuler™ DNA loading dye was added to all DNA 
samples prior to loading them onto the agarose gel. Fermentas MassRuler™ 
DNA ladder mix (5 µl) was loaded alongside the DNA samples onto the 
agarose gel. The agarose gel was run at constant voltage of 100 V until the 
DNA loading dye line had migrated approximately ¾ of the way down the gel.      
 
2.4.5 Purification of DNA fragments from agarose gels 
DNA fragments were separated by agarose gel electrophoresis and the bands 
of interest were carefully excised from the gel using a scalpel-blade while 
visualising the DNA bands with Invitrogen Safe Imager™. The DNA fragments 
were purified using Wizard® SV Gel and PCR clean-up System (Promega) by 
following the supplied protocol.  
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2.4.6 Ligation of DNA fragments  
Ligation reactions that contained 50 ng of linearized vector and sufficient insert 
to give a molar ratio of 3:1, 5:1, and 6:1 (insert to vector) were performed in 
thin-wall PCR tubes. 2,000 units of T4 DNA ligase (2,000,000 units/ml from 
New England Biolabs) and the supplied 10xT4 DNA ligase reaction buffer 
(New England Biolabs) was used in a total reaction volume of 25 µl.  
The tubes were incubated at 21 °C for 16 h in a DNA Engine Dyad® peltier 
thermal cycler (Bio-Rad). The temperature was then lowered to 4 °C and the 
samples were used to transform E. coli OmniMAX2 cells within 1hr.   
  
2.4.7 Preparation of competent bacterial cells for transformation 
2.4.7.1 Electro-competent Shewanella oneidensis MR-1  
S. oneidensis MR-1 was grown on solid-phase LB medium under standard 
conditions, from which a single colony was used to inoculate 10 ml LB medium 
that was grown under standard conditions. Subsequently, 100 ml LB medium 
(in 250 ml Erlenmeyer flask) was inoculated with 2% v/v inoculum from the 10 
ml LB culture and was grown at 30 °C with orbital shaking at 200 rpm until the 
cell density reached OD600 ~ 0.4 AU. The cells were pelleted by centrifugation 
at 3,220 g for 15 min at 4 °C. The supernatant was discarded and the cells 
were resuspended in 16.5 ml of ice-cold filter-sterilized 1 M sorbitol (per cell 
pellet from 50 ml of culture). The cells were pelleted by centrifugation as 
before. The supernatant was discarded and the cells were resuspended in 2 
ml of ice-cold filter-sterilized 1 M sorbitol (per cell pellet from 50 ml of culture). 
The resulting electro-competent cells were used within 15 min, as they do not 
remain viable any longer. The cells were kept on ice at all times.  
       
2.4.7.2 Chemically competent Escherichia coli strains  
E. coli strains were grown on solid-phase LB medium under standard 
conditions, from which a single colony was used to inoculate 10 ml LB medium 
that was grown under standard conditions. Subsequently, 100 ml LB medium 
(in 250 ml Erlenmeyer flask) was inoculated with 2% v/v inoculum from the 10 
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ml LB culture and was grown at 30 °C with orbital shaking at 200 rpm until the 
cell density reached OD600 ~ 0.5 AU. The cell culture was then incubated on 
ice for 10 min before the cells were pelleted by centrifugation at 3,220 g for 15 
min at 4 °C. The supernatant was discarded and the cells were resuspended 
in 10 ml of ice-cold filter-sterilized 50 mM Ca2Cl (per cell pellet from 50 ml of 
culture). The suspension was incubated on ice for 15 min before the cells were 
pelleted by centrifugation as before. The supernatant was discarded and the 
cells were resuspended in 1 ml of ice-cold filter-sterilized 100 mM Ca2Cl, 15% 
v/v glycerol (per cell pellet from 50 ml of culture). The cells were aliquoted into 
50 µl aliquots (working on ice), flash-frozen in liquid nitrogen, and stored at  
-80 °C.   
 
2.4.8 Transformation of competent bacterial cells 
2.4.8.1 Transformation of Shewanella oneidensis MR-1 by 
electroporation 
The transformation of S. oneidensis MR-1 by electroporation was based on 
previously described work (91). Electro-competent S. oneidensis MR-1 cells 
were placed on pre-cooled electroporation Bio-Rad Gene Pulser® cuvettes 
(390 µl cells for 0.2 cm gap cuvettes, or 50 µl cells for 0.1 cm gap cuvettes). 
Plasmid DNA in the range of 0.1 µg to 0.5 µg was also added to the cuvettes. 
It must be noted that no equilibration is necessary for electroporation. The 
cuvettes were then transferred from ice to Micropulser™ Electroporation 
Apparatus (Bio-Rad) and a single pulse of 1.10 kV or 0.55 kV  was delivered 
for 0.2 cm or 0.1 cm gap cuvettes respectively. Care was taken to remove 
water condensation from the cuvettes by gently wiping the exterior of the 
electrodes with tissue-paper before pulse-delivery. Subsequently, the cells 
were transferred to a sterile Eppendorf tube and 800 µl or 300 µl of pre-
warmed at 30 °C LB medium was added for 0.2 cm or 0.1 cm gap cuvettes 
respectively. The cells were allowed to recover by incubation at 30 °C for  
1.5 h to 2 h with intermittent mixing by inversion. The cells were, lastly, plated 
on selective solid-phase LB medium supplemented with 30 µg/ml kanamycin 
and were incubated at 30 °C for 48 h.  
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Cell colonies from the selective plates were used to inoculate solid-phase LB 
medium supplemented with kanamycin (50 µg/ml) and were further incubated 
at 30 °C for 48 h. Cell colonies were used to inoculate 10 ml LB medium 
supplemented with kanamycin (50 µg/ml) and were grown under standard 
conditions. Cultures that exhibited good growth were used for mini-prep for 
plasmid analysis by Sanger sequencing, as well as for making glycerol stocks. 
        
2.4.8.2 Transformation of Escherichia coli strains by heat shock 
Chemically competent E. coli strains pre-aliquoted into 50 µl aliquots were 
thawed on ice. Sufficient DNA was added and the suspension was incubated 
on ice for 30 min. Subsequently, a heat-shock was delivered by incubation at 
42 °C for 60 – 120 s, before incubation on ice for 5 min. Then, 300 µl of pre-
warmed at 37 °C LB medium was added in each tube. The cells were allowed 
to recover by incubation at 37 °C for 45 min to 1 hr with intermittent mixing by 
inversion. The cells were lastly plated on selective solid-phase LB medium 
supplemented with the appropriate antibiotic(s) and were incubated at 37 °C 
for 16 h in order to allow selection of the transformed bacterial cells.       
 
2.4.9 Sanger sequencing of plasmids  
DNA sequencing of pBAD202/D-TOPO type of plasmids (pLS167 and pTL01-
pTL04) was performed with the Sanger method using PBAD forward (5’-ATG 
CCA TAG CAT TTT TAT CC-3’), or PBAD reverse primers (5’-GAT TTA ATC 
TGT ATC AGG-3’) by ©Source BioScience. The DNA concentration for 
samples submitted for Sanger sequencing was 100 ng/µl.  
Bases were called by ABI Basecaller by © Source BioScience and no further 
processing of the chromatograms was conducted. The Phred quality score for 
all sequencing results was 30. That is, 1 in 1,000 probability of incorrect base 
calling, or 99.9% base call accuracy.   
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2.4.10 Preparation of glycerol stocks of bacterial cultures 
Bacterial cultures that had been grown under standard conditions were used 
for preparing glycerol stocks. Cryovials (2.5 ml) containing 500 µl of 50% v/v 
glycerol were sterilized by autoclaving them at 121 °C for 20 min. A volume of 
500 µl of bacterial cell culture was added in a sterile cryovial (containing 50% 
v/v glycerol) using standard aseptic technique. The suspension was mixed by 
inversion, flash-frozen with liquid nitrogen, and stored at -80 °C.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 40 - 
2.5 Biochemical Methods 
2.5.1 UV-visible absorbance spectroscopy 
Spectroscopic experiments were performed at ambient conditions using a 
Shimadzu UV-2450 UV-VIS spectrophotometer and a quartz-crystal cuvette 
with 0.1 cm path-length unless otherwise stated. Spectra of reduced protein 
samples were obtained by addition of excess of sodium dithionite to the 
quartz-crystal cuvette and mixing by inversion immediately before 
measurements. Sodium dithionite powder was dissolved in degassed buffer 
and used immediately.   
 
2.5.2 Sodium-dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) 
SDS-PAGE was performed on hand-casted mini gels with 1.0 mm thickness 
using a Bio-Rad Mini-PROTEAN® cell casting apparatus.  
The recipe for resolving and stacking gel solutions is shown in table 1. 
Table 1: Recipe of resolving and stacking solutions for the preparation of two 
mini-gels.  
Components 12.5% Resolving 15% Resolving 6% Stacking 
10% w/v SDS 0.1 ml 0.1 ml 50 µl 
40% w/v Acrylamide 3.475 ml 4.22 ml 0.77 ml 
2% w/v bis-acrylamide 0.45 ml 0.49 ml 0.39 ml 
0.5 M Tris-HCl,  
pH 6.8 
- - 0.75 ml 
1.5 M Tris-HCl,  
pH 8.8 
2.81 ml 2.81 ml - 
water 4.267 ml 3.48 ml 3.2 ml 
10% w/v Ammonium 
persulphate  
37 µl 37 µl 30 µl 
TEMED 24 µl 24 µl 9 µl 
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Tetramethylethylenediamine (TEMED) was added last and immediately prior 
to pouring each gel. The resolving gel was poured first. A layer of isopropanol 
was carefully poured on top of it and it was allowed to set for approximately 
20 min at room temperature. Once the gel was set, the isopropanol layer was 
removed before the stacking gel was poured on top of the resolving gel. A Bio-
Rad Mini-PROTEAN® 10-well 1.0 thickness comb was placed and the gel was 
allowed to set for approximately 20 min at room temperature.    
The mini-gels were run in a Bio-Rad Mini-PROTEAN® Tetra Vertical 
Electrophoresis Cell at room temperature in running buffer. Typically, two or 
four mini-gels were run until the dye reached the end of the mini gel at constant 
current of 40 mA or 60 mA respectively using a Bio-Rad PowerPac™ Basic 
Power Supply. The running buffer consisted, at final concentration, of 25 mM 
Tris-HCl pH 8.6, 192 mM glycine, and 0.1% w/v SDS.  
 
2.5.3 Treatment of samples for SDS-PAGE analysis 
Samples for SDS-PAGE analysis were mixed with denaturing loading buffer, 
briefly vortexed, and incubated at either (a) 90 °C for ~ 15 min, or (b) 37 °C 
for between 1 to 2 h. Usually, condition a was used for globular proteins, while 
condition b was used for membrane proteins. Samples containing whole cells 
were treated using condition a and briefly centrifuged at 13,000 g.  
The loading buffer consisted, at final concentration, of 50 mM Tris-HCl pH 6.8, 
20% w/v glycerol, 2% w/v SDS, 2% v/v β-mercaptoethanol, and 0.01% w/v 
bromophenol blue. 
The loading buffer of samples for mini-gels that were to be subjected to the 
haem staining procedure consisted, at final concentration, of 6 M urea, 5% 
w/v SDS, 0.1 % w/v glycerol, and 0.05% w/v bromophenol blue. This allows 
the elimination of the reducing agent β-mercaptoethanol that prohibits the 
oxidation of the chromogenic reagent tetramethylbenzidine (TMBZ) during the 
haem staining procedure (described in section 2.5.5 SDS-PAGE mini-gel 
staining with Haem staining).   
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2.5.4 SDS-PAGE mini-gel staining with Coomassie stain 
Visualisation of proteins resolved by SDS-PAGE on a mini-gel was performed 
by Coomassie stain (92). The mini-gel was incubated in Coomassie stain for 
16 h with gentle orbital shaking at room temperature. Subsequently, the mini-
gel was de-stained until background staining was removed by several (usually 
three) 30 min washes in de-staining solution with gentle orbital shaking at 
room temperature. 
The Coomassie staining solution consisted, at final concentration, of 1.21 mM 
Coomassie brilliant blue R-250, 50% v/v methanol, and 10% v/v acetic acid. 
For preparing the Coomassie staining solution, the components were mixed 
and were stirred at room temperature for 4 h before being filtered with 
standard coffee filter paper. The de-staining solution consisted, at final 
concentration, of 40% v/v methanol, and 10% v/v acetic acid. Both the 
Coomassie staining and de-staining solutions were stored at room 
temperature. 
Alternatively, the mini-gels were stained by incubation in Expedeon 
InstantBlue™ protein stain for 15 min with gentle orbital shaking at room 
temperature (a de-staining step was not required).  
    
2.5.5 SDS-PAGE mini-gel staining with Haem staining 
Visualisation of c-type cytochromes was performed by haem staining of SDS-
PAGE mini-gel that utilizes the haem-associated peroxidase activity to the 
oxidation of the chromogenic reagent TMBZ that turns blue when it is oxidised. 
This haem staining procedure of electrophoretically resolved cytochromes are 
particular specific for c-type cytochromes since c-type haems are covalently 
bound to the polypeptide. In contrast, b-type haems are not covalently bound 
to the polypeptide and may dissociate from the protein under denaturing 
conditions, allowing them to migrate out of the gel during electrophoresis. 
This procedure was based on previously described work (93). The mini-gel 
was incubated in 80 ml of 0.25 M sodium acetate pH 5.0 for at least 20 min at 
room temperature with gentle orbital shaking in a container that was covered 
with aluminium foil in order to prevent light degradation of the light sensitive 
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TMBZ. Subsequently, a TMBZ solution was prepared by dissolving 40 mg of 
TMBZ in 40 ml methanol and was added to the sodium acetate solution 
containing the pre-equilibrated mini-gel. The mini-gel was further incubated 
for 14 min at room temperature with gentle orbital shaking. Lastly, 400 µl of ≥ 
30% hydrogen peroxide was added to the main solution and was incubated 
for 16 h at room temperature with gentle orbital shaking. 
      
2.5.6 Western blot 
Samples for immunodetection analysis were prepared as described in section 
2.5.3 treatment of samples for SDS-PAGE analysis and the proteins were 
electrophoretically resolved as described in section 2.5.2 sodium-dodecyl 
sulphate polyacrylamide gel electrophoresis. 
Subsequently, the mini-gel was incubated in transfer buffer (47.8 mM Tris-HCl 
pH 8.3, 38.6 mM glycine, 20% v/v methanol) for 15 min at room temperature 
with gentle orbital shaking. The gel was then subjected to semi-dry electro-
transfer of proteins from the mini-gel onto a Bio-Rad nitrocellulose membrane 
with 0.45 µm pore size using a Millipore MilliBlot Graphite Electroblotter II. The 
electrode assembly for protein electro-transfer was from bottom (positive 
electrode) to top (negative electrode): 2x Whatman® gel blotting paper, 
nitrocellulose membrane, mini-gel, 2x Whatman® gel blotting paper. All of the 
components were soaked in transfer buffer immediately before being 
assembled. Electro-transfer was conducted at room temperature under 
constant current at 150 mA for 42 min (for one mini-gel) or for 61 min (for two 
mini-gels) using a Bio-Rad PowerPac™ Basic Power Supply.  
Alternatively, electro-transfer of resolved proteins from a mini-gel onto a 
nitrocellulose membrane was performed with the Bio-Rad Trans-Blot® 
Turbo™ RTA Mini Nitrocellulose Transfer kit, following the provided protocol, 
and operating a Bio-Rad Trans-Blot® Turbo™ Transfer System, according to 
the manufacturer’s instructions.    
The nitrocellulose membrane was then blocked with blocking buffer, 3% w/v 
bovine serum albumin (BSA) in TBST, for 16 h at room temperature with roller-
mixing. TBST buffer consisted, at final concentration, of 25 mM Tris-HCl pH 
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7.5, 150 mM NaCl, and 1% v/v Tween®20.  Subsequently, the membrane was 
incubated with the primary antibody for 1.5 h at room temperature with roller-
mixing before being washed with TBST buffer 4x 20 min under the same 
conditions. The membrane was then further incubated with the secondary 
antibody (when necessary) for a further of 1.5 h before being washed with 
TBST buffer 4x 20 min under the same conditions. 
The membrane was developed with the application of Pierce™ 1-Step NBT-
BCIP chromogenic reagent for alkaline phosphatase (AP) probes using the 
manufacturer’s instructions that were provided with the product.  
The antibodies that were used for Western blotting were as follows: 
1. Anti-6X His tag® antibody [HIS-1] (alkaline phosphatase) ab49746 
purchased from abcam®. This is a monoclonal antibody with clone 
number HIS-1 and IgG2a isotype, provided at 1.8 mg ml-1. This 
antibody was used at 1:5,000 in TBST buffer containing 3% w/v BSA.   
2. Goat Anti-Rabbit IgG H&L (alkaline phosphatase) ab97048 purchased 
from abcam®. This is a polyclonal antibody with IgG isotype, provided 
at 1.0 mg ml-1. This antibody was used at 3:20,000 in TBST buffer 
containing 3% w/v BSA.  
3. Rabbit Anti-CymA2 kindly donated by Professor Julea Butt. This is a 
monoclonal antibody against a CymA epitope 
(NEVLASAHGGGKAGC), provided at 1.88 mg ml-1. This antibody was 
used at final concentration of 0.6 µg/ml in TBST buffer containing 3% 
w/v BSA.   
 
2.5.7 Protein quantification 
The quantification of total protein of solutions was performed with the micro 
bicinchoninic acid (µBCA) assay in a 96-well plate. BSA was used for 
producing a calibration curve in triplicate with a range from 0 to 1 µg µl-1. A 
calibration curve was derived from BSA standards for each 96-well plate; a 
typical calibration curve is shown in figure 13. The sample volume was 10 µl, 
while the total reaction volume was 210 µl. The samples of unknown 
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concentration were diluted 2- and 10-fold in order to avoid extrapolation. Each 
unknown sample was performed in triplicate.   
Pierce™ BCA Protein Assay Reagent A was mixed with 4% w/v Copper 
sulphate at 50:1 ratio respectively to yield the final reagent solution. A volume 
of 200 µl of the final reagent solution was added to each well containing 10 µl 
of sample. Subsequently, the plate was incubated at 37 °C for 30 min. The 
plate was then transferred to room temperature and was left to cool down for 
5 min before absorbance readings at 551 nm were taken with Multiskan™ FC 
Microplate Photometer (ThermoFisher Scientific).    
 
 
Figure 13: A typical BCA calibration curve using BSA standards. Triplicate 
samples of known BSA concentration plotted against their measured 551 nm 
absorbance values. The line of best fit (in red) was computed by linear fitting of 
the points and was used for the interpolation of the values of the samples of 
unknown protein concentration.  
 
Purified recombinant forms of CymA and purified native form of FccA protein 
samples were quantified spectrophotometrically from their obtained spectra 
using the Beer-Lambert law: 
𝐴𝑏𝑠𝜆1 = 𝜀𝜆1  ∙ 𝐶 ∙  𝑙   (1) 
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where 𝐴𝑏𝑠𝜆1 and  𝜀𝜆1 are the absorbance and extinction coefficient 
respectively at wavelength λ1, 𝐶 is the concentration, and 𝑙 is the cuvette path 
length .The extinction coefficient values that were used for CymA and FccA 
were 𝜀407 𝑛𝑚
𝐶𝑦𝑚𝐴 = 380 ± 38 𝑚𝑀−1 𝑐𝑚−1 (1) and 𝜀410 𝑛𝑚
𝐹𝑐𝑐𝐴 = 728.4 𝑚𝑀−1 𝑐𝑚−1 (57) 
respectively. 
 
2.5.8 Protein crystallisation screens 
Protein crystallisation screens were performed in 96-well 3-drop plates with 
30 µl reservoir crystallisation solution and with purified CymAsol at 1 mg ml-1. 
Crystallisation solutions were added manually to reservoir of each well. Drops 
1, 2, and 3 contained 1:1, 1:2, and 2:1 ratios of protein to crystallisation 
solution respectively, and were mixed and dispensed automatically by 
Formulatrix NT8 automated nanolitre volume liquid handler operated by 
Formulatrix 2.0 Rock Maker software. The plates were sealed with clear 
polystyrene standard lid and were deposited in the Formulatrix Rock Imager 
1000, where the plates were incubated at room temperature and automatically 
imaged according to a user-defined imaging schedule. Optical imaging of the 
individual drops were performed at: time of plate deposition (0 d 0 hr), 0 d 12 
h, 1 d 12 h, 2 d 12 h, 3 d 12 h, 5 d 12 h, 8 d 12 h, 13 d 12 h, 21 d 12 h, and 
34 d 12 h. Ultraviolet two-photon excited fluorescence (UV-TPEF) and 
second-harmonic generation (SHG) imaging of the individual drops were 
performed at: 5 d 12 h, 13 d 12 h, 21 d 12 h, and 34 d 12 h.  
The commercially available screens that were performed (seven in total) are 
as follows: 
1. JCSG Core I, II, III, and IV Suites (Qiagen) 
2. PACT Suite (Qiagen) 
3. MemGold2™ (Molecular Dimensions) 
4. Morpheus® (Molecular Dimensions) 
This allowed the screening of 672 different solution compositions for 
crystallizing CymAsol at room temperature and at three different protein to 
solution ratios for each. Thus, the total number of different conditions that were 
assayed was 2,016.   
- 47 - 
2.5.9 Handling of lipids and preparation of lipid mixtures 
Lipids were purchased from Avanti® Polar Lipids Limited as chloroform 
solutions in glass ampoules. The provided lipid concentration, which was 
typically within 10% error, was used for calculations. The glass ampoules were 
stored at -20 °C for long-term storage. Working aliquots of 5 mg lipids were 
prepared in glass vials; the chloroform was evaporated under a current stream 
of nitrogen gas and the vials were placed in a vacuum desiccator for at least 
4 h to ensure complete removal of residual chloroform. The vials, containing 
5 mg of dry lipids, were stored under nitrogen gas in a sealed glass round 
flask at -20 °C. 
Lipid mixtures were prepared by dissolving the lipids in 1:1 methanol: 
chloroform solution. Quinones were dissolved in chloroform and working stock 
solutions were stored in glass vials at -20 °C. Appropriate volumes of each 
required lipid and/or quinones were mixed into a glass vial. Subsequently, the 
organic solvents were evaporated under a current stream of nitrogen gas and 
then the vials were placed in a vacuum desiccator for at least 4 h to remove 
residual organic solvents. The vials, containing dry lipid mixtures with/without 
quinones, were stored under nitrogen gas in a sealed glass round flask at -20 
°C.  
         
2.5.10 Preparation of homogeneous solutions of liposomes 
Aliquots of lipids or lipid mixtures (5 mg) were used in the preparation of 
homogenous solutions of liposomes. The dry lipids were hydrated with the 
addition of buffer (typically: 20 mM MOPS pH 7.4, 30 mM Na2SO4) and vortex-
mixed to ensure complete suspension of the dry lipids. At this stage, the 
solution of liposomes is highly heterogeneous. In order to homogenise the 
formed liposomes, the solution was extruded 11 times through a 200 nm pore 
size (unless otherwise stated) Whatman® Nuclepore™ track-etched 
membrane using an Avanti® mini extruder. The resulted solutions of liposomes 
was considered to be homogenous and was used on the day of preparation.  
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2.5.11 Reconstitution of CymA† into liposomes 
CymA† proteoliposomes were prepared by the octyl-glycoside (OG) rapid 
dilution method, as described previously (88, 94). An aliquot of the desired 
lipids or lipid mixtures (5 mg) was hydrated and resuspended in 20 mM MOPS 
pH 7.4, 30 mM Na2SO4 buffer to a concentration of 9 mg ml-1 by vortex-mixing. 
Subsequently, 250 mM OG stock solution (prepared in the same buffer) was 
added to the liposome solution, which was pipette mixed in order to dissolve 
the liposomes. The concentration of OG at this step was 55 mM. CymA† was 
then added at 1%, 1.5%, or 2% w/w (protein: lipid). The concentration of OG 
at this step was around 51 mM. The mixture was then incubated for 15 min on 
ice. Subsequently, ice-cold buffer was rapidly added to the mixture providing 
rapid dilution of approximately 140-fold. The formed proteoliposomes were 
pelleted by ultra-centrifugation at 131,000 g for 60 min at 4 °C. The pellet was 
resuspended in buffer at concentration of 5 mg ml-1 (assuming no lipid loses). 
The resuspended proteoliposomes were homogenised by extruding the 
solution 11 times through a 200 nm pore size Whatman® Nuclepore™ track-
etched membrane using an Avanti® mini extruder. At this stage, each CymA† 
reconstitution was spectrophotometrically assayed for the incorporation of 
CymA†. UV-visible absorbance spectra were taken where, in a successful 
protein reconstitution, the Soret γ-band (at wavelengths 407 nm → 419 nm, 
which corresponds to CymA) can be observed; a representative example is 
shown in figure 14. The proteoliposome solution was used on the day of 
preparation.  
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Figure 14: Representative UV-visible absorbance spectra of oxidized and 
reduced CymA†-proteoliposomes. The presence of the Soret γ-band at 
CymA-specific wavelengths of 407 nm and 419 nm for oxidized and reduced 
CymA respectively as an indication for the incorporation of CymA† into 
liposomes. The slope is due to light scattering by the proteoliposomes.  
   
2.5.12 Methyl-viologen spectrophotometric assay for fumarate 
reductase activity 
Fumarate reductase activity was assayed in various samples during the FccA 
purification by coupling the reduction of fumarate by FccA to the oxidation of 
reduced methyl-viologen. The protocol that was followed was according to the 
published literature with modifications (90).  
Final concentration of 0.5 mM methyl-viologen in buffer (20 mM HEPES pH 
7.0, 100 mM NaCl) containing 1 mM fumarate was first reduced in situ to an 
absorbance at 600 nm of approximately between 1.5 and 2.0 AU by the 
addition of 1 M sodium dithionite. Methyl-viologen exhibits strong absorbance 
at 600 nm at its reduced form, while no significant absorbance occurs at its 
oxidised form. The absorbance at 600 nm was then measured over time at 4 
°C while the sample was introduced.  
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All solutions that were used for this assay were degassed by adequate purging 
with nitrogen gas and all experiments were conducted under anoxic 
conditions. It must be noted that this assay was performed qualitatively during 
only the first purification preparation (for optimisation reasons) in order to 
monitor the presence of FccA during the various purifications steps. 
Representative traces are shown in figure 15 detailing what was assigned as 
positive or negative result for FccA-specific fumarate reduction, while table 2 
lists the results of the samples that were assayed.  
 
Table 2: Fumarate reductase activity was qualitatively determined for various 
samples from the initial FccA purification. Figure 3 illustrates representative 
traces of a positive and a negative result. *some FccA loses during this step.        
Sample Activity result 
Isolated periplasmic fraction Positive 
Flow-through (IEC) Negative 
Wash (IEC) Negative 
High-salt fractionation (supernatant) Positive 
High-salt fractionation (pellet) Positive* 
Flow-through (ultrafiltration) Negative 
Wash 1 (ultrafiltration) Negative 
Wash 2 (ultrafiltration) Negative 
Wash 3 (ultrafiltration) Negative 
Wash 4 (ultrafiltration) Negative 
Purified FccA Positive 
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Figure 15: Representative traces of methyl-viologen fumarate reductase 
activity assay as a qualitative test for the presence of FccA.  Gaps in the 
recordings are due to the removal of the cuvette for the addition of solutions. 
Changes in the background absorbance values were attributed to displacing 
the cuvette and/or due to dilution effect. A: Representative trace of a sample 
with negligent fumarate reductase activity. Samples that exhibited similar 
activity traces were classed as a negative result for activity. B: Representative 
trace of a sample with clear fumarate reductase activity. Samples that exhibited 
similar activity traces were classed as a positive result for activity. C: This is a 
control trace, where FccA was added without the presence of its substrate, 
fumarate, in order to assay for background reactions.   
 
2.5.13 Diaphorase spectrophotometric activity assay  
The diaphorase spectrophotometric activity assay (detailed in section 5.2.2 
CymA† is able to interact with FccA in vitro) was based on previously 
published work (1).  
All stock solutions were prepared under a nitrogen atmosphere (inside the 
glovebox) with degassed buffer by purging extensively with nitrogen gas. The 
components of the assay were mixed in buffer (20 mM HEPES pH 7.0, 0.5 
mM EDTA, 0.05% w/v n-Dodecyl-beta-Maltoside (DDM)) inside the glovebox 
at final concentrations of 100 µM NADH, 10 µM menadione, 1 mM fumarate, 
1 µM CymA†, and 1 µM FccA. The solution was then incubated inside the 
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glovebox for approximately 15 min with mild stirring, before it was placed in a 
plastic disposable spectrophotometric cuvette with 1.0 cm path-length. The 
cuvette was sealed and was transferred outside the glovebox for 
spectrophotometric measurements (measuring absorbance of NADH at 340 
nm over time), which were conducted under anoxic conditions at room 
temperature. Diaphorase from Clostridium kluyveri (purchased from Sigma) 
was added using a Hamilton’s syringe at final concentration of 3 µM to the 
sealed cuvette in order to initiate the reaction.  
The initial rate of the reaction was calculated according to the following 
formula: 
   𝑟𝑎𝑡𝑒 =  − 
∆[𝑁𝐴𝐷𝐻]
∆𝑡
       (2) 
The concentration of NADH was calculated using the Beer-Lambert law with  
𝜀340 𝑛𝑚
𝑁𝐴𝐷𝐻 = 6,220 𝑀−1 𝑐𝑚−1.  
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2.6 Protein Purification Procedures 
2.6.1 Manual nickel affinity chromatography 
Manual nickel affinity chromatography was performed at room temperature 
using a GE Healthcare Life Sciences HisTrap™ HP 5ml column operated 
manually with the use of syringes. 
   
2.6.2 ӒKTA chromatography 
Automated chromatography was performed at 4 °C with a GE Healthcare Life 
Sciences ӒKTA pure 25 L chromatographic system with a GE Healthcare Life 
Sciences Fraction collector F9-R operated by GE Healthcare Life Sciences 
Unicorn 7 software. Chromatograms shown in this thesis were produced by 
plotting the exported raw data with OriginPro 8.6 software.  
  
2.6.3 Isolation of bacterial membranes 
The harvested bacterial cell pellet was resuspended in resuspension buffer at 
4.36 ml per 1 g of wet cell mass. The suspension was kept on ice and fully 
homogenized by an IKA® Ultra-Turrax® homogenizer. The homogenized 
suspension was passed twice through a Constant Systems TS5/40/AB/GA 
cell disruptor operated at 30 Kpsi pressure and 5 °C temperature  in order to 
lyse the bacterial cells. The lysate was collected in a pre-chilled Duran bottle 
resting on ice.  
The lysate was centrifuged at 12,000 g for 50 min at 4 °C in order to pellet cell 
debris. The supernatant was collected and centrifuged at 131,000 g for 60 min 
at 4 °C in order to pellet the membranes. The supernatant was discarded and 
the membranes were resuspended in the resuspension buffer and the solution 
was homogenised using a hand-held glass homogeniser while working on ice. 
The membranes were collected by centrifugation at 131,000 g for 60 min at 4 
°C; this washing step was repeated two more times. The washed and 
homogenised membranes in resuspension buffer can be flash-frozen in liquid 
nitrogen and stored at -80 °C.    
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The resuspension buffer consisted of 100 mM Hepes pH 7.5, 100 mM NaCl, 
and Roche cOmplete™ EDTA-free protease inhibitor cocktail (according to 
the manufacturer’s instructions) or Roche cOmplete™ protease inhibitor 
cocktail (according to the manufacturer’s instructions).   
 
2.6.4 Purification of CymA† 
The isolated and washed bacterial cell membranes were resuspended in 
solubilisation buffer (20 mM Tris-HCl pH 8.0, 0.5 M NaCl, 5 mM imidazole, 1% 
w/v DDM) at 12.5 ml per membranes derived from ~ 39 g wet cell mass of 
bacterial pellet and the solution was homogenised using a hand-held glass 
homogeniser while working on ice. The solution was incubated for 4 h at 4 °C 
with roller-mixing. Any remaining insoluble material was removed by ultra-
centrifugation at 131,000 g for 60 min at 4 °C. The supernatant was filtered 
manually through a 0.45 µm pore size filter. This constituted the column load. 
The load was loaded onto a pre-equilibrated GE Healthcare Life Science 
HisTrap™ HP 5 ml column with binding buffer (20 mM Tris-HCl pH 8.0, 0.5 M 
NaCl, 5 mM imidazole, 0.1% w/v DDM) slowly (during manual nickel affinity 
chromatography) or at 0.5 ml min-1 (during ӒKTA chromatography). 
Subsequently, the column was washed with 5-10 column volumes (CVol) of 
binding buffer followed by 8-10 CVol of binding buffer containing 30-50 mM 
imidazole slowly (during manual chromatography) or at 1.0 ml min-1 (during 
ӒKTA chromatography). Step-elution was performed slowly during manual 
chromatography with binding buffer containing 130 mM and 300 mM 
imidazole. For ӒKTA chromatography, a gradient of increasing imidazole 
concentration was applied from 50 mM to 500 mM imidazole over 10 Cvol and 
from 500 mM to 1 M imidazole over 5 CVol at 1.0 ml min-1.  
The desired fractions, after SDS-PAGE analysis, were pooled and dialysed 
with two buffer exchanges (2 h incubation and 16 h incubation at 4 °C) against 
20 mM Hepes pH 7.5 150 mM NaCl using ThermoFisher Scientific 
SnakeSkin™ dialysis tubing with 10 kDa molecular weight cut-off.  
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The dialysed protein sample was concentrated using a Vivaspin® spin-
concentrator with 10 kDa molecular weight cut-off filter by centrifugation at 
3,220 g and at 4 °C until the desired volume was reached. 
The concentrated protein sample was quantified, aliquoted, flash-frozen in 
liquid nitrogen, and stored at -80 °C.     
     
2.6.5 Purification of recombinant TEV protease  
The purification of TEV protease was based on a kindly supplied protocol by 
Dr Vincent Postis.  
The harvested bacterial cell pellet was resuspended in resuspension buffer 
(50 mM Tris-HCl pH 8.0, 400 mM NaCl, 0.5 mM EDTA)  at 2 ml per 1 g of wet 
cell mass. The suspension was kept on ice and fully homogenized by an IKA® 
Ultra-Turrax® homogenizer. The homogenized suspension was passed twice 
through a Constant Systems TS5/40/AB/GA cell disruptor operated at 30 Kpsi 
pressure and 5 °C temperature  in order to lyse the bacterial cells. The lysate 
was collected in a pre-chilled Duran bottle resting on ice.  
The lysate was centrifuged at 131,000 g for 60 min at 4 °C in order to pellet 
insoluble material. The supernatant was collected and DNase I was added to 
an approximate final concentration of 10 µg ml-1 in order to digest DNA 
resulting in a less viscous solution. The solution was stirred at 4 °C before it 
was supplemented with imidazole to final concentration of 35 mM, and filtered 
manually through a 0.45 µm pore size filter. This constituted the column load.  
The column load was loaded onto a pre-equilibrated GE Healthcare HisTrap™ 
HP 5 ml column with binding buffer (50 mM Tris-HCl pH 8.0, 400 mM NaCl, 
35 mM imidazole, 0.32 mM tris(2-carboxyethyl)phosphine (TCEP)) at 2 ml 
min-1 at 4 °C. The column was washed with binding buffer until the UV signal 
was stable (maximum of 20 CVol). Subsequently, elution was performed by 
applying a gradient of imidazole from 35 mM to 500 mM imidazole over 30 
Cvol and from 500 mM to 1 M imidazole over 5 Cvol at 2 ml min-1 and at 4 °C. 
The desired fractions, after SDS-PAGE analysis, were pooled and dialysed 
with two buffer exchanges (2 h incubation and 16 h incubation at 4 °C) against 
50 mM Tris-HCl pH 8.0, 200 mM NaCl, 2 mM EDTA, 125 µM TCEP using 
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ThermoFisher Scientific SnakeSkin™ dialysis tubing with 10 kDa molecular 
weight cut-off.  
The dialysed protein sample was quantified with µBCA assay, aliquoted, flash-
frozen in liquid nitrogen, and stored at -80 °C. It must be noted that TEV 
protease aggregates at concentrations approximately ≥ 5 mg ml-1, which is 
why the purified sample was not concentrated.    
  
2.6.6 Purification of native FccA 
The purification of native FccA was based on previously published work (90). 
The initial purification attempt was conducted together with Dr Colin Lockwood 
at the University of East Anglia. This section describes the purification 
approach that was developed from the work that was conducted at the 
University of East Anglia, but with reference to the instrumentation that was 
used for further purification preparations at the University of Leeds.  
The harvested cell pellet was subjected to a crude periplasmic extraction since 
the periplasm is the cellular location at which FccA is found. Furthermore, 
periplasmic extraction allows the elimination of most of the globular cytosolic 
proteins aiding the isolation of pure FccA. The cell pellet was resuspended in 
‘lysis’ buffer (100 mM Tris-HCl pH 8.0, 500 mM sucrose, 3 mM EDTA, 2 mg 
ml-1 lysozyme from chicken egg white, Roche cOmplete™ EDTA-free 
protease inhibitor cocktail) at 10 ml per 1.7 g of wet cell mass. The suspension 
was incubated for 40 min at 37 °C with gentle orbital shaking. Subsequently, 
the suspension was centrifuged at 15,000 g for 45 min at 4 °C. The 
supernatant, which constituted the periplasmic fraction, was diluted 1-fold with 
20 mM Tris-HCl pH 8.0, and filtered manually through a 0.45 µm pore size 
filter. This constituted the column load. 
A GE Healthcare Life Sciences HiTrap™ DEAE (sepharose) FF 5 ml column 
was pre-equilibrated with 5 CVol of 20 mM Tris-HCl pH 8.0, 1 M NaCl buffer, 
followed by 10 CVol of 20 mM Tris-HCl pH 8.0 buffer. The column load was 
loaded on the pre-equilibrated column at 1 ml min-1 at 4 °C. The column was 
then washed with 5 CVol of 20 mM Tris-HCl pH 8.0, 5 mM NaCl. Elution was 
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performed by applying a salt gradient from 5 mM to 600 mM NaCl over 60 
CVol and from 600 mM to 1 M NaCl over 5 CVol at 1 ml min-1 at 4 °C. 
The desired fractions, after SDS-PAGE analysis, were pooled and were 
subjected to 50% ammonium sulphate fractionation cut in order to precipitate 
contaminating proteins. The high salt fractionation was performed in a cold-
room (4 °C), and the salt was added very slowly into the solution under 
constant stirring. Once all of the salt was added and dissolved, the solution 
was stirred for another 15 min before it was centrifuged at 15,000 g for 20 min 
at 4 °C. The supernatant, containing FccA, was carefully collected and filtered 
through a 0.22 µm pore size filter. Subsequently, the filtered supernatant was 
dialysed with two buffer exchanges (2 h incubation and 16 h incubation at 4 
°C) against 20 mM HEPES pH 7.4, 150 mM NaCl using ThermoFisher 
Scientific SnakeSkin™ dialysis tubing with 10 kDa molecular weight cut-off.  
The dialysed protein sample was concentrated using a Vivaspin® spin-
concentrator with 50 kDa molecular weight cut-off filter by centrifugation at 
3,220 g and at 4 °C until the desired volume was reached. 
The concentrated protein sample was further purified by size exclusion 
chromatography in 20 mM HEPES pH 7.4, 150 mM NaCl. The protein sample 
was injected onto a pre-equilibrated GE Healthcare Life Sciences HiLoad™ 
16/600 Superdex 200 pg preparatory grade column at approximately 10 mg 
ml-1 FccA. The size exclusion chromatography was performed at 0.5 ml min-
1 at 4 °C.  
The desired peak fractions, after SDS-PAGE analysis, were pooled and were 
concentrated using a Vivaspin® spin-concentrator with 50 kDa molecular 
weight cut-off filter by centrifugation at 3,220 g and at 4 °C until the desired 
volume was reached.  
The concentrated final protein sample was quantified, aliquoted, flash-frozen 
with liquid nitrogen, and stored at -80 °C.    
 
2.6.7 Purification of CymAsol 
The purification of CymAsol  was modelled on previously published work (89). 
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Firstly, the {His6-MBP-TEV cleavage site-CymAsol} protein construct was 
purified by ÄKTA nickel affinity chromatography. The harvested cell pellet was 
subjected to a crude periplasmic extraction since the protein construct was 
engineered to localise in the periplasm. Furthermore, periplasmic extraction 
allows the elimination of most of the globular cytosolic proteins aiding the 
elimination of contaminating proteins. The cell pellet was resuspended in TSE 
buffer (20% w/v sucrose, 30 mM Tris-HCl pH 8.3, 1 mM EDTA, 0.5 mg ml-1 
lysozyme from chicken egg white, Roche cOmplete™ EDTA-free protease 
inhibitor cocktail) at 30 ml per approximately 16 g of wet cell mass. The 
suspension was incubated for 20 min at room temperature with roller-mixing. 
Subsequently, an equal volume to the TSE buffer volume of ice-cold 1 M NaCl 
was added and the suspension was incubated for another 15 min at 4 °C with 
roller-mixing. The suspension was then centrifuged at 25,000 g for 30 min at 
4 °C. The supernatant, which constituted the periplasmic fraction, was 
carefully collected, supplemented with 5 mM imidazole and 3 mM MgCl2 at 
final concentration, and filtered through a 0.45 µm pore size filter. This 
constituted the column load.  
The column load was loaded onto a pre-equilibrated GE Healthcare HisTrap™ 
HP 5 ml column with binding buffer (20 mM Tris-HCl pH 8.0, 0.5 mM NaCl, 5 
mM imidazole) at 0.5 ml min-1 at 4 °C. The column was washed with 5-10 CVol 
of binding buffer, followed by 5-10 CVol of buffer containing 50 mM imidazole 
at 1 ml min-1 and at 4 °C. Subsequently, elution was performed by applying a 
gradient of imidazole from 50 mM to 400 mM imidazole over 25 Cvol and from 
400 mM to 1 M imidazole over 3 Cvol at 1 ml min-1 and at 4 °C. 
The desired fractions, after SDS-PAGE analysis, were pooled and quantified 
with µBCA assay and TEV protease was added to 2:1 (TEV protease: protein) 
protein amount ratio. The TEV-specific proteolytic cleavage reaction was 
performed during dialysis; the solution was dialysed for 20 h at 4 °C against 
20 mM Tris-HCl pH 8.0, 0.5 M NaCl using ThermoFisher Scientific 
SnakeSkin™ dialysis tubing with 10 kDa molecular weight cut-off in order to 
remove excess of imidazole. 
The dialysed solution was subjected to a manual reverse nickel affinity 
chromatography in order to bind all proteins. The CymAsol (without tags), 
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unable to bind to the nickel column, was run through the column and collected 
in the flow-through fraction. A pre-equilibrated GE Healthcare Life Sciences 
HisTrap™ HP 5 ml column with 20 mM Tris-HCl pH 8.0, 0.5 M NaCl was used 
for reverse affinity purification. 
The flow-through was concentrated using a Vivaspin® spin-concentrator with 
10 kDa molecular weight cut-off filter by centrifugation at 3,220 g and at 4 °C 
until the desired volume was reached. Subsequently, the protein sample, 
containing CymAsol, was loaded onto a pre-equilibrated GE Healthcare Life 
Sciences HiLoad™ 16/600 Superdex 75 pg preparatory grade column with 20 
mM HEPES pH 7.5, 150 mM NaCl for size exclusion chromatography with 
flow rate 1 ml min-1 at 4 °C. The sample was injected onto the column at an 
approximate concentration of 3 mg ml-1.  
The desired peak fractions, after SDS-PAGE analysis, were pooled and were 
concentrated using a Vivaspin® spin-concentrator with 10 kDa molecular 
weight cut-off filter by centrifugation at 3,220 g and at 4 °C until the desired 
volume was reached.  
The concentrated final protein sample was quantified, aliquoted, flash-frozen 
with liquid nitrogen, and stored at -80 °C.       
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2.7 Electrochemical Methods 
2.7.1 Cyclic voltammetry & Electrochemical cell set-up 
Cyclic voltammetry (CV) is a surface sensitive electrochemical method, where 
electron transfer occurs at the interfacial region between redox active 
molecules and the surface of the electrode. Proteins with metal co-factors, 
which are usually involved in electron relay either to an active site within the 
same protein or to another partner protein, are able to electrically interact with 
the electrode and they are studied via a variety of electrochemical methods 
including cyclic voltammetry.  
In CV, the potential are cycled through a defined potential window linearly over 
time at a defined scan rate. Once the potential reaches the defined end, it 
swipes back in the opposite direction until it reaches back to the starting 
potential. During the potential cycling the output current is measured and 
plotted against the potential. Normally, reductive current is shown as negative 
current, while oxidative current is shown as positive.   
An electrochemical cell (schematically depicted in figure 16), which was able 
to hold a volume of 2 ml, was assembled with a three-electrode standard set-
up: an ultra-flat modified gold working electrode (described in sections 2.7.2 
Preparation of gold electrodes and 2.7.3 Modification of gold electrodes); 
a platinum wire as a counter electrode in order to close the electrical circuit; 
and a Radiometer Analytical Hg/Hg2SO4 reference electrode (+0.651 V vs 
SHE at 20 °C). The working ultra-flat modified gold electrode was embedded 
in a poly-tetrafluroethylene (PTFE) electrode holder that was sealed with a 
rubber O-ring. Another rubber O-ring was used to seal the PTFE electrode 
holder and the glass cell. The assembled electrochemical cell was housed in 
a Faraday’s cage in order to minimise electrical noise during the 
electrochemical measurements.  
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Figure 16: Schematic representation of the electrochemical cell setup in cross-
sectional view. 
 
2.7.2 Preparation of gold electrodes 
The preparation of ultra-flat template-stripped gold electrodes was performed 
as described previously (95). 
Silicon wafers (N<100>, 100 mm diameter, 1-10 Ohm cm, 525 µm thickness, 
SSP grade polish) were cleaned by three discreet steps of ≥ 5 min  sonication 
per step. The silicon wafer was submersed in dichloromethane (step 1), 
ethanol (step 2), and 10% v/v Decon® 90 (step 3). The silicon wafer was dried 
under a stream of nitrogen gas after each sonication step. A layer of 150 nm 
of gold was deposited onto the cleaned silicon wafers by evaporation using 
an Edwards 306 evaporator (according to the manufacturer’s instructions). 
The cleaning and gold evaporation procedures were performed by Dr Mengqiu 
Li, Dr Ee Taek Hwang, or Dr George Heath. 
Fisherbrand™ plain glass microslides were manually cut with a diamond pen 
cutter in order to produce 13 mm x 13 mm glass squares. The glass squares 
were cleaned by three discreet steps of 10 min sonication per step. The glass 
squares were submersed individually in isopropanol (step 1), 10% v/v Decon® 
90 (step 2), and water (step 3). Between steps 2 and 3, the glass squares 
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were rinsed with copious amounts of water to ensure complete removal of 
residual Decon® 90.  
The two components of EPOXY Technology EPO-TEK® 377 glue were mixed 
at 1:1 ratio and any trapped air was removed using a vacuum desiccator for 
1-2 h. Subsequently, the glue was used to glue the cleaned glass squares 
onto the gold layer of the provided silicon wafer. The glue was cured for 2 h 
at 120 °C using a hot plate. The resulting silicon wafer with the glued glass 
squares on its gold layer was stored at room temperature.  
A glued glass square onto the gold layer of the silicon wafer was stripped 
carefully using a surgical scalpel blade immediately before use, yielding an 
ultra-flat template-stripped gold electrode.            
 
2.7.3 Modification of gold electrodes 
The ultra-flat template-stripped gold electrodes were modified with a self-
assembled monolayer (SAM) of organic thiol compounds with varying length 
exploiting the strong interaction between sulphur and gold. The organic thiol 
compounds had terminating functional chemical groups or chemical moieties 
with which the surface of the gold electrode was modified. As part of the work 
presented in this thesis the following organic thiol compounds were used 
either on their own or as part of a thiol mixture:  
• 8-mercapto-1-octanol (Sigma; 98% purity) 
• 6-mercapto-1-hexanol (Sigma or Fluka; 97% purity) 
• 8-amino-1-octanethiol (Dojindo; 97.6% purity) 
• EO3-cholesteryl (96) (kindly provided by Dr Lars Jeuken) 
The formation of SAMs was achieved by incubating the electrodes for 16 h at 
room temperature submerged in a solution of total thiol concentration of 1 mM 
in isopropanol. The electrode was rinsed with isopropanol and dried under a 
stream of nitrogen gas immediately prior to use in the assembly of the 
electrochemical cell (described in section 2.7.1 Electrochemical cell set-up).  
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2.7.4 Electrochemical measurements 
All electrochemical measurements were performed under a nitrogen 
atmosphere (≤ 0.1 ppm O2) in an MBRAUN LABmaster glovebox workstation 
at room temperature and in 20 mM MOPS pH 7.4, 30 mM Na2SO4 buffer 
unless otherwise stated. The buffer solutions and water used for rinsing the 
reference electrode were degassed with nitrogen gas and equilibrated under 
a nitrogen atmosphere (inside the glovebox) for at least four weeks before 
they were used in experiments.  
Electrochemical measurements were conducted with an Autolab (Eco-
chemie) electrochemical analyser that carries a PGSTAT30 potentiostat, a 
SCANGEN module, and a FRA2 frequency analyser, which was operated with 
Nova 1.8 or Nova 1.10 software. Cyclic voltammetry experiments were 
routinely carried out by holding the potential at 0.5 V for 5 s before cycling at 
various scan rates. 
Peaks were integrated using the Nova software with manually determination 
of the baseline. Cyclic voltammograms shown in this thesis were produced by 
plotting the exported analysed data with OriginPro 8.6 software. The data 
were typically smoothed with a 10-point adjacent averaging method and they 
were visibly inspected for conformity with the raw data (an example is given 
in figure 17). In cases where the smoothed data showed deviations from the 
raw data, a 5- or 8-point adjacent-averaging was performed instead.    
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Figure 17: Comparison between raw and smoothed data by the 10-point 
adjacent averaging method for cyclic voltammograms. An overlay of cyclic 
voltammetric data before (raw data; black line) and after (10-point adjacent 
averaging method) smoothing. This visible inspection was conducted for all 
voltammograms presented in this thesis.   
      
2.7.5 Formation of a protein film on modified gold electrodes 
The formation of a protein film on the surface of the modified gold electrodes 
(described in section 2.7.3 Modification of gold electrodes) was performed 
in an assembled electrochemical cell (described in section 2.7.1 
Electrochemical cell set-up). The modified electrode was incubated with the 
target protein at ≥ 0.1 µM in buffer (20 mM MOPS pH 7.4, 30 mM Na2SO4) for 
20 min at room temperature inside the glovebox. Subsequently, the electrode 
was washed with 2 ml of buffer three times in order to remove excess protein. 
The amount of electro-active adsorbed protein ( Γ ) was estimated according 
to the following formula: 
    Γ =  
peak area
𝑛 ∙𝐹 ∙𝐴 ∙ 𝜐
     (2) 
where n is the number of electrons for a protein molecule, F is the Faraday’s 
constant (96,485.332 C mol-1), A is the area of the electrode (0.2 cm2), 𝜐 is 
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the scan rate (V s-1), and peak area for the area of the reductive or oxidative 
non turn-over signal (V·A).  
 
2.7.6 Formation of a tethered lipid bilayer membrane (tBLM) on 
modified gold electrodes 
For tBLM experiments, an electrode was modified with SAM containing a 
mixture of EO3-cholesteryl and 6-mercapto-1-hexanol (as described in section 
2.7.3 Modification of gold electrodes). EO3-cholesteryl carries a cholesterol 
moiety that provides tethering points for the lipid bilayer membrane. The 
modified electrodes were analysed by electrochemical impedance 
spectroscopy that allows the coverage of EO3-cholesteryl to be estimated 
under the assumption of a linear additive correlation as fractions of complete 
coverage of the individual thiols (97). Thus: 
Ctotal = χ1 C’1 + χ2 C’2    (3) 
where Ctotal is the capacitance of the SAM experimentally determined by 
electrochemical impedance spectroscopy, χ is the surface fraction, and C’ is 
the capacitance of a pure thiol SAM. The notations ‘1’ and ‘2’ denote the 
fractional components of a mixed SAM, in this case, EO3-cholesteryl and 6-
mercapto-1-hexanol respectively. The capacitance values that were used in 
equation (3) for EO3-cholesteryl and 6-mercapto-1-hexanol were  
0.78 µF cm-2 and 4.3 µF cm-2 respectively (experimentally determined).  
The modified electrode was incubated in situ with liposomes or 
proteoliposomes at final concentration of 0.5 mg ml-1 and 10 mM CaCl2 (in 
order to screen the charges and therefore enable the aggregation of 
liposomes or proteoliposomes, aiding to their spontaneous rupture) for 
approximately 1 h at room temperature. Subsequently, the electrodes were 
washed in situ with 2 ml of buffer twice in order to remove excess of liposomes 
or proteoliposomes, followed by a wash with 1 mM EDTA (in water) in order 
to chelate any Ca+2 ions, followed by two further buffer washes in order to 
remove any residual EDTA. It must be noted that care was taken not to disrupt 
the formed tBLM by maintaining the meniscus of the solutions above the 
tBLM. The formation of the tBLM was monitored with electrochemical 
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impedance spectroscopy, where a drop in the capacitance value is indicative 
of a formed tBLM, normally below 1.2 µF cm-2   as previously established for 
this system (97). A representative example of the formation of tBLM monitored 
with electrochemical impedance spectroscopy is shown in figure 18 in the 
form of  a Cole-Cole plot. Formed tBLMs that exhibited a drop in the 
capacitance value ≤ 2.3 µF cm-2 were deemed acceptable for electrochemical 
experiments for the work presented in this thesis.     
  
 
Figure 18: Overlay of electrochemical impedance spectroscopy Cole-Cole 
plots before (SAM; blue line) and after (tBLM; red line) the formation of 
tBLM on a SAM modified gold electrode. A representative example for 
monitoring the formation of tBLM that was conducted for all tBLM 
electrochemical experiments in order to verify the formation of tBLM. Y” and Y’ 
denote the imaginary and real components of admittance (Y) respectively, while 
ω denotes the angular frequency. The depicted Y/ω (s Ω-1) is equivalent to the 
capacitance, C (units: F where C V-1 is equivalent to s Ω-1). Thus, the radius of 
the semi-circle is half of the capacitance (F). For comparative reasons, the 
capacitance is divided by the surface area of the electrode (cm2) and, therefore, 
the capacitance is reported in F cm-2.     
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2.8 Biophysical Methods 
2.8.1 Quartz-crystal microbalance with dissipation (QCM-D) 
2.8.1.1 Experimental details 
QCM-D experiments were performed with a Biolin Scientific 4-channel Q-
sense Analyzer at 21 °C and SiO2-coated crystals (QSX 303; 14095_A). 
Fluidic flow was controlled with a Biolin Scientific Ismatec IPC-N 4 peristaltic 
pump operated at 70 µl min-1, unless otherwise stated. All solutions were 
degassed prior to use. The crystals were cleaned in four consecutive steps 
immediately prior to use: (a) 20 min sonication in 0.4% w/v SDS, (b) 20 min in 
Milli-Q grade water, (c) 20 min UV/ozone treatment with a Spectrum UVOCS 
10x10/ OES UV-ozone cleaning system, and (d) 10 min sonication in milli-Q 
grade water. The crystals were dried under a stream of nitrogen gas. 
Subsequently, the crystals were mounted on the cells, as per the 
manufacturer’s instructions, and calibrated in air first and then in water before 
being equilibrated first in water and then in buffer. Each equilibration step was 
performed under constant flow until the baseline signal became stable 
(normally between 3 h and 5 h, depending on the crystal quality).  
Liposomes (as described in section 2.5.10 Preparation of homogeneous 
solutions of liposomes) or proteoliposomes (as described in section 2.5.11 
Reconstitution of CymA† into liposomes) were introduced to an 
equilibrated crystal at 0.5 mg ml-1 in 20 mM MOPS pH 7.4, 30 mM Na2SO4 
buffer containing 10 mM CaCl2. The Ca2+ ions screen the surface charge 
promoting aggregation, which along with their exposure to the SiO2 surface 
cause their spontaneous rupture and formation of a solid-supported lipid 
bilayer membrane. Excess of liposomes or proteoliposomes was removed by 
a water step. Then, buffer containing 1 mM EDTA was used to chelate Ca2+ 
ions, followed by a buffer step to remove residual EDTA and to establish the 
baseline signal of the formed bilayer. Representative traces of this process for 
the formation of a solid-supported lipid bilayer membrane is shown in figure 
19. 
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Figure 19: A representative trace of a solid supported lipid bilayer membrane 
formation from the spontaneous rupture of 10% w/w CL/POPC liposomes 
monitored with QCM-D. 1: buffer equilibration to ensure that there is no drift. 
2: introduction of liposomes at 0.5 mg ml-1 and 10 mM CaCl2. Initially the 
liposomes are adsorbed on the surface which is mediated by the screening of 
their surface charge by CaCl2 and observed as a drop in Δf. The liposomes are 
then spontaneously rupture, realising the trapped buffer, which is observed as 
an increase in and stabilization of Δf. 3: Milli-Q water wash in order to remove 
intact liposomes and CaCl2. 4: Buffer wash with 1 mM EDTA in order to chelate 
residual Ca2+ ions. 5: buffer wash in order to remove EDTA and establish the 
baseline of the experiment. Δf = 25 Hz is the ideal value of a good quality 
uniform POPC bilayer membrane (98).           
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2.8.2 Isothermal Titration Calorimetry  
2.8.2.1 Experimental details 
Protein samples were co-dialysed in the same buffer, which consisted of 20 
mM MOPS pH 7.4, 150 mM NaCl in two consecutive steps: (a) 2 h at 4 °C, 
and (b) 16 h at 4 °C. A sample of the final buffer was kept for control 
experiments. All solutions (including protein samples) were degassed prior to 
use. The ITC cell contained CymAsol at 10 µM. FccA of various concentrations 
comprised the titrant, which was loaded in the syringe. ITC experiments were 
conducted with a MicroCal™ iTC200 (Malvern) at the following settings: 
reference power of 5 µcal s-1, 60 s initial delay, 750 rpm stirring, 25 °C 
temperature, initial sacrificial injection of 0.5 µl with 1 s duration, 19 injections 
of 2 µl with 4 s duration each, and 120 s spacing between each injection.        
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Chapter 3 – An improved Approach for the production of 
Homologously Expressed Recombinant CymA† from 
Shewanella oneidensis MR-1 
 
3.1 Introduction 
The dissimilatory metal-reducing Shewanella oneidensis MR-1 has become 
an important organism for microbial electrochemistry due to its metabolic 
versatility for a range of applications in the areas of microbial fuel cell 
technology, biosensor technology, bioremediation, and electrosynthesis. At 
the centre of the anaerobic respiration lies CymA – a transmembrane 
tetrahaem c-type cytochrome that is responsible for the re-oxidation of the 
menaquinone pool of the inner membrane.  
The purification of CymA for the elucidation of its structural and mechanistic 
details has seen several attempts, but with limited success. Field et al. were 
the first to report the purification of CymA from Shewanella frigidimarina 
NCIMB400 in native form, but with a low yield of 5 mg of purified CymA from 
20 L of culture (250 µg L-1 of culture) (35). More than a decade later, Marritt 
et al. reported the overexpression and purification of a recombinant CymA 
from S. oneidensis LS447 (1). The LS447 strain is the transformed S. 
oneidensis MR-1 with the pLS167 plasmid. The pLS167 plasmid is the 
expression vector with the cloned cymA gene. The expression vector is a 
modified pBAD202/D-TOPO based system for homologous and heterologous 
overexpression of multihaem-cytochromes in S. oneidensis MR-1 (99). The 
pBAD202/D-TOPO plasmid from Invitrogen incorporates a His-patch 
thioredoxin on the N-terminus as well as a V5 epitope and a His6 tag on the 
C-terminus of recombinant proteins. The modified system for multihaem-
cytochromes contains a stop codon at the end of the His-patch thioredoxin 
encoding region, resulting in the incorporation of only the C-terminal 
modifications on the recombinant protein. Thus, in this case, the purified 
recombinant CymA carried a V5 epitope followed by a His6 tag on the C-
terminus (referred to as CymA‡). However, this protein construct did not bind 
to immobilised metal ion affinity columns, which resulted in a laborious 
purification procedure that comprised of various ion-exchange and size 
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exclusion chromatographic steps (1). As a result, the yield was considered 
low for an overexpression approach, though higher than purifying CymA in 
native form. Moreover, the purified fractions of the CymA‡ were not consistent 
in that recombinant CymA co-purified with varying amounts of quinone 
molecules. Such co-purification of quinone-containing contaminants, or bound 
quinone molecules to purified CymA‡ was not previously reported, when 
native CymA was purified (35). This was addressed to some extent by the 
addition of washing steps that reduced the amount of quinone molecules (1). 
Hence, this construct exhibits inherent issues that may promote incorrect 
folding and, by extension, alter the properties of the protein. Furthermore, the 
presence of tags on the C-terminus may interfere with protein-protein 
interactions, rendering this protein construct unsuitable for such studies.  
This chapter presents an improved approach for the production of pure 
recombinant CymA (referred to as CymA†) that is suitable for, but not limited 
to, protein-protein interaction studies. It begins with the presentation of an 
approach for designing new genes that address tag interference issues, as 
well as for re-constructing the expression vector for the easy sub-cloning of 
those recombinant genes. Subsequently, it presents the results of expression 
in S. oneidensis MR-1 and purification of CymA†. Finally, the biochemical, 
biophysical, and electrochemical characterization of the purified CymA† is 
presented.     
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3.2 Results 
3.2.1 Gene design and vector re-construction  
The working CymA model is based on the crystal structure of NrfH, a 
homologue of CymA, which is solved as an NrfH2A4 complex to a resolution 
of 2.3 Å from Desulfovibrio vulgaris. NrfH and, by extension, our CymA model 
has a single N-terminal transmembrane α-helix and a periplasmic-facing 
globular domain that houses the four haems. Thus, the design of the new 
genes focuses on adding N-terminal tags for affinity purification purposes and 
abandoning any C-terminal modifications.  
The cymA gene (PubMed Gene ID: 1172176) was designed to allow fusion of 
a His8 tag followed by a human rhinovirus 3 C (HRV3C) proteolytic site to the 
N-terminus of CymA (cymA01). The His8 tag was used for affinity purification 
purposes, while the HRV3C site was incorporated to allow for the removal of 
the His8 tag, should it be deemed necessary. In order to allow for directional 
cloning, two unique restriction sites were also incorporated into the design: 
NcoI at the start of cymA01, which included the start codon in its sequence, 
and HindIII immediately after an incorporated stop codon at the end of the 
gene in order to abolish the addition of any C-terminal modifications. The DNA 
sequence was, lastly, subjected to codon optimisation for optimal fusion of the 
N-terminal modifications during overexpression in S. oneidensis MR-1 using 
JCat Codon Adaptation Tool (Apendix B). The cymA01 gene is schematically 
depicted in figure 20, while the complete and annotated DNA sequence is 
presented in appendix B. The gene synthesis of cymA01 was outsourced to 
GenScript, which provided the cymA01 gene cloned in a pUC57 vector.    
 
 
Figure 20: Schematic representation of cymA01 gene that encode for His8-
HRV3Csite-CymA. The start and stop codons are shown in green and red 
respectively. The NcoI and HindIII restrictions sites are underlined, while the 
nucleotide position of restriction is indicated with arrows.  
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The pLS167 plasmid was kindly donated by Professor Julea Butt and with 
permission from Dr. Liang Shi, who is the original creator of pLS167. The 
restriction sites NcoI and HindIII were chosen for providing directional cloning. 
The region between NcoI and HindIII allows the removal of the N-terminal 
modifications that the pBAD202/D-TOPO provides (vector map shown in 
figure 21), along with any cloned gene up to where the region that provides 
the C-terminal modifications is. 
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Figure 21: pBAD202/D-TOPO (Invitrogen) vector map. The map is annotated to 
show the key features of the vector: KanR: region encoding gene that confers 
kanamycin resistance, Ori: origin of replication, AraC: encoding gene that 
confers tight regulation of the promoter, Ara promoter: promoter region, RBS: 
ribosomal binding site, NcoI: position of the restriction site, HindIII: position of 
the restriction site, araO1/ araO2: operator regions, ara 1|2: binding sites of 
araC for the activation of transcription, CAP BS: binding site of the cAMP 
binding protein for the activation of the transcription, His-Patch-Thr: region 
encoding His-Patch thioredoxin, EK: region encoding enterokinase recognition 
site, V5-epitope: C-terminal V5-epitope, 6xHis: C-terminal His6 tag, rrnB 
terminator and rrnB T2 terminator: strong transcription termination regions. 
The vector map was produced using CLC Genomics Workbench 9.5.1 
software.   
 
The cymA01 gene was restricted from the pUC57 vector with the use of NcoI 
and HindIII restriction enzymes, isolated by agarose gel electrophoresis, and 
purified from the agarose gel. The pLS167 was also restricted with the same 
restriction enzymes and the linearized vector was isolated by agarose gel 
electrophoresis, and purified from the agarose gel. Subsequently, the cymA01 
gene and the restricted linear vector were ligated, yielding the pTL01 vector. 
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A general version of pTL01 vector map is shown in figure 22, where the 
desired gene is presented as ‘insert’.  
 
 
Figure 22: pTL vector map. The map is annotated to show the key features of the 
vector: KanR: region encoding gene that confers kanamycin resistance, Ori: 
origin of replication, AraC: encoding gene that confers tight regulation of the 
promoter, Ara promoter: promoter region, RBS: ribosomal binding site, NcoI: 
position of the restriction site, HindIII: position of the restriction site, araO1/ 
araO2: operator regions, ara 1|2: binding sites of araC for the activation of 
transcription, CAP BS: binding site of the cAMP binding protein for the 
activation of the transcription, Insert: cymA01 gene, V5-epitope: C-terminal 
V5-epitope, 6xHis: C-terminal His6 tag, rrnB terminator and rrnB T2 
terminator: strong transcription termination regions. The vector map was 
produced using CLC Genomics Workbench 9.5.1 software.  
 
The correct ligation of the cymA01 gene to the re-constructed expression 
vector was assayed by Sanger sequencing of pTL01 vector. Subsequently, S. 
oneidensis MR-1 was transformed with pTL01 by electroporation. Competent 
Escherichia coli BL21 (DE3), already carrying pEC86 that encodes the ccm 
haem maturation cassette, was also transformed with pTL01 by heat shock. 
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3.2.2 Small-scale gene overexpression trials 
The overexpression of the His8-HRV3Csite-CymA protein construct was 
assayed in small-scale liquid cultures of both S. oneidensis MR-1 and E. coli 
BL21 (DE3)/pEC86. The expression conditions were optimised for pLS167 by 
Marritt et al (2012 (1); as well as unpublished data), and thus temperature and 
medium screens were not performed. The bacterial cells were grown in LB 
under microaerobic conditions at 30 °C and shaking at 200 rpm. Protein 
expression was induced when the cultures reached mid-exponential phase 
(OD600 ~ 0.7) with 1 mM L-arabinose. The expression was allowed for 18 h 
before the cells were harvested by centrifugation and subjected to ultrasonic 
lysis in buffer containing 100 mM HEPES pH 7.4, 100 mM NaCl. The 
suspension was centrifuged at 15,000 g for 30 min at 4 °C to pellet insoluble 
material. The resuspended pellet in the same buffer (100 mM HEPES pH 7.4, 
100 mM NaCl), constituted the insoluble fraction.  
Samples of the insoluble fractions of non-induced and induced cells were 
analysed by SDS-PAGE (figure 23). Although Coomassie-stained SDS-
PAGE did not show any prominent bands appearing in the samples of the 
induced cells of either expression system (panel A figure 23), haem-stained 
SDS-PAGE provided an indication of some protein overexpression (panel B 
figure 23). The sample of the insoluble fraction of induced S. oneidensis MR-
1/pTL01 on haem-stained SDS-PAGE showed a band with increased intensity 
that run at about 20 kDa, when compared to the sample of the insoluble 
fraction of non-induced S. oneidensis MR-1/pTL01 (red box in panel B figure 
23). For the E. coli BL21 (DE3)/pEC86 expression system, some leaky-
expression of a c-type cytochrome was observed that run at about 15 kDa 
(arrow in panel B figure 23) while no bands were observed in the induced 
sample on haem-stained SDS-PAGE. This small-scale expression trial was 
replicated with consistent results. Thus, S. oneidensis MR-1/pTL01 was 
selected as a potential candidate for the overexpression of recombinant CymA 
and was used for large-scale expression and purification. 
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 Figure 23: Electrophoretic profiles of protein expression from insoluble 
fractions of non-induced (-) and after 16 h of induced with 1 mM L-
arabinose (+) lysed S. oneidensis MR-1/pTL01 (MR1) and E. coli BL21 
(DE3)/pEC86/pTL01 (BL21) cells. A: 15% SDS-PAGE stained with 
Coomassie stain. B: 15% SDS-PAGE stained with c-type cytochrome-specific 
haem-stain. Lane M: molecular mass protein markers. 
      
 
3.2.3 Expression and purification of CymA† from Shewanella 
oneidensis MR-1 
S. oneidensis MR-1/pTL01 was grown in TB medium in order to support higher 
cell mass during large-scale expression cultures. The cells were grown to mid-
exponential phase (OD600 ~ 0.7) under microaerobic conditions at 30 °C with 
orbital shaking at 200 rpm, before they were induced with 1 mM L-arabinose. 
To further support overexpression of the CymA protein construct for a period 
of 16 h the agitation speed of the orbital shaking was reduced to 180 rpm. 
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The purification of recombinant CymA from DDM-solubilised membranes was 
achieved by immobilised-Ni2+ affinity chromatography. During manual 
chromatography, a two-step-elution was performed at 130 mM and 300 mM 
imidazole. The electrophoretic purification profile is shown in figure 24, which 
shows a prominent band at approximately 20 kDa with the majority of it eluting 
at 300 mM imidazole, although smaller amounts also eluted at 130 mM 
imidazole (red box). There is also indication that binding of the target protein 
may have been incomplete since the disappearance of a protein band cannot 
be distinctly observed when the load and flow-through samples are compared 
(red box in figure 24).  
 
 
Figure 24: Immobilised-Ni2+ affinity electrophoretic purification profile from 
DDM-solubilized S. oneidensis MR-1/pTL01 membranes that shows 
elution of a prominent band at approximately 20 kDa at 300 mM imidazole. 
15% SDS-PAGE stained with Coomassie stain. M: molecular mass protein 
markers; LD: column load; FT: flow-through during binding; W: 5 mM binding 
buffer wash; E1-E3: 130 mM imidazole eluates; E4-E5: 300 mM imidazole 
eluates.  
 
The purification was replicated with the use of an ÄKTA pure 25 
chromatographic system at 4 °C with a flow rate of 0.5 ml min-1. Elution was 
performed by employing a gradient with increasing imidazole concentration at 
a flow rate of 1 ml min-1. The chromatogram (figure 25) resolved two peaks 
at 220 mM and 280 mM imidazole. The target protein eluted at 280 mM 
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imidazole, while the peak at 220 mM imidazole eluted a high number of 
contaminating proteins as observed on SDS-PAGE (figure 26).  
 
0 100 150 200
0
200
400
600
800
1000
1200
1400
Volume (ml)
A
b
s
o
rb
a
n
c
e
 a
t 
2
8
0
 n
m
1
2
0
20
40
60
80
100
P
ro
p
o
rt
io
n
 o
f 
1
 M
 I
m
id
a
z
o
le
 (
%
)
 
Figure 25: Immobilised-Ni2+ affinity chromatographic elution profile with the 
application of a gradient of imidazole concentration on HisTRAP-HP 
column. The column equilibration and subsequent protein loading onto the 
column are truncated. Chromatography was performed at 4 °C with a flow rate 
of 0.5 ml min-1 during binding and of 1 ml min-1 for all subsequent steps. The 
buffer composition was 20 mM Tris-HCl pH 8.0, 0.5 M NaCl, 0.1% w/v DDM 
and varying imidazole concentration.   
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Figure 26: Electrophoretic analysis of elution peak fractions from immobilized-
Ni2+ affinity chromatography. 15% SDS-PAGE stained with Coomassie stain 
of chromatographic peak fractions 1 and 2 as shown in figure 6. M: molecular 
mass protein markers.  
 
The concentrated purified protein sample electrophoretically resolved three 
prominent protein bands, running at approximately 35 kDa, 20 kDa, and 11 
kDa on SDS-PAGE (figure 27), all of which stain for c-type cytochromes 
(panel B figure 27).  
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Figure 27: Electrophoretic profile of purified recombinant CymA by single step 
immobilised-Ni2+ affinity chromatography performed manually. 15% SDS-
PAGE stained with Coomassie stain (A), and haem-stain (B). M: molecular 
mass protein markers.  
 
The 20 kDa band was excised and analysed by liquid chromatography 
coupled to mass spectroscopy upon trypsin digestion that identified two 
unique peptides (R.IYENQPETMKPMAVR.M: residues 161-175; and 
F.NTQAWLDENR.K: residues 126-135), giving 12% protein coverage, for 
CymA from S. oneidensis MR-1. Although the theoretical molecular mass of 
the holoprotein construct is 25,468 Da (taken into account the incorporation 
of four haems with an approximate molecular mass of 616.5 Da per haem), 
the 20 kDa band is judged to be recombinant CymA that has been partially 
denatured and, therefore, run lower than expected. This is supported by the 
fact that c-type haems are covalently bound to the polypeptide, often providing 
extra stability.  
The protein sample was further analysed by size exclusion chromatography 
with a subsequent immunodetection approach in order to determine whether 
the 35 kDa and 11 kDa bands are the product of an SDS-PAGE artefact, as 
well as identify them. Size exclusion chromatography performed at 4 °C  
partially separated those bands and, hence, excluded the possibility of an 
SDS-PAGE induced artefact (figure 28). Subsequent immunodetection of the 
peak fractions detected the three protein bands with monoclonal antibodies 
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against both CymA-specific and poly-His epitopes (figure 29). Thus, it is 
concluded that the 20 kDa band is partially denatured recombinant CymA in 
monomeric form carrying a His-tag, while the 35 kDa band may be CymA in 
oligomeric form. This electrophoretic profile has been previously described for 
CymA. The 11 kDa band is thought to may have been derived as a product of 
a C-terminal truncation since it carries a His-tag that is located on the N-
terminus of this CymA construct. The purity is estimated to be > 90 % and the 
final typical yield from this purification approach is 2 mg CymA L-1 of culture. 
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Figure 28: Size exclusion chromatographic profile of purified CymA with 
HiLoad 16/600 Superdex 200 prep-grade column. The void volume (Vo) is 45 
ml. The chromatography was performed with ÄKTA pure 25 at 4 °C with a flow 
rate of 0.5 ml min-1. The buffer composition was 20 mM HEPES pH 7.5, 150 
mM NaCl, and 0.05% w/v DDM. The concentration of purified CymA that was 
injected onto the column was 1.7 mg ml-1.    
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Figure 29: Electrophoretic analysis of peak fractions from size exclusion 
chromatography of purified recombinant CymA with subsequent 
immunodetection of the three prominent bands with monoclonal 
antibodies against both CymA-specific and poly-His epitopes. A: 15% 
SDS-PAGE stained with Coomassie stain. B: Western blot with α-poly-His mAb. 
C: Western blot with α-CymA mAb. M: molecular mass protein markers, CymA: 
purified recombinant CymA sample that was loaded onto the column, 1-3 S: 
peak fractions from size exclusion chromatography as shown in figure 9.    
 
Modulation of the rate of protein expression with a decreased concentration 
of L-arabinose from 1 mM to 0.5 mM to support the correct folding of the 
recombinant protein during overexpression, along with EDTA-containing 
protease inhibitors during cell disruption to avoid proteolytic degradation from 
native proteases, significantly reduced the 11 kDa band (figure 30). 
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Figure 30: Electrophoretic profile of purified recombinant CymA by single step 
immobilised-Ni2+ affinity chromatography performed with ÄKTA pure 25. 
15% SDS-PAGE stained with Coomassie stain. M: molecular mass protein 
markers. EDTA-containing protease inhibitors along with a decreased 
concentration of 0.5 mM L-arabinose eliminates low molecular mass 
truncations that were observed in earlier preparations. 
 
 
3.2.4 Biochemical and electrochemical characterisation of 
purified CymA† 
Purified recombinant CymA was analysed spectrophotometrically and the 
obtained UV-visible (λ = 250 nm – 800 nm) absorbance spectra of oxidised 
and reduced CymA are shown in figure 31. The spectrum of the oxidised 
CymA resolved a broad shoulder between 500 nm and 600 nm and a peak at 
407 nm that corresponds to the Soret γ-band of light absorption by the haems. 
The spectrum of reduced CymA showed the resolution of the Soret α- and β- 
bands at 551 nm and 522 nm respectively, while the Soret γ-band shifted to 
418 nm. The purity ratio of A407/ A280 was 3.7. The recorded spectra showed 
characteristic features for c-type cytochromes and were in agreement with 
published spectra for CymA (1).  
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Figure 31: UV-visible absorbance spectra of oxidised and reduced purified 
recombinant CymA. Measurements were conducted at ambient conditions in 
20 mM HEPES pH 7.5 and 150 mM NaCl. The spectra are baseline corrected. 
The spectrum of fully reduced CymA was obtained by addition of excess of 
dithionite.   
 
CymA catalyses the reduction of menaquinone at the inner membrane of S. 
oneidensis MR-1 in order to support the anaerobic respiratory pathways by 
allowing electron flow during the oxidation of organic compounds in 
maintaining  the proton gradient for ATP synthesis. The catalytic activity of 
CymA has been well characterized in vitro by protein film electrochemistry on 
modified gold electrodes (39). Thus, protein film electrochemistry was 
employed in order to assess whether the purified recombinant CymA 
maintained activity. To this end, ultra-flat gold electrodes were modified with 
a self-assembled monolayer of 8-amino-1-octanethiol and 8-mercapto-1-
octanol at a ratio of 1:10 respectively in order to promote the electrostatic 
adsorption of CymA, forming a protein film onto the electrode. The electrode 
was poised by cycling the applied potential between -0.3 V and +0.3 V that 
resolved non-turnover signals of CymA (figure 32). That is the reductive and 
oxidative peaks as CymA is being reduced and oxidized. Upon addition of 
menaquinone-containing liposomes, the substrate for CymA, a catalytic 
reductive wave was observed (figure 33) with the same magnitude as 
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previously described (39). Thus, the purified recombinant CymA is 
catalytically active.  
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Figure 32: Cyclic voltammetry of CymA protein film resolving non-turnover 
signals. SAM: 1:10 NH3+/OH- thiol self-assembled monolayer. CymA film: 
adsorbed CymA protein film after removing excess of CymA by three buffer 
washes. The measurements were performed under a nitrogen atmosphere (02 
≤ 0.1 ppm) at ambient conditions and at a scan rate of 10 mV s-1. The buffer 
composition was 20 mM MOPS pH 7.4 and 30 mM Na2SO4.     
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Figure 33: Cyclic voltammetry of CymA protein film resolving catalytic 
reductive signal on addition of menaquinone (MQ7)- containing POPC-
liposomes. SAM: 1:10 NH3+/OH- thiol self-assembled monolayer. The 
measurements were performed under a nitrogen atmosphere (02 ≤ 0.1 ppm) at 
ambient conditions and at a scan rate of 10 mV s-1. The buffer composition was 
20 mM MOPS pH 7.4 and 30 mM Na2SO4.    
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3.3 Conclusions 
The expression of multihaem cytochromes is particularly challenging for a 
number of reasons: (a) haem incorporation is ATP-dependent that increase 
the energetic requirements of the organism during overexpression; (b) these 
proteins are usually involved in respiratory pathways, which their 
overexpression can interfere with the normal metabolic functions; and (c) 
some of those enzymes, like CymA, are transmembrane proteins, which the 
inherent issues of overexpressing and purifying membrane proteins in general 
add to the overall challenges.  
Current methodologies in circumventing some of those challenges involve the 
homologous expression of the target proteins. As such, S. oneidensis had 
been employed to homologously overexpress CymA with a modified 
pBAD/TOPO expression system under the tight regulation of the arabinose 
promoter. Here, further improvements on this system were presented with a 
resulting purification approach that is reproducible, while eliminating tag 
interference issues that may result from the presence of purification tags on 
the C-terminus of the protein. From the characterization of this new protein 
construct, the properties of CymA were not altered, while the purity and yield 
were significantly increased to > 90% and 2 mg per litre of culture respectively. 
Specifically, higher molecular mass contaminants that were previously seen 
(1) were eliminated. It must be noted that the yield was not previously reported 
(1). Moreover, CymA appears catalytically active under previously established 
electrochemical methods. However, it must be noted that the observed 
catalytic behaviour of CymA by protein film electrochemistry shows a reversal 
on the catalytic bias. That is, under the current understanding, CymA in vivo 
is responsible for the oxidation of the quinone pool, while the reduction of 
menaquinone is what was observed here. This is in complete agreement with 
the published literature (39), though, it is currently unknown whether this may 
imply the involvement of a yet undiscovered regulatory mechanism, or that the 
observed in vitro behaviour of CymA is an artefact.      
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Chapter 4 – Heterologous Expression in Escherichia coli and 
Purification of Recombinant Shewanella oneidensis MR-1 
CymAsol: Paving the Road Towards the Structural 
Determination of CymA 
4.1 Introduction 
The transmembrane quinol dehydrogenase CymA is a key component of the 
anaerobic respiratory system of S. oneidensis, which exhibits unique and 
versatile metabolic abilities. CymA belongs to the NapC/NirT family of quinol 
dehydrogenases, whose members are ubiquitous in anaerobic organisms. 
However, quinol dehydrogenases are usually part of larger multiprotein 
membrane complexes, which is in contrast to CymA that no co-purification of 
any of its partner proteins has been seen during its purification (1, 35). 
Moreover, sequence analysis of its closest homologues with bioinformatics 
suggests that CymA is evolutionary distinct (figure 34) and limited 
conservation with the closest homologues of CymA, except the highly 
conserved CXXCH motifs of the four haems (figure 35).  
 
 
Figure 34: Phylogenetic tree of CymA and its closest homologues. WsNrfH: 
Wolinella succinogenes NrfH, DvNrfH: Desulfovibrio vulgaris NrfH, SdNrfH: 
Sulfurospirillum deleyianum NrfH, SoCymA: Shewanella oneidensis CymA, 
PdNapC: Paracoccus denitrificans NapC, EcNapC: Escherichia coli NapC, 
HiNapC: Haemophilous influenza NapC. The tree was generated with Multiple 
Sequence Comparison by Log-Expectation by EMBL-EBI.  
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Figure 35: Multisequence alignment of CymA with its closest homologues. 
Limited conservation is observed across the protein other than the highly 
conserved CXXCH motifs of the four haems along with key residues that are 
involved in the co-ordination of the haems. SoCymA: Shewanella oneidensis 
CymA; EcNapC: Escherichia coli NapC; DvNrfH: Desulfovibrio desulfuricans 
NrfH; WsNrfH: Wolinella succinogenes NrfH; HiNapC: Haemophilus influenza 
NapC; PdNapC: Paracoccus denitrificans NapC; and SdNrfH: Sulfurospirillum 
deleyianum NrfH. The multisequence alignment was performed with T-Coffee 
(100, 101).  
 
The closest homologue of CymA is NrfH with ~60% homology. NrfH of 
Desulfovibrio vulgaris, though, is part of a stable NrfH2A4 complex. As such, 
homology modelling of CymA based on NrfH reveals limiting information about 
the structural characteristics of CymA (figure 36). The model shows an N-
terminal transmembrane α-helix and a second membrane-associated α-helix 
that closely resemble those of NrfH, not much else, however, is revealed from 
the model. Moreover, NrfH only exists as part of a strong multiprotein complex 
SoCymA    1 MNWRAL--F-------------KPSA-KYSILALLVVGIVIGVVG-YFATQQTLHA-TST 
DvNrfH    1 MSEEKS--R-------------NGPA-R---LKLVLGGATLGVVA-LATVAFGMKY-TDQ 
EcNapC    1 MGNSDRKPGL----IKRLWKWWRTPS-RLALGTLLLIGFVGGIVF-WGGFNTGMEK-ANT 
WsNrfH    1 MNKSKF--L--------------VYS------SLVVFAIALGLFVYLVNASKALSYLSSD 
HiNapC    1 MSEKKP--NI----LKRFWQWFRKPS-RMAIGTIIILSAIGGILS-WVGFNYGLEK-TNT 
PdNapC    1 MGWIRASIRWIWGRVTWFWRVISRPSSFLSIGFLTLGGFICGVIF-WGGFNTALEI-TNT 
SdNrfH    1 MMQKLL--L-------------FIKS-K--LFLFGAVGVVIGLFF-SLAMYEGLHR-TSD 
 
 
SoCymA   43 DAFCMSCHSNHSL-KNEVLASAHGG-GKAGVTVQCQDCHLPHGPV-DYLIKKIIV-SKDL 
DvNrfH   40 RPFCTSCHIMNPV-GVTHKLSGH-------ANISCNDCHAPHNLL-AKLPFKAIAGARDV 
EcNapC   54 EEFCISCHEMRNTVYQEYMDSVHYN-NRSGVRATCPDCHVPHEFV-PKMIRKLKA-SKEL 
WsNrfH   39 PKACINCHVMNPQ-YATWQHSSHA------ERASCVECHLPTGNMVQKYISK----ARDG 
HiNapC   52 EQFCASCHMQ-DA-YPEYLHSVHYQ-TRTGVGASCPDCHVPHEFG-AKMKRKIIA-AKEV 
PdNapC   59 EKFCTSCHEMRDNVYQELMPTVHFS-NRSGVRASCPDCHVPHEWT-DKIARKMQA-SKEV 
SdNrfH   41 DKFCIVCHEMAPM-VAAYHNDVHGGAGKTGIKVTCVTCHLPHDNVLAYIATKARNGVVEG 
 
 
SoCymA   99 YGFLT---IDGFNTQAWLDENRKEQADKALAYFRGNDSANCQHCHTRIYENQPETMKPMA 
DvNrfH   91 YMNTL----GHPGD--------LILAGMETKEV---VNANCKACHTMTNVEVAS------ 
EcNapC  111 YGKIF----GVIDTPQKFEAHRLTMAQNEWRRMKDNNSQECRNCHNFEYMDTTA-QKSVA 
WsNrfH   88 WNHSVAFTLGTYDH-------SMKISEDGARRV----QENCISCHASLSSTLLE-NAD-- 
HiNapC  107 YAHYT----GKVDTLEKFNAHRLEMAQNEWARMKANDSKECRNCHNVDRMNFND-QRSVA 
PdNapC  116 WGKIF----GTISTREKFLEKRLELAKHEWARLKANDSLECRNCHAAVAMDFTK-QTRRA 
SdNrfH  100 AIHFF----GNPDAIDW-HANR-------AKKEHFVEDGGCIGCHTNYKTNTNISAKGLK 
 
 
SoCymA  156 VRMHTNNFKKDPETRKTCVDCHKGVAHPYPKG---------------------------- 
DvNrfH  130 -----------MEAKKYCTDCHRNVQHMRMKPISTRE----V--AD-------------- 
EcNapC  166 AKMHDQAV---KD-GQTCIDCHKGIAHKLPDM-REVE----PG----------------- 
WsNrfH  134 -RNHQFNDPKGA-SERLCWECHKSVPHGKVRSLTA-T----PDNLGVREV---------- 
HiNapC  162 ARMHQKMK---TE-GKTCIDCHKGIAHQLPDM-SGVE----SGFKD---E---------- 
PdNapC  171 PQIHERYL---ISGEKTCIDCHKGIAHQLPDM-TGIE----PGWLEPPELRGEEQAWLGG 
SdNrfH  148 MHAHYDSL-KDTDKKIGCASCHVEVGHHGLKSMLNYYKPEYPYYNGKLDKK--------- 
 
 
SoCymA      --------------- 
DvNrfH  159 --------------E 
EcNapC  200 --------------F 
WsNrfH  177 --------------K 
HiNapC  200 --------------K 
PdNapC  223 GAEAVHRYLATVETR 
SdNrfH  198 -KEEVEKKLNET-LK 
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with NrfA, from which it is hypothesised that structurally NrfH and CymA 
should have significant differences in their globular domains in order for the 
latter to be able to interact with a great number of different proteins.  
  
 
Figure 36: Structural homology model of CymA. A homology model was built 
using, as a template, the resolved crystal structure of NrfH (PDB: 2VR0), which 
was identified as the one with the closest homology to CymA by SWISS-
MODEL (102, 103). A: structure of the CymA model. B: Quality comparison 
graph. The global model quality estimate score was 0.48, which is indicative of 
a low quality model (the closest to 1 the score is, the more reliable the model 
is).   
 
Although a larger number of S. oneidensis proteins that comprise its anaerobic 
respiratory system had their crystal structures resolved, the crystal structure 
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of CymA remains elusive. This has been mainly due to limitations in producing 
sufficient quantities of the protein in a high quality monodisperse solution in 
order to enable crystallographic studies. However, a high-throughput system 
for the expression and purification of multi-haem cytochromes from S. 
oneidensis has been developed for their heterologous expression in E. coli 
(89). The pMKL1 plasmid from this system was explored in this chapter for the 
production of CymAsol. The pMKL1 plasmid encodes for a 6xHis-MBP-CymAsol 
construct with an engineered TEV proteolytic site at the end of MBP for the 
removal of the tags. CymAsol refers to a truncated soluble version of CymA,  
without the first 31 amino acids that comprise the majority of the 
transmembrane α-helix, but leaving intact the quinone binding site.   
This chapter presents the first reported crystallisation attempt in the quest of 
elucidating the crystal structure of CymA. Firstly, the production of high quality 
recombinant CymAsol was presented, along with its characterization. Finally, 
the preliminary results of seven different crystallisation screens are presented, 
paving the way for the structural determination of CymA.  
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4.2 Results 
4.2.1 Expression and purification of CymAsol 
E. coli BL21 cells were co-transformed with pMKL1 and pEC86, which were 
grown in TB medium in order to support higher cell mass during large-scale 
expression cultures. The cells were grown to mid-exponential phase (OD600 ~ 
0.7) under microaerobic conditions at 30 °C with orbital shaking at 200 rpm, 
before they were induced with 50 µM IPTG. Normally, in an E. coli protein 
expression system, the ratio of the culture volume to the volume capacity of a 
flask is 1:5. However, this ratio was reduced to 1:2, which along with a 
decrease of the agitation speed, resulted in microanaerobic conditions in order 
to promote the incorporation of the four c-type haems. Moreover, the lower 
temperature, from the ideal for E. coli (37 °C), was employed for slowing 
protein overexpression and, by extension, promote correct protein folding.     
Initially, the full CymAsol construct carrying a 6xHis-tag and MBP was purified 
from the isolated soluble periplasmic fraction of overexpressing cells by 
immobilised-Ni2+ affinity chromatography. The electrophoretic purification 
profile is shown in figure 37, which shows two prominent bands at around 65 
kDa and around 40 kDa that both stain with an anti-His antibody on Western 
blot. These two bands are present in the load and in the eluates but not in the 
flowthrough or the wash samples. Thus, the purification was efficient with no 
loss in the form of unbound material. The full construct has an approximately 
theoretical molecular mass of 64 kDa, while a truncated version lacking the 
CymAsol has a theoretical molecular mass of 43 kDa (MBP of 42 kDa plus 
6xHis of 1kDa). Thus, it was concluded that the two prominent bands from the 
purification are of the construct with and without CymAsol (denoted as whole 
and truncated respectively in figure 37). Such truncation was observed before 
when MBP is employed as an aid in expressing difficult proteins or increasing 
the solubility of the target protein (104).  
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Figure 37: Immobilised-Ni2+ affinity electrophoretic purification profile from the 
periplasmic fraction of E. coli BL21 pMKL1/pEC86 cells overexpressing 
6xHisMBPCymAsol construct. 15% SDS-PAGE stained with Coomassie stain 
(top gel) or Western blot with anti-His antibody (bottom gel). M: molecular mass 
protein markers; LD: column load; FT: flow-through during binding; W9: 5 mM 
binding buffer wash; E16, E17, E19, E21, E23, and E24 eluates upon 
application of imidazole.   
 
Subsequently, the eluates containing the protein of interest were pooled and 
subjected to proteolytic reaction mediated by TEV protease overnight at 4 °C 
for the removal of the tags. It was empirically observed that the cleavage 
reaction was not very efficient and TEV protease was required ideally at a 
ratio of  1:2 of total protein (mg) to TEV protease (mg). The mixture was then 
subjected to a reverse immobilised-Ni2+ affinity chromatography, where only 
CymAsol without tags came through the flowthrough. Typical yields from 1L of 
culture were 32 mg of total purified proteins (quantified by µBCA), from which 
256 µg of CymAsol (quantified spectrophotometrically) were purified. It must be 
noted that care should be taken during the reverse affinity chromatographic 
step as to use excess of IMAC resin or columns in order to allow for the vast 
amount of TEV protease and non-cleaved/ contaminating material to bind.  
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The purified CymAsol was further polished by a S75 size exclusion 
chromatographic step (figure 38) in order to ensure high quality 
monodispersed material for crystallographic studies. The final purified  
CymAsol resulted in a >90% purity, determined by SDS-PAGE and shown in 
figure 39. 
 
 
Figure 38: Size exclusion chromatographic profile of purified CymAsol with 
HiLoad 16/600 Superdex 75 prep-grade column. The void volume (Vo) is 45 
ml. The chromatography was performed with ÄKTA pure 25 at 4 °C with a flow 
rate of 0.5 ml min-1. The buffer composition was 20 mM HEPES pH 7.5, 150 
mM NaCl.    
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Figure 39: Electrophoretic profile of purified recombinant CymAsol after size 
exclusion chromatography. 15% SDS-PAGE stained with Coomassie stain 
(A), and Western blot with anti-CymA antibody (B). M: molecular mass protein 
markers.  
 
4.2.2 Biochemical and electrochemical characterization of 
purified CymAsol  
Purified recombinant CymAsol was analysed spectrophotometrically and the 
obtained UV-visible (λ = 250 nm – 800 nm) absorbance spectra of oxidised 
and reduced CymAsol are shown in figure 40. The spectrum of the oxidised 
CymAsol resolved a broad shoulder between 500 nm and 600 nm and a peak 
at 407 nm that corresponds to the Soret γ-band of light absorption by the 
haems. The spectrum of reduced CymAsol showed the resolution of the Soret 
α- and β- bands at 551 nm and 522 nm respectively, while the Soret γ-band 
shifted to 418 nm. The purity ratio of A407/ A280 was 5.4. 
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Figure 40: UV-visible absorbance spectra of oxidised and reduced purified 
recombinant CymAsol. Measurements were conducted at ambient conditions 
in 20 mM HEPES pH 7.5 and 150 mM NaCl. The spectra are baseline 
corrected. The spectrum of fully reduced CymAsol (red line) was obtained by 
addition of excess of dithionite.   
 
Protein film electrochemistry was employed to characterise the electrical 
properties of CymAsol, as well as assay whether it is catalytically active in a 
similar manner as described for CymA† in chapter 3. Upon protein adsorption, 
non-turnover signals were observed (figure 41), which are in agreement with 
those for CymA. Subsequently, upon addition of menaquinone-loaded 
liposomes a catalytic reductive wave was observed (figure 42) with a slightly 
greater in magnitude signal than it had been observed for CymA. This can be 
explained by the truncation of most of the highly hydrophobic transmembrane 
α-helix, which could potentially allow for a quicker dissociation from the 
liposomes. Thus, the purified CymAsol is catalytically active, with its electrical 
properties unaltered.   
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Figure 41: Cyclic voltammetry of CymAsol protein film resolving non-turnover 
signals. SAM: 1:10 NH3+/OH- thiol self-assembled monolayer. CymAsol film: 
adsorbed CymAsol protein film after removing excess of CymAsol by three buffer 
washes. The measurements were performed under a nitrogen atmosphere (02 
≤ 0.1 ppm) at ambient conditions and at a scan rate of 10 mV s-1. The buffer 
composition was 20 mM MOPS pH 7.4 and 30 mM Na2SO4.     
 
Figure 42: Cyclic voltammetry of CymAsol protein film resolving catalytic 
reductive signal on addition of menaquinone (MQ7)- containing POPC-
liposomes. SAM: 1:10 NH3+/OH- thiol self-assembled monolayer. The 
measurements were performed under a nitrogen atmosphere (02 ≤ 0.1 ppm) at 
ambient conditions and at a scan rate of 10 mV s-1. The buffer composition was 
20 mM MOPS pH 7.4 and 30 mM Na2SO4.     
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4.2.3 Protein crystallisation: preliminary results 
Although the production of CymAsol was challenging with low output yield, 
sufficient material was produced and used to set up crystallisation trays at 1 
mg ml-1 protein concentration. This was possible because of, firstly, 
technological advances in liquid handling technologies that are able to 
accurately handle liquid volumes at the nL level. Secondly, a 10-fold lower 
protein concentration was used than what one would normally use for 
crystallisation. This was based on the hypothesis, that was partially in 
agreement with empirical observation during the purification, of a decreased 
solubility of CymAsol that were based on its partial truncation of the 
transmembrane α-helix and the intact second membrane-associated N-
terminal α-helix.  
As this was the first attempt to crystallise CymA of any form, initially four 
commercially available screens were employed, which contain a wide range 
of conditions for globular proteins: JCSG Core I, II, III, and IV Suites. 
Subsequent screens were set up with a  screen that assays various conditions 
of PEG polymer as the precipitating agent (PACT Suite), as well as two 
screens that are specifically designed for membrane proteins (MemGold2™ 
and Morpheus®). A three-drop 96-well plate setup was employed, where drop 
1, 2, and 3 were at 1:1, 1:2, and 2:1 protein to crystallization solution ratio 
respectively with incubation at room temperature and monitoring over 34 days.  
The drops were imaged at specified intervals during this period of time with 
optical imaging, along with UV-TPEF and SHG imaging. UV-TREF allows UV 
imaging of excited amino acids with aromatic residues (such as tryptophan) 
while minimising protein damage that can be used to identify protein crystals 
from salt crystals. SHG imaging allows the identification of chiral crystals that 
appear white against a black background and it is particularly useful in 
identifying microcrystals that would have otherwise been missed when for 
example heavy protein precipitation is seen. 
Figure 43 shows representative examples of the different drops that were 
observed during this screening. Those varied from clear drops, where the 
protein is in solution (panel A figure 43) to protein precipitation of various 
degrees and morphologies (panels B-F figure 43).  
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Figure 43: Representative images of the different types of drops that were 
observed during crystallization screening of CymAsol. 
 
The lower protein concentration that was employed was of initial concern in 
analysing the results of those trials. In order to gain a better understanding of 
the effect of this, all the drops of all the trials were analysed at the end of the 
incubation period. The drops were categorised into three groups: clear drops 
(C) as seen in panel A of figure 43, drops with precipitation (P) as seen in 
panels B to F of figure 43, and of blanks (where no drop was dispensed 
during the automatic liquid handling procedure). The results are summarised 
in table 3. The high accuracy and efficiency of the automatic liquid handling 
machine produced minimal blank wells with no drops (0-1% of the total drops 
per screen). The JCSG I, II, III, and IV screens had a ratio closer to 1:1 
between clear drops and drops with protein precipitation, while the membrane 
protein-specific screens had a shifted ratio closer to 1:4. However, almost all 
of the drops (98%) in the Pact screen had protein precipitation of varying 
levels.  
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Table 3: Summary of the crystallisation results for CymAsol. The counts of each 
drop per screen are shown, which were categorized as clear drops (C), drops 
with precipitation (P), and blanks (B) where no drops were dispensed by error. 
The total counts were converted into % total drops per screen.   
 
The rationale of this analysis stems from the principles of protein 
crystallisation during which both the protein and the precipitant concentration 
are important in having the protein arriving into the nucleation zone in order to 
promote its crystallisation. Undersaturated, seen as clear drops, and 
supersaturated material, seen as drops with heavy precipitation, sit at the two 
extremes of the precipitation spectrum and far from the nucleation zone 
(figure 44). As such, screens where the majority of the drops are clear or 
highly saturated would indicate that a change in the initial protein 
concentration is required before assaying the crystallisation conditions 
themselves or addressing protein regions with high disorder. Empirically a 
ratio of 1:1 or slightly shifted ratio towards precipitation of the number of drops 
within a particular screen is recognized as an acceptable ratio for 
crystallisation screening. Thus, although CymAsol was at 1 mg ml-1, acceptable 
ratios of clear drops to drops with precipitation were observed for most of the 
screens, yielding a degree of confidence during these screens.   
Screen
C P B C P B C P B
Drop 1 45 50 1 31 64 1 43 53 0
Drop 2 18 78 0 28 66 2 28 66 2
Drop 3 40 55 1 49 47 0 54 42 0
Total 103 183 2 108 177 3 125 161 2
% Total 36% 64% 1% 38% 61% 1% 43% 56% 1%
Screen
C P B C P B C P B
Drop 1 51 45 0 1 95 0 18 78 0
Drop 2 43 53 0 2 94 0 24 72 0
Drop 3 51 44 1 2 94 0 22 74 0
Total 145 142 1 5 283 0 64 224 0
% Total 50% 49% 0% 2% 98% 0% 22% 78% 0%
Screen
C P B
Drop 1 11 85 0
Drop 2 17 79 0
Drop 3 12 84 0
Total 40 248 0
% Total 14% 86% 0%
Morpheous 
JCSG I JCSG II JCSG III
JCSG IV Pact MemGold2
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Figure 44: A schematic diagram of the different zones of protein state as a 
function of protein concentration versus precipitant concentration. In the 
undersaturated zone the protein is soluble and in solution, while at the other 
extreme in the supersaturated zone/ precipitation zone, most of the protein has 
precipitated out of solution. In the metastable zone, the protein may exhibit 
atypical precipitation to some degree, while in the nucleation zone, the protein 
if possible will start packing in a crystal lattice. The figure was reproduced with 
modifications from (105).  
 
Overall, no crystals were obtained from those experiments. More specifically, 
no chiral crystals were observed with SHG imaging in any drop from any 
screen. However, some protein precipitation in patterns with observed 
“growth” was observed in some drops (figure 45) that showed UV absorption 
with UV-TREF imaging. Although they did not yield a crystal, those conditions 
(table 4) and/ or expansion around those conditions in future trials may prove 
fruitful.  
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Figure 45: Drops with protein precipitation in patterns with positive UV-TREF 
imaging from the crystallisation screening of CymAsol. The drops with 
atypical/ in pattern precipitation that grew overtime. Snapshots at time zero and 
at day 3 and day 34 were shown, along with the UV-TREF imaging at day 34.   
 
Table 4: Composition of the crystallisation solutions. The solution composition 
and the protein to solution ratio of the drops from figure 41 that showed protein 
precipitation in patterns with positive UV-TREF imaging.   
Screen Position Composition protein to 
solution ratio 
MemGold2 D8 0.2 M Magnesium formate dihydrate  
0.5 M Tris pH 8.0 
19% w/v PEG 3350 
1:1 
MemGold2 D10 0.2 M Ammonium nitrate 
0.05 M HEPES pH 7.0 
20% w/v PEG 3350 
1:1 
PACT Suite F5 0.2 M Sodium nitrate 
0.1 M bis-Tris propane pH 6.5  
20% w/v PEG 3350 
1:2 
PACT Suite E2 0.2 M Sodium fluoride  
20% w/v PEG 3350 
1:1 
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4.3 Conclusions 
CymA is a distinct member of the NapC/NirT family of quinol dehydrogenases 
as in contrast to the majority of the members of this family CymA is not part of 
a multiprotein membrane complex. This does not come as a surprise, though, 
when the fact that it is able to interact with a number of different periplasmic 
proteins is taken into account. One can assume that the globular domain of 
CymA must be significantly structurally different. Thus, the elucidation of its 
crystal structure is hoped to shed some light into its mechanistic details of 
CymA, but it has been challenging due to the limitations in producing sufficient 
amounts of pure protein in a homogenous solution. Here, the first attempt to 
crystallise a soluble truncated version of CymA was presented, where 2,016 
different conditions were assayed. The preliminary results of this 
crystallisation screening, although they have not been very fruitful, they have 
indicated a few conditions that could be of interest in the future. Notably, the 
same precipitant, 19-20% w/v PEG 3350, was found in all of the promising 
drops that showed atypical protein precipitation, along with 0.2 M of salt. Thus, 
it is likely that further screening closely around 20% w/v PEG 3350 may 
uncover the conditions necessary for crystallising CymA.   
As part of this work, the heterologous expression and purification of this 
soluble truncated version of CymA was also presented. Although CymAsol has 
been used in previous studies (39, 88), it lacked a purification protocol and its 
purification has not been presented before, while its characterisation has been 
limited. The final output yield (~0.3 mg of untagged CymAsol per litre of culture) 
has been limited both in comparison with soluble proteins in general (tens to 
hundreds of mg per litter of culture) and even to CymA (~2 mg per litre of 
culture). The limitation lies on the TEV protease cleavage reaction. However, 
this could be overcome by a linker between the MBP and the proteolytic site 
in order to address occlusion of the site by the MBP tag. Also, a different 
protease that has improved activity in comparison to TEV (such as the 
HRV3C) could be tried. Lastly, an on-the-column proteolytic cleavage could 
also potentially be tested for improving the final output yield.  
The crystallisation screening of soluble proteins is straight-forward, where the 
target protein is mixed with the different crystallisation solutions that screen 
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different conditions (at varying ratios), and dispensed in drops. In contrast, 
membrane proteins are more challenging to crystallise and it usually involves 
a pre-screening of different detergents and/or lipid mixtures. Because of this 
and of time constrains CymAsol was selected as a target. Nonetheless, purified 
CymA described herein could potentially yield a crystal, since it can be 
obtained at higher quantities.  
Approaches involving the co-crystallisation of CymA or CymAsol with 
antibodies (106, 107) may help address flexible regions of increased disorder. 
Lastly, besides the standard approach of generating different constructs with 
varied truncations of CymA, an MBP fusion with the target protein has great 
potential for proteins that are resistant to crystallisation (108).         
- 105 - 
Chapter 5 – The evaluation of CymA: FccA interaction points 
to a weak transient nature of interaction 
5.1 Introduction 
The anaerobic respiratory system of S. oneidensis is comprised of a great 
number of different terminal reductases, as well as electron mediating 
proteins. This allows a metabolic versatility that is unique to Shewanella 
species by the utilisation of different anaerobic pathways based on the 
availability of terminal electron acceptors in the environment. CymA is a 
central pillar of the exhibited versatility by acting as an electron distribution 
hub from the inner membrane quinone pool, where it is located, to a plethora 
of periplasmic proteins. The promiscuity of CymA maintains the electron flow 
and, by extension, contributes to the maintenance of the proton gradient for 
ATP synthesis. As such, the interactome of CymA has been of particular 
research interest in advancing our understanding with respect to the 
mechanistic details that allow specific protein-protein interactions to take 
place for the large number of its identified partners, and the factors that 
regulate those. 
Protein – protein interactions in nature are divided into permanent and 
transient ones with KD in the nano- and micromolar range respectively. 
Transient protein complexes are further subdivided into weak and strong; a 
strong transient protein complex describes a protein complex that is strongly 
bound only when it is triggered by, for instance, the binding of its substrate. 
Overall, features, such as residue conservation (109, 110), the lever of surface 
planarity (111), and the level of disorder (flexible regions) (112) distinctly 
define the protein – protein interfaces from the rest of the protein. Specifically, 
since transiently interacting proteins need to remain soluble when they are 
dissociated, they are often comprised of a mixture of polar and non-polar 
residues that are solvent exposed (113). In contrast, strongly interacting 
proteins that form permanent protein complexes have very hydrophobic 
residues on their interface (113). Moreover, the interface of permanent protein 
complexes are larger than weak transient complexes and do not involve 
electrostatic interactions to the extend that the proteins that interact transiently 
do (114). It must be noted, though, that sometimes a protein may exhibit 
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features from both groups (permanent complexes and weak transient 
complexes) and can, thus, be difficult to categorise it based on those 
parameters alone.        
The periplasmic fumarate reductase FccA of S. oneidensis is necessary for 
the terminal reduction of fumarate to succinate via CymA. However, the nature 
of FccA: CymA interaction has recently come under intense debate due to 
contradicting evidence of two published research articles (87, 88). On the one 
hand, CymA and FccA in purified form were studied by NMR in vitro in 
solution. From these studies, their KD was determined at ~0.4 mM (87), which 
since KD = Koff / Kon, this high KD implies that CymA and FccA interact 
transiently through weak interactions (high Koff). However, it must be noted 
that those experiments were conducted in the absence of DDM detergent, 
which was used for the purification of CymA. Thus, DDM detergent was 
introduced into the experiment during protein titration and its contribution, or 
lack of, to the observations or to the determined KD has not been shown.  
On the other hand, purified CymA, CymAsol, and FccA were studied by cyclic 
voltammetry, an electrochemical method, and by QCM-D monitoring (88). In 
both of those approaches, a lipid bilayer membrane system with reconstituted 
CymA was employed in order to mimic the native environment of CymA. For 
cyclic voltammetry, the lipid bilayer membrane, which contained menaquinone 
in order to support catalysis, was tethered to the surface of the electrode by 
cholesterol tethers, while for QCM-D the lipid bilayer membrane was solid 
supported on the surface of the quartz crystal. Regarding CymAsol, the same 
lipid bilayer membrane systems were employed, but with CymAsol adsorbed 
on the surface of the membrane. Reductive catalytic waves were obtained by 
cyclic voltammetry when FccA with fumarate were introduced. However, the 
onset of the catalytic wave did not coincide with the onset of the non-turnover 
reductive menaquinone signal. In order to address this, the competitive 
inhibitor of CymA, HQNO, was employed, which diminished the observed 
catalytic signal. However, HQNO was dissolved in DMSO, which is 
detrimental to protein stability (115, 116). The lack of a control experiment with 
only DMSO and the fact that competitive inhibition was not observed raise 
questions around this line of experimentation. The QCM-D binding studies 
showed binding of FccA in the presence of fumarate to the CymA-
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reconstituted lipid bilayer membrane, which was retained during a subsequent 
washing step. The quantification of the bound FccA (as seen as mass 
deposition) could not be explained stoichiometrically (88). Thus, the authors 
argued in support of the formation of a long-lived stable complex between 
CymA and FccA (88). Those binding studies, though, are limited in scope 
without investigating the binding kinetics that could have also served as a way 
of explaining the deposited mass (the observed binding event). Overall, their 
proposed model of interaction comes in direct contradiction to the previously 
described NMR studies.  
Having designed a new CymA construct with no C-terminal tags that could 
interfere in protein-protein interactions experiments, and developed a 
reproducible purification strategy, this controversy surrounding the nature of 
FccA: CymA interaction was investigated. The initial aim was to employ the 
same systems of the second paper described above in further probing those 
observations with the ultimate goal to map any contributing factors that may 
regulate a potential FccA: CymA complex formation. As such, this chapter 
begins with the purification and characterization of native FccA from S. 
oneidensis, in order to validate the quality and activity of all the purified 
proteins that were used. The ability of those two proteins to interact was then 
validated in vitro by a biochemical spectroscopic assay. Subsequently, cyclic 
voltammetry and QCM-D were employed, which did not show any catalytic or 
binding events that could be attributed to FccA. Moreover, the systems 
themselves were further investigated providing explanations of the obtained 
data, before validating their conclusions by isothermal titration calorimetry.    
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5.2 Results 
5.2.1 Expression, purification, and characterisation of native FccA 
S. oneidensis MR-1 was grown in 5L Duran bottles anaerobically in LB 
medium that was supplemented with fumarate, which promoted the 
expression of FccA. The way this was achieved was by incubating fully filled 
5L Duran bottles at 30 °C with no agitation for 24 h. Although this was not 
resulted in a strictly anoxic environment, it takes advantage of the metabolic 
versatility of S. oneidensis, along with the limited oxygen diffusion. The cells, 
therefore, start growing by using the readily available dissolved oxygen in the 
medium first until the level of which significantly drops. At that point, the cells 
switch to using fumarate as the terminal electron acceptor in order to promote 
their growth, since fumarate is at much higher levels than the limited dissolved 
oxygen and by extension promotes the survival of the organism. 
Native FccA was then purified from the isolated soluble periplasmic fraction of 
the harvested cells. Initially, the periplasmic proteins were fractionated by IEC 
(figure 46). FccA was eluted at around 120 mM NaCl, which was identified by 
SDS-PAGE from the molecular mass, along with confirmation from haem 
staining of the gel (figure 47).  
The pooled fractions from the IEC were subjected to 50% ammonium sulphate 
fractionation to reduce the contaminating proteins, before it was polished with 
a S200 size exclusion chromatographic step (figure 48). The final purified 
native FccA was of >95% purity, determined by SDS-PAGE. The 
electrophoretic profile of FccA post high-salt fractionation and of the final FccA 
are shown in figure 49. 
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Figure 46: Ion exchange chromatographic purification profile of the elution 
over a gradient of NaCl from the periplasmic fraction of S.oneidensis  
MR-1 grown anaerobically with fumarate for FccA purification. The 
chromatography was performed with ÄKTA pure 25 at 4 °C with a flow rate of 
1 ml min-1 in 20 mM Tris-HCl pH 8.0 with a gradient of NaCl concentration. The 
red arrow indicates the point of FccA elution and the green numbered circles 
indicate the fractions that were analysed by SDS-PAGE (figure 46). 
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Figure 47 Ion exchange electrophoretic purification profile from the 
periplasmic fraction of S. oneidensis MR-1 grown anaerobically with 
fumarate for FccA purification. 15% SDS-PAGE stained with Coomassie 
stain (top gel) or c-type haem staining (bottom gel). M: molecular mass protein 
markers; LD: column load; FT: flow-through during column loading; 10, 12, 14, 
15, 19, 23 eluting fractions corresponding to the chromatographic profile in 
figure 45.  
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Figure 48: Size exclusion chromatographic profile of FccA with HiLoad 16/600 
Superdex 200 prep-grade column. The void volume (Vo) is 45 ml. The 
chromatography was performed with ÄKTA pure 25 at 4 °C with a flow rate of 
0.5 ml min-1. The buffer composition was 20 mM HEPES pH 7.5, 150 mM NaCl.    
 
 
Figure 49: Electrophoretic profile of FccA after fractionation (A) and after size 
exclusion chromatography (B). 15% SDS-PAGE stained with Coomassie 
stain. M: molecular mass markers.  
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Purified native FccA was analysed spectrophotometrically and the obtained 
UV-visible (λ = 250 nm – 700 nm) absorbance spectra of oxidised and reduced 
FccA are shown in figure 50. The spectrum of the oxidised FccA resolved a 
broad shoulder between 500 nm and 600 nm and a peak at 409 nm that 
corresponds to the Soret γ-band of light absorption by the haems. The 
spectrum of reduced FccA showed the resolution of the Soret α- and β- bands 
at 551 nm and 523 nm respectively, while the Soret γ-band shifted to 420 nm. 
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Figure 50: UV-visible absorbance spectra of oxidised and reduced purified 
native FccA. Measurements were conducted at ambient conditions in 20 mM 
HEPES pH 7.5 and 150 mM NaCl. The spectra are baseline corrected. The 
spectrum of fully reduced FccA was obtained by addition of excess of dithionite.   
 
Protein film electrochemistry was employed to assess the electrical properties 
of purified native FccA, as well as to validate its catalytic activity with 
electrochemical methods. The non-turnover signals and subsequent reductive 
catalytic wave of significant magnitude upon addition of 1 mM fumarate in 
solution are shown in figure 51. Thus, native FccA was highly pure and 
catalytically active.    
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Figure 51: Cyclic voltammetry of FccA protein film resolving (A) non-turnover 
and (B) turnover signals upon addition of 1 mM fumarate in solution. SAM: 
1:10 NH3+/OH- thiol self-assembled monolayer. FccA film: adsorbed CymAsol 
protein film after removing excess of CymAsol by three buffer washes. The 
measurements were performed under a nitrogen atmosphere (02 ≤ 0.1 ppm) at 
ambient conditions and at a scan rate of 10 mV s-1. The buffer composition was 
20 mM MOPS pH 7.4 and 30 mM Na2SO4.     
 
 
5.2.2 CymA† and FccA are able to interact in vitro 
The initial question was whether CymA† and FccA were able to interact with 
each other. In order to address this, a biochemical assay was employed which 
couples the oxidation of NADH to menadione reduction by the diaphorase 
from Clostridium kluyveri to the sequential reduction of CymA, FccA, and 
ultimately fumarate to succinate (schematically depicted in figure 52). In this 
spectrophometrically based assay the amount of NADH was monitored at  
340 nm over time. The assay was performed under anoxic conditions in the 
presence of DDM at room temperature. The assay buffer was 20 mM Hepes 
pH 7, 0.5 mM EDTA, 0.05% DDM. CymA† and FccA were at a final 
concentration of 1 µM, fumarate at 1 mM, NADH at 100 µM, menadione at 
~10 µM (a more polar analogue of menaquinone), and diaphorase was in 
excess at 3 µM.      
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Figure 52: Diagram of the diaphorase assay. The sequential reduction (flow of 
electrons) is shown of the individual components that comprise this assay. 
Diaphorase initiates the reaction by oxidizing NADH and reducing menadione 
(Q), which in turn reduces CymA, and then FccA via CymA, which catalyses 
the terminal reduction of fumarate to succinate.  
 
 
A steady drop in absorbance at 340 nm upon addition of diaphorase, which 
initiates the reaction by the coupled NADH oxidation and menadione 
reduction, was observed with an initial rate of 3.3 (±0.3, n=3) μM NADH 
oxidised min-1 (a represenative trace is shown in panel B figure 53). As a 
control, CymA† was eliminated and no change in the absorbance at 340 nm 
was observed (represenative trace is shown in panel A figure 53). 
Furthermore, in order to verify the necessity of CymA† in the observed change 
of measured signal, a further experiment was conducted, where the CymA† 
was added last (representative trace is shown in panel C figure 53). This 
addition of CymA† re-established a change overtime of NADH oxidation. 
Thus, CymA† is able to interact in vitro under those conditions with FccA and 
it is necessary for the sequential FccA-specific reduction of fumarate.    
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Figure 53: Diaphorase assay traces (absorbance at 340 nm overtime), where 
CymA is necessary and required for the specific reduction of FccA via 
CymA. The assay consisted of 1 µM FccA and CymA, 100 µM NADH, 3 µM 
diaphorase, 10 µM menadione, and 1 mM fumarate. The assay buffer was 20 
mM HEPES pH 7.0, 0.5 mM EDTA, 0.05% w/v DDM. The assay was performed 
under anoxic conditions at room temperature.   
 
5.2.3 Binding of FccA to a CymA†-ssBLM system is not observed 
during QCM-D measurements  
Having established that CymA and FccA are able to interact in vitro, the 
surface sensitive technique of QCM-D was employed in order to investigate 
further the nature of their interaction. That is, it is employed as a mass sensor 
that is able to monitor in real time without the need of labelling the association 
and dissociation of molecules on its surface with a reported sensitive of 0.5 
ng cm-2. QCM-D is comprised of a quartz crystal sandwiched between two 
electrodes, whose surface can be coated with various materials to suit a wide 
range of applications. The quartz crystal, upon application of an alternating 
current, oscillates at its resonance frequency. When the application of the 
current is stopped, the oscillation decays exponentially while any changes in 
its resonance frequency and in its energy dissipation (the loss of energy per 
period from the total energy of the system) are displayed. Mass 
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measurements  can then be made by using the Sauerbrey equation that links 
the change in frequency (Δf) to the change in mass (Δm): Δf = - Cf ∙ Δm, where 
Cf is the sensitivity factor of the crystal that is used. Change in the dissociation 
(ΔD) is linked with the softness of the material/solution on the surface of the 
crystal.  
In the experiments described in this thesis a silicon oxide quartz crystal is used 
in order to promote the rupture of liposomes or proteoliposomes of CymA and 
the spontaneous assembly of a solid-supported lipid bilayer. As such, CymA 
in an artificial lipid bilayer environment that mimics its native environment can 
be used to investigate the association of FccA, when FccA is in a continuous 
slow flow in a buffer solution over the bilayer. All the measurements were 
conducted at room temperature.  
CymA†-proteoliposomes of 10% w/w CL/POPC were employed since that 
lipid mixture was previously used in obtaining what was reported as FccA 
binding, although the authors could not ascribe the binding stoichiometry from 
mass calculations (88). Thus, initially, this replication attempt of those data 
would have served as the basis for further characterizing the FccA binding to 
CymA and later be extended to investigate unpublished observations of the 
necessity of fumarate in promoting FccA: CymA binding. However, extensive 
experimentation with this system by QCM-D monitoring, did not produce any 
evidence of FccA association that would have been observed as a shift in Δf 
(representative trace is shown in figure 54). Same traces of no FccA 
association were obtained in the presence or absence of fumarate, when FccA 
concentration was doubled, and when FccA was incubated in situ (by stopping 
the continuous flow of solution). Taking into account that (1) a stoichiometry 
could not be ascribed, and (2) the lack of kinetic information of the association 
and dissociation events, the published traces of FccA binding could be 
explained as a non-specific binding event. This non-specific binding could 
further be explained by either a contaminating protein in the FccA production, 
where the non-specific binding of the contaminant to the lipids most likely 
mediated electrostatically. Or of the formation of a non-uniform solid 
supported lipid bilayer that would have been resulted in areas of solvent 
exposed silicon oxide crystal surface, where FccA would bind to the surface 
non-specifically.  
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Figure 54: QCM-D binding experiment with CymA 10% w/w CL/POPC solid 
supported lipid bilayer membrane and FccA in solution in the presence of 
1 mM fumarate, where no association of FccA is observed. The experiment 
was conducted at room temperature. The wash buffer composition was 20 mM 
MOPS pH 7.4 and 30 mM Na2SO4.  
 
 
5.2.4 Electrochemical investigations in a tBLM system and with 
FccA does not resolve catalytic activity  
A tethered bilayer lipid membrane (tBLM) system was used in order to 
electrochemically investigate the CymA:FccA interaction. A tBLM system 
employs thiol-terminated cholesterol tethers in a mixture of thiols to modify the 
surface of a gold electrode. Liposomes are then incubated in situ in the 
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presence of calcium chloride, where spontaneously ruptured and formed a 
suspended bilayer lipid membrane. Calcium chloride is usually required when 
charged lipids are used, where it screens their surface charge and by 
extension promotes their aggregation onto the surface of the modified 
electrode. The percentage of the cholesterol tethers on the surface is also 
important in allowing sufficient space between the electrode and the lipid 
bilayer membrane in order to accommodate the liposome-reconstituted 
membrane proteins.  
CymA was reconstituted in liposomes containing menaquinone-7 (MQ7), its 
substrate. The tBLM is electrochemically linked to the MQ7 in the bilayer, 
where under non-turnover conditions the oxidation and the reduction of MQ7 
is observed as the voltage is cycled through the varying potentials. Previously 
reported data showed a reductive wave of the MQ7 reduction using the same 
system upon addition of FccA in the presence of fumarate (88). Generally, 
during catalysis, the oxidation peak of MQ7 disappears, as all MQ7 molecules 
are oxidised by CymA and the reduction peak of MQ7 appears as a catalytic 
wave. That is, as the electrode reduces MQ7 it is concurrently being oxidised 
by CymA. Thus, it provides indirectly evidence of the terminal fumarate 
reduction by FccA via CymA. All of the electrochemical investigations reported 
in this thesis were conducted at room temperature under anoxic conditions (in 
a N2 atmosphere inside a glovebox).  
10% w/w CL/POPC CymA†-tBLM and FccA 
Initially, CymA† was reconstituted in 10% w/w CL/POPC and used to form a 
tBLM on the surface of a modified electrode in a replication attempt of the 
previously reported data under the published conditions (88). This would have 
formed the basis for further probing the system in gaining a more detailed 
understanding of the nature of CymA: FccA interactions during catalysis. 
However, upon extensive investigation (a representative trace is shown in 
figure 55) no evidence of catalytic activity was observed. The amount of 
CymA was doubled during reconstitution in order to address potential 
limitations in the available CymA with the correct orientation on the tBLM, as 
well as lowering the pH to 6 in order to further resemble the pH at the 
periplasmic space of S. oneidensis, although the later can very slightly in 
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nature. In order to understand this controversy in obtained data from the 
published data the system was further explored.      
 
Figure 55: Representative trace of cyclic voltammetry of CymA 10% CL/POPC 
tBLM and addition of 1 µM FccA in the presence of 1 mM fumarate, where 
no catalysis is observed. SAM: 6-mercaptohexanol/ EO3C. The 
measurements were performed under a nitrogen atmosphere (02 ≤ 0.1 ppm) at 
ambient conditions and at a scan rate of 10 mV s-1. The buffer composition was 
20 mM MOPS pH 7.4 and 30 mM Na2SO4.     
 
 
E. coli polar lipids CymA†-tBLM and FccA 
E. coli polar lipids were employed to replace the CL/POPC under the rationale 
that the former would resemble more the native lipid composition of S. 
oneidensis in case protein: lipid interactions may be a contributing factor in 
vivo. The increased amount of CymA reconstituted was maintained, and both 
pH 7.4 and pH 6 were tested along with increasing concentration of FccA. 
However, none of which provided any evidence of catalysis either 
(representative traces are shown in panel A figure 56). The rate of the cycling 
voltage was also lowered to 1 mV/s in order to allow more time at any given 
potential in order to address the possibility of a slow reaction. No evidence of 
catalysis was obtained either (representative trace is shown in panel B figure 
56). Considering that neither QCM-D nor electrochemical methods provided 
evidence of interaction between CymA and FccA, a new hypothesis was 
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formed, which was based on an impure FccA sample. Should an impure FccA 
sample was used previously (88), then a missing protein that would have been 
unknowingly present in that sample may be part of the fumarate reduction 
anaerobic pathway.   
 
 
Figure 56: Representative trace of cyclic voltammetry of CymA E. coli polar 
lipids tBLM and addition of FccA in the presence of 1 mM fumarate, where 
no catalysis is observed. SAM: 6-mercaptohexanol/ EO3C. The 
measurements were performed under a nitrogen atmosphere (02 ≤ 0.1 ppm) at 
ambient conditions and at a scan rate of (A) 10 mV s-1, and (B) 1 mV s-1. The 
buffer composition was 20 mM MOPS pH 7.4 and 30 mM Na2SO4. The coloured 
lines in the key indicate the final solution concentrations of fumarate and FccA. 
The same CymA-containing tBLM was used for each set of measurements.     
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E.coli polar lipids CymA†-tBLM and periplasmic proteins from S. oneidensis  
In testing the new hypothesis of a missing component from the FccA-specific 
fumarate reduction via CymA, the periplasmic proteins of anaerobically grown 
S. oneidensis MR-1 with fumarate (as described for FccA purification) was 
isolated. The electrophoretic profile is shown in figure 57, where FccA is 
estimated to be 20-30% present of the total proteins (panel A figure 57). 
Moreover, fumarate reductase activity of the isolated periplasmic proteins was 
verified by methyl-viologen assay (raw data are presented in panel B figure 
57). Having established that both FccA was present and that the sample 
exhibited fumarate reductase activity, it was used in a tBLM system of 
reconstituted CymA in E. coli polar lipids at ~1 mg ml-1. However, those 
conditions also did not provide any evidence of catalysis. A representative 
trace is shown in figure 58, where only a minor shift in the redox peaks of 
MQ7 is observed. This shift is due to a pH difference between the buffer and 
the sample which alters the redox potentials of MQ7. Thus, an investigation 
was prompted into the system that could explain both the previously obtained 
traces that had been interpreted as catalysis (88), and the lack of evidence for 
catalysis under a great number of different conditions that were presented 
here. 
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Figure 57: Isolation of periplasmic globular proteins from anaerobically grown 
S. oneidensis MR-1  in the presence of fumarate with fumarate reductase 
activity. A. Coomassie-stained SDS-PAGE of the fraction 1 (sup) and 2 (per2) 
of the soluble components of the periplasm, as well as the cytoplasmic fraction 
(cyt). The FccA was visually estimated from this gel to be between 20-30%. B. 
Methyl-viologen assay for fumarate reductase activity of the two fractions. The 
second fraction (per2) was used in electrochemical experiments.    
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Figure 58: Representative trace of cyclic voltammetry of CymA E. coli polar 
lipids tBLM and addition of periplasmic proteins from S. oneidensis MR-
1 anaerobically grown with fumarate, where no catalysis is observed. 
SAM: 6-mercaptohexanol/ EO3C. The measurements were performed under a 
nitrogen atmosphere (02 ≤ 0.1 ppm) at ambient conditions and at a scan rate of 
10 mV s-1. The buffer composition was 20 mM MOPS pH 7.4 and 30 mM 
Na2SO4.     
 
5.2.5 The effect of oxygen in a CymA†-tBLM system during 
electrochemical investigations 
 The investigation of the system was further guided by a closer inspection of 
the published data (88), where the onset of the reported catalysis (~ 0 V) did 
not coincide with the onset of MQ7 reduction. This is important as it would 
imply that electrons do not flow through MQ7, but it is a different redox reaction 
that is occurring on the electrode. This resulted in investigating the effect of 
dissolved oxygen in a CymA†-tBLM. More specifically, two questions have 
arisen: (1) what would the impact of dissolved oxygen be? And (2) whether 
oxygen could accumulate in the electrochemical cell during cyclic 
voltammetry?     
When dissolved oxygen was introduced at 27 µM concentration, a reductive 
catalytic wave was observed of significant magnitude and with an onset at 
around ~ 0 V (panel A figure 59). Moreover, the oxidation peak of MQ7 
disappeared, in effect replicating the published data (88) (panel A figure 59). 
The magnitude of the reductive catalytic current was increased when the 
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concentration of dissolved oxygen increased, and persisted when cyclic 
voltammetric measurements were taken after 15 min and 30 min (panel B 
figure 59). Nonetheless, it is more likely that other factors, along with oxygen, 
may have contributed in obtaining the published data than oxygen alone. 
However, this explains to a degree the controversy.    
   
 
Figure 59: Cyclic voltammetry of CymA E. coli polar lipids tBLM and addition 
of small volumes of air-equilibrated buffer, where (A) a reductive wave is 
observed that (B) persists overtime. SAM: 6-mercaptohexanol/ EO3C. The 
measurements were performed under a nitrogen atmosphere (02 ≤ 0.1 ppm) at 
ambient conditions and at a scan rate of 10 mV s-1. The buffer composition was 
20 mM MOPS pH 7.4 and 30 mM Na2SO4. Red lines: air-equilibrated buffer was 
added to the shown final concentration of dissolved oxygen. Blue and magenta 
lines are the measurements after 15 min and 30 min respectively inside the 
glovebox (N2 atmosphere) without changing the solution.      
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5.2.6 The influence of bilayer membrane surface charge in the 
adsorption of CymAsol 
CymAsol was previously used both in investigations of the FccA: CymA 
interaction both by electrochemical methods and by QCM-D measurements 
(88), which could not be replicated under the published conditions. As such, 
an investigation into that system was necessary in understanding this 
controversy. This investigation was guided by observations during CymAsol 
production, where, as mentioned before, the whole or truncated construct 
(6xHisMBPCymAsol or 6xHisMBP respectively) could escape in the 
flowthrough, along with the untagged CymAsol, during reverse affinity 
chromatography after the TEV proteolytic cleavage reaction. Hence, the 
whole construct was purified at around 90% purity (figure 60).  
 
 
Figure 60: Electrophoretic profile of purified 6xHisMBPCymAsol whole 
construct. 15% SDS-PAGE stained with Coomassie stain (left gel) and c-type 
haem staining (right). M: molecular mass protein markers.  
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The rationale was to investigate the electrostatic non-specific binding of either 
pure CymAsol or of the whole construct (and by the process of elimination the 
6xHisMBP component of the construct) on three different lipid bilayers: POPC 
that is neutral at physiological pH, mixture with DOTAP that is positively 
charged at physiological pH, or mixture with CL that is negatively charged at 
physiological pH. Strong binding of the whole construct was observed to 
negatively charged lipid bilayer by QCM-D (panel B figure 61) and not to 
either neutral or to a positively charged one (panels A and C figure 61).  
On the other hand, pure CymAsol binding was observed to a positively charged 
lipid bilayer (panel F figure 61) and not to either a neutral or to a negatively 
charged one (panels D and E figure 61). Incidentally, the conditions that have 
been previously used in the published data (88) were of those where binding 
of the whole construct is observed and not of pure CymAsol.  
Thus, any electrochemical or binding data that had been previously obtained 
with CymAsol could not be attributed to CymAsol. That is, the whole construct 
and more specifically the presence of the 42 kDa MBP occludes the binding 
site of CymAsol rendering it catalytically inactive. Moreover, the evidence 
presented here can also provide some explanation of the non-specific nature 
of binding that was previously observed during QCM-D measurements.      
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Figure 61: QCM-D binding experiments of HisMBPCymAsol (A-C) or pure 
untagged CymAsol (D-F) on lipid bilayer membranes with different net 
surface charges, where the whole construct only binds to negatively 
charged membrane while pure untagged CymAsol only binds to positively 
charged membrane. Introduction of the proteins occurs at the markers 
segment after the ssBLM segment. QCM-D experiments were conducted 
at room temperature. The buffer composition was 20 mM MOPS pH 7.4 
and 30 mM Na2SO4, which was also used for the wash step.   
 
5.2.7 Probing CymAsol: FccA interaction by ITC 
Having arrived to the understanding that the previously published evidence 
that argued the formation of a stable complex of CymA: FccA (88) may to an 
extend have stemmed from a misinterpretation of the obtained data, as well 
as in order to verify that the evidence presented in this thesis, the CymA:FccA 
interaction was probed by ITC.  
ITC is able to directly monitor the changes in temperature of a stirring solution 
as another is titrated, whose energy is also quantified from the power that is 
required to maintain the cell at the baseline temperature. As such, it is 
employed to determine the thermodynamic parameters of interactions in 
solution. Also, any results that show that no interactions are taking place in 
solution can be trusted more than of other techniques that indirectly probe 
interactions of biomolecules. This was the reason of employing this technique 
in case CymA and FccA associate very weakly, most likely due to a transient 
nature of interaction, which would have been implied from the very high 
reported KD of ~0.4 mM for these proteins.  
CymAsol was chosen over CymA, since the latter would require the presence 
of DDM detergent. DDM molecules could exchange within the formed micelles 
and, therefore, give false signals. CymAsol was in the cell at 10 µM and FccA 
at 100 µM (panel C figure 62) and 390 µM (panel D figure 62) was titrated. 
Control titrations of buffer to buffer and of buffer to CymAsol are shown in 
panels A and B respectively of figure 62. No interactions were observed by 
ITC during those conditions. Usually, a good quality (i.e. sufficient points 
before and after binding saturation of available binding sites) binding curve is 
obtained with the titrant at concentration 10-fold higher than the KD, it can be 
concluded that the KD of CymA:FccA interaction must be >3.9 µM, which is in 
agreement with the reported KD of 0.4 mM. It should be noted that some 
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changes in power was seen when FccA at 390 µM was titrated (panel D 
figure 62). This is most likely due to the very high viscosity of FccA at that 
concentration, which is also the limitation in obtaining a binding curve by ITC 
should the KD be as high as previously reported.    
        
 
Figure 62: Isothermal titration profiles with 10 µM CymAsol in the cell and FccA 
as titrant. A: control titration of buffer to buffer in order to assess for buffer 
mismatch. B: control titration of buffer to CymAsol. C: FccA titration at 100 µM. 
D: FccA titration at 390 µM. The titrations were conducted at room temperature. 
The cell temperature was maintained at 25 °C.  
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5.3 Conclusions 
The nature of the FccA: CymA interaction was the focus of this chapter. 
Initially, the ability of these two proteins to interact in vitro was demonstrated 
with the diaphorase assay where an initial rate of 3.3 (±0.3, n=3) μM NADH 
oxidised min-1, which although it seems as a particularly slow reaction, it was 
slightly higher than what has been reported before (1). This is most likely 
attributed to the presence of detergent, the use of a menaquinone analogue, 
and /or a combination of those factors, without excluding other possibilities 
that may exist and result in lowering the apparent rate of the reaction. 
Nonentheless, the purified proteins used throughout in this thesis were able 
to specifically interact in vitro.  
However, the replication of previously published data, which were linked with 
the presence of a stable long-lived complex between CymA and FccA were 
not replicated, both under the previously published conditions and under 
several other conditions. Although it appears that these two proteins do not 
form a stable complex, its presence under perhaps certain regulatory 
elements cannot be ruled out completely at the present time. However, from 
multisequence allignment and the resulting structural model of CymA that 
were presented in chapter 4, the CymA surface of the globular domain is not 
strongly hydrophobic, which further supports that CymA and FccA interact 
through weak transient interactions. Moreover, the negatively charged 
proprionate groups of the four haems provide a negatively charged surface 
that CymA may employ in interacting with its binding partners transiently, 
instead of through hydrophobic interactions that are normally found in 
permanent protein complexes.  
It must also be noted that the tBLM system that was used for the 
electrochemical measurements, it was limited in the amount of CymA present 
in the formed lipid bilayer membrane. This was addressed here by increasing 
significantly the amount of CymA during reconstitution. The number of 
accessible for interactions CymA molecules in the tBLM more generally limits 
this approach as the orientation of CymA during the tBLM formation is random. 
A way to address this could be by directly tethering CymA on the surface 
through its N-terminal tags that would significatly increase the electrode 
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coverage of CymA in a favouring orientation and reconstituting it into a lipid 
bilayer membrane in situ. This approach, among other similar ones, have 
been used successfully before and have been recently reviewed elsewhere 
(117).  
New evidence were presented from direct investigations into the employed 
systems that provided a coherent explanation and attributing the signals to 
technical faults that led the authors to misinterpret the obtained data. More 
specifically, catalytic reductive waves were shown to be due to the presense 
of dissolved oxygen. This was further supported by QCM-D bindings studies 
of the whole and truncated forms of CymAsol, where under the published 
conditions (10% CL/POPC), only the whole catalytically inactive form, carrying 
6xHisMBP tags, could bind.   
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Chapter 6 – Discussion and Future Directions 
Although S. oneidensis is a particularly challenging organism to work with, its 
unique metabolic profile has given it a model organism status for microbial 
electrochemistry. However, the current approaches for the overexpression 
and production of purified proteins are diverse and protein-specific. Moreover, 
the transformation of S. oneidensis presents yet another challenge, as foreign 
plasmids can only be electroporated into the organism with very low 
transformation efficiency. By further improving the current expression vector, 
an improved approach was presented here for the production of one of the 
most challenging membrane proteins, CymA. However, in moving forward, the 
underlying difficulties in genetically modifying S. oneidensis, emphasises the 
need for the development of a new strain that could be used specifically for 
the production of homologous proteins, but also for metalloproteins in general. 
Similar genomic changes to address proteolytic degradation, but also to 
facilitate the homologous and heterologous expression of a target protein has 
already been achieved for E. coli. Moreover, the technological advances that 
the field of molecular biology has seen, including the more recently 
CRISPR/Cas9 system, makes the manipulation of genomes much easier than 
it has been in the past. Thus, the development of an expression strain of S. 
oneidensis will ease the production of metalloproteins, opening up the field to 
more researchers as well.  
Developments on the front of CymA crystallisation and by extension the 
resolution of its crystal structure have also been reported as part of this work. 
Although its limited success in obtaining a crystal, several approaches are 
now more easier to take with the use of tools presented here in terms of gene 
cloning and purification of CymA protein constructs. Thus, the next steps could 
involve, but are not limited to, both the crystallisation screening of the full 
length CymA, and the production of several truncated constructs for 
eliminating highly flexible regions.    
The main contributions of this thesis arrive from partly resolving the debate of 
CymA: FccA interaction. Also, since our current understanding of the 
anaerobic respiratory system of S. oneidensis involves the interaction of a 
number of different proteins with CymA under dynamic redox environments, 
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where this organism is found, the formation of stable complexes seems 
unlikely. That is, such complexes will compromise the survival of the organism 
under those dynamic environments by restricting access to CymA molecules 
for one partner protein when the former is complexed with a different partner 
protein with a low koff. Taking into account, now, that these two proteins most 
likely interact transiently, new approaches can be employed in conclusively 
proving this, as well as further characterising those interactions. Two methods 
are of particular interest for future studies, without excluding others. First, 
further NMR studies for the validation of the previously obtained data, 
especially in the presence of detergent, as well extending basic NMR studies 
to include paramagnetic probes as a signal boost. Second, taking advantage 
of the ease of purification of the new CymA construct reported herein, a Foster 
resonance energy transfer (FRET) based experiments can be designed with 
fluorescence probes tagged to both proteins at different locations in mapping 
their interactions. However, it must be noted that care should be taken to 
address the intrinsic fluorescence of the haems of both CymA and FccA and 
the FAD of FccA.       
Lastly, the applications of this work are primarily to the fields of biotechnology 
and electrosynthesis. For example, S. oneidensis remarkable ability of 
extracellular metal reduction has already found interest for its use for 
bioremediation for the removal of pollutants from water. Strong pollutants, 
such as U and Cr, would primarily exist in the soluble forms of U(VI) and Cr(VI) 
in a contaminated area, which, through reduction by S. oneidensis, can be 
converted to the insoluble oxide-state that is less toxic. Such change of 
physical state of the pollutants will greatly aid their removal and, hence, the 
final de-contamination of water. Such bioremediation strategies can be 
enhanced through the reconstitution of the desired molecular pathways in E. 
coli, or the transformation of S. oneidensis strains, by fine-tuning their 
metabolism for a certain bioremediation application, so the environmental and 
human hazard are minimised. Lastly, molecular understanding of the flow of 
electrons during bacterial respiration, and especially, extracellular bacterial 
respiration, can be exploited for nanoscale biosensor applications. That is, 
when a target molecule binds to a genetically engineered protein, a cascade 
of electron relay would be initiated transferring electrons along a modified 
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protein-wire to an electrode (instead of the native solid oxides found in the 
environment), where the signal can be amplified and translated. It is, hence, 
reasonable to envisage that when such applications are commercialised, they 
will help the society.  
  
- 135 - 
List of References 
1. Marritt, S.J., Lowe, T.G., Bye, J., McMillan, D.G.G., Shi, L., 
Fredrickson, J., Zachara, J., Richardson, D.J., Cheesman, M.R., 
Jeuken, L.J.C. and Butt, J.N. A functional description of CymA, an 
electron-transfer hub supporting anaerobic respiratory flexibility in 
Shewanella. Biochemical Journal. 2012, 444, pp.465-474. 
2. Dietrich, L.E.P., Tice, M.M. and Newman, D.K. The co-evolution of life 
and Earth. Current Biology. 2006, 16(11), pp.R395-R400. 
3. Schopf, J. and Packer, B. Early Archean (3.3-billion to 3.5-billion-year-
old) microfossils from Warrawoona Group, Australia. Science. 1987, 
237(4810), pp.70-73. 
4. Schopf, J.W., Kudryavtsev, A.B., Agresti, D.G., Wdowiak, T.J. and 
Czaja, A.D. Laser–Raman imagery of Earth's earliest fossils. Nature. 
2002, 416(6876), pp.73-76. 
5. Lyons, T.W., Reinhard, C.T. and Planavsky, N.J. The rise of oxygen in 
Earth's early ocean and atmosphere. Nature. 2014, 506(7488), pp.307-
315. 
6. Catling, D.C. and Claire, M.W. How Earth's atmosphere evolved to an 
oxic state: A status report. Earth and Planetary Science Letters. 2005, 
237(1-2), pp.1-20. 
7. Vargas, M., Kashefi, K., Blunt-Harris, E.L. and Lovley, D.R. 
Microbiological evidence for Fe (III) reduction on early Earth. Nature. 
1998, 395(6697), pp.65-67. 
8. Seckbach, J. Origins: Genesis, Evolution and Diversity of Life.  
Springer, 2006. 
9. Myers, C. and Nealson, K.H. Bacterial manganese reduction and 
growth with manganese oxide as the sole electron acceptor. Science. 
1988, 240(4857), pp.1319-1321. 
10. Lovley, D.R., Stolz, J.F., Nord, G.L. and Phillips, E.J. Anaerobic 
production of magnetite by a dissimilatory iron-reducing 
microorganism. Nature. 1987, 330(6145), pp.252-254. 
11. Park, H.S., Kim, B.H., Kim, H.S., Kim, H.J., Kim, G.T., Kim, M., Chang, 
I.S., Park, Y.K. and Chang, H.I. A Novel Electrochemically Active and 
Fe(III)-reducing Bacterium Phylogenetically Related to Clostridium 
- 136 - 
butyricum Isolated from a Microbial Fuel Cell. Anaerobe. 2001, 7(6), 
pp.297-306. 
12. Pham, C.A., Jung, S.J., Phung, N.T., Lee, J., Chang, I.S., Kim, B.H., 
Yi, H. and Chun, J. A novel electrochemically active and Fe (III)‐
reducing bacterium phylogenetically related to Aeromonas hydrophila, 
isolated from a microbial fuel cell. Fems Microbiology Letters. 2003, 
223(1), pp.129-134. 
13. Finneran, K.T., Johnsen, C.V. and Lovley, D.R. Rhodoferax 
ferrireducens sp. nov., a psychrotolerant, facultatively anaerobic 
bacterium that oxidizes acetate with the reduction of Fe (III). 
International Journal of Systematic and Evolutionary Microbiology. 
2003, 53(3), pp.669-673. 
14. Holmes, D.E., Bond, D.R. and Lovley, D.R. Electron transfer by 
Desulfobulbus propionicus to Fe (III) and graphite electrodes. Applied 
and Environmental Microbiology. 2004, 70(2), pp.1234-1237. 
15. Weber, K.A., Achenbach, L.A. and Coates, J.D. Microorganisms 
pumping iron: anaerobic microbial iron oxidation and reduction. Nature 
Reviews Microbiology. 2006, 4(10), pp.752-764. 
16. Debby, H. and Hammer, B.W. Bacteriology Of Butter-Bacteriological 
Studies On Surface Taint Butter. 1931. 
17. Khashe, S. and Janda, J.M. Biochemical and Pathogenic Properties of 
Shewanella alga and Shewanella putrefaciens. Journal of clinical 
microbiology. 1998, 36(3), pp.783-787. 
18. Kozińska, A. and Pekala, A. First isolation of Shewanella putrifaciens 
from freshwater fish-a potential new pathogen of fish. Bull. Eur. Ass. 
Fish Pathol. 2004, 24(4), p.189. 
19. Shewan, J.M., Hobbs, G. and Hodgkiss, W. A Determinative Scheme 
for the Identification of Certain Genera of Gram-Negative Bacteria, with 
Special Reference to the Pseudomonadaceae. Journal of Applied 
Bacteriology. 1960, 23(3), pp.379-390. 
20. Lee, J., Gibson, D. and Shewan, J.M. A numerical taxonomic study of 
some Pseudomonas-like marine bacteria. Journal of General 
Microbiology. 1977, 98(2), pp.439-451. 
- 137 - 
21. Macdonell, M.T. and Colwell, R.R. Phylogeny of the Vibrionaceae, and 
Recommendation for 2 New Genera, Listonella and Shewanella. 
Systematic and Applied Microbiology. 1985, 6(2), pp.171-182. 
22. Venkateswaran, K., Moser, D.P., Dollhopf, M.E., Lies, D.P., Saffarini, 
D.A., MacGregor, B.J., Ringelberg, D.B., White, D.C., Nishijima, M. and 
Sano, H. Polyphasic taxonomy of the genus Shewanella and 
description of Shewanella oneidensis sp. nov. Int J Syst Bacteriol. 
1999, 49(2), pp.705-724. 
23. Beliaev, A.S., Klingeman, D.M., Klappenbach, J., Wu, L., Romine, 
M.F., Tiedje, J.M., Nealson, K.H., Fredrickson, J.K. and Zhou, J. Global 
transcriptome analysis of Shewanella oneidensis MR-1 exposed to 
different terminal electron acceptors. Journal of Bacteriology. 2005, 
187(20), pp.7138-7145. 
24. Nealson, K.H. and Saffarini, D. Iron and manganese in anaerobic 
respiration: environmental significance, physiology, and regulation. 
Annual Reviews in Microbiology. 1994, 48(1), pp.311-343. 
25. Liu, C., Gorby, Y.A., Zachara, J.M., Fredrickson, J.K. and Brown, C.F. 
Reduction kinetics of Fe (III), Co (III), U (VI), Cr (VI), and Tc (VII) in 
cultures of dissimilatory metal‐reducing bacteria. Biotechnology and 
Bioengineering. 2002, 80(6), pp.637-649. 
26. Bencheikh-Latmani, R., Williams, S.M., Haucke, L., Criddle, C.S., Wu, 
L., Zhou, J. and Tebo, B.M. Global transcriptional profiling of 
Shewanella oneidensis MR-1 during Cr (VI) and U (VI) reduction. 
Applied and Environmental Microbiology. 2005, 71(11), pp.7453-7460. 
27. Myers, C., Carstens, B., Antholine, W. and Myers, J. Chromium (VI) 
reductase activity is associated with the cytoplasmic membrane of 
anaerobically grown Shewanella putrefaciens MR‐1. Journal of Applied 
Microbiology. 2000, 88(1), pp.98-106. 
28. Scott, J.H. and Nealson, K.H. A biochemical study of the intermediary 
carbon metabolism of Shewanella putrefaciens. Journal of 
Bacteriology. 1994, 176(11), pp.3408-3411. 
29. Myers, C.R. and Myers, J.M. Cloning and sequence of cymA a gene 
encoding a tetraheme cytochrome c required for reduction of iron(III), 
- 138 - 
fumarate, and nitrate by Shewanella putrefaciens MR-1. Journal of 
Bacteriology. 1997, 179(4), pp.1143-1152. 
30. Rodrigues, M.L., Oliveira, T.F., Pereira, I.A. and Archer, M. X‐ray 
structure of the membrane‐bound cytochrome c quinol dehydrogenase 
NrfH reveals novel haem coordination. Embo j. 2006, 25(24), pp.5951-
5960. 
31. Kern, M., Einsle, O. and Simon, J. Variants of the tetrahaem 
cytochrome c quinol dehydrogenase NrfH characterize the 
menaquinol-binding site, the haem c-binding motifs and the 
transmembrane segment. Biochem. J. 2008, 414, pp.73-79. 
32. Cartron, M., Roldan, M., Ferguson, S., Berks, B. and Richardson, D. 
Identification of two domains and distal histidine ligands to the four 
haems in the bacterial c-type cytochrome NapC; the prototype 
connector between quinol/quinone and periplasmic oxido-reductases. 
Biochem. J. 2002, 368, pp.425-432. 
33. Schwalb, C., Chapman, S.K. and Reid, G.A. The tetraheme 
cytochrome CymA is required for anaerobic respiration with dimethyl 
sulfoxide and nitrite in Shewanella oneidensis. Biochemistry. 2003, 
42(31), pp.9491-9497. 
34. Rodrigues, M.L., Scott, K.A., Sansom, M.S., Pereira, I.A. and Archer, 
M. Quinol Oxidation by c-Type Cytochromes: Structural 
Characterization of the Menaquinol Binding Site of NrfHA. Journal of 
Molecular Biology. 2008, 381(2), pp.341-350. 
35. Field, S.J., Dobbin, P.S., Cheesman, M.R., Watmough, N.J., Thomson, 
A.J. and Richardson, D.J. Purification and magneto-optical 
spectroscopic characterization of cytoplasmic membrane and outer 
membrane multiheme c-type cytochromes from Shewanella 
frigidimarina NCIMB400. Journal of Biological Chemistry. 2000, 
275(12), pp.8515-8522. 
36. Myers, C.R. and Myers, J.M. Role of menaquinone in the reduction of 
fumarate, nitrate, iron(III) and manganese(IV) by Shewanella 
putrefaciens MR-1. Fems Microbiology Letters. 1993, 114(2), pp.215-
222. 
- 139 - 
37. Myers, J.M. and Myers, C.R. Role of the tetraheme cytochrome CymA 
in anaerobic electron transport in cells of Shewanella putrefaciens MR-
1 with normal levels of menaquinone. Journal of Bacteriology. 2000, 
182(1), pp.67-75. 
38. Nishijima, M., Araki-Sakai, M. and Sano, H. Identification of isoprenoid 
quinones by frit-FAB liquid chromatography–mass spectrometry for the 
chemotaxonomy of microorganisms. Journal of microbiological 
methods. 1997, 28(2), pp.113-122. 
39. McMillan, D.G.G., Marritt, S.J., Butt, J.N. and Jeuken, L.J.C. 
Menaquinone-7 Is Specific Cofactor in Tetraheme Quinol 
Dehydrogenase CymA. Journal of Biological Chemistry. 2012, 287(17), 
pp.14215-14225. 
40. Todorovic, S., Rodrigues, M.L., Matos, D. and Pereira, I.s.A. Redox 
Properties of Lysine-and Methionine-Coordinated Hemes Ensure 
Downhill Electron Transfer in NrfH2A4 Nitrite Reductase. The Journal 
of Physical Chemistry B. 2012, 116(19), pp.5637-5643. 
41. Arnoux, P., Sabaty, M., Alric, J., Frangioni, B., Guigliarelli, B., Adriano, 
J.-M. and Pignol, D. Structural and redox plasticity in the heterodimeric 
periplasmic nitrate reductase. Nature Structural & Molecular Biology. 
2003, 10(11), pp.928-934. 
42. Brigé, A., Leys, D., Meyer, T.E., Cusanovich, M.A. and Van Beeumen, 
J.J. The 1.25 Å resolution structure of the diheme NapB subunit of 
soluble nitrate reductase reveals a novel cytochrome c fold with a 
stacked heme arrangement. Biochemistry. 2002, 41(15), pp.4827-
4836. 
43. Gao, H., Yang, Z.K., Barua, S., Reed, S.B., Romine, M.F., Nealson, 
K.H., Fredrickson, J.K., Tiedje, J.M. and Zhou, J. Reduction of nitrate 
in Shewanella oneidensis depends on atypical NAP and NRF systems 
with NapB as a preferred electron transport protein from CymA to 
NapA. Isme Journal. 2009, 3(8), pp.966-976. 
44. Kern, M., Volz, J. and Simon, J. The oxidative and nitrosative stress 
defence network of Wolinella succinogenes: cytochrome c nitrite 
reductase mediates the stress response to nitrite, nitric oxide, 
- 140 - 
hydroxylamine and hydrogen peroxide. Environmental Microbiology. 
2011, 13(9), pp.2478-2494. 
45. Poock, S.R., Leach, E.R., Moir, J.W., Cole, J.A. and Richardson, D.J. 
Respiratory detoxification of nitric oxide by the cytochromec nitrite 
reductase of Escherichia coli. Journal of Biological Chemistry. 2002, 
277(26), pp.23664-23669. 
46. Rodrigues, M.L., Oliveira, T.F., Pereira, I.A. and Archer, M. X-ray 
structure of the membrane-bound cytochrome c quinol dehydrogenase 
NrfH reveals novel haem coordination. Embo j. 2006, 25(24), pp.5951-
5960. 
47. Cunha, C.A., Macieira, S., Dias, J.M., Almeida, G., Gonçalves, L.L., 
Costa, C., Lampreia, J., Huber, R., Moura, J.J. and Moura, I. 
Cytochrome c Nitrite Reductase from Desulfovibrio desulfuricans 
ATCC 27774 The relevance of the two calcium sites in the structure of 
the catalytic subunit NrfA. Journal of Biological Chemistry. 2003, 
278(19), pp.17455-17465. 
48. Lukat, P., Rudolf, M., Stach, P., Messerschmidt, A., Kroneck, P.M.H., 
Simon, J. and Einsle, O. Binding and reduction of sulfite by cytochrome 
c nitrite reductase. Biochemistry. 2008, 47(7), pp.2080-2086. 
49. Kemp, G., Clarke, T., Marritt, S., Lockwood, C., Poock, S., Hemmings, 
A., Richardson, D., Cheesman, M. and Butt, J. Kinetic and 
thermodynamic resolution of the interactions between sulfite and the 
pentahaem cytochrome NrfA from Escherichia coli. Biochem. J. 2010, 
431, pp.73-80. 
50. Youngblut, M., Judd, E.T., Srajer, V., Sayyed, B., Goelzer, T., Elliott, 
S.J., Schmidt, M. and Pacheco, A.A. Laue crystal structure of 
Shewanella oneidensis cytochrome c nitrite reductase from a high-yield 
expression system. Journal of Biological Inorganic Chemistry. 2012, 
17(4), pp.647-662. 
51. Judd, E.T., Youngblut, M., Pacheco, A.A. and Elliott, S.J. Direct 
electrochemistry of Shewanella oneidensis cytochrome c nitrite 
reductase: evidence of interactions across the dimeric interface. 
Biochemistry. 2012, 51(51), pp.10175-10185. 
- 141 - 
52. Angove, H.C., Cole, J.A., Richardson, D.J. and Butt, J.N. Protein film 
voltammetry reveals distinctive fingerprints of nitrite and hydroxylamine 
reduction by a cytochrome c nitrite reductase. Journal of Biological 
Chemistry. 2002, 277(26), pp.23374-23381. 
53. Bollag, J.-M. and Henninger, N.M. Effects of nitrite toxicity on soil 
bacteria under aerobic and anaerobic conditions. Soil Biology and 
Biochemistry. 1978, 10(5), pp.377-381. 
54. Barrett, E. and Kwan, H. Bacterial reduction of trimethylamine oxide. 
Annual Reviews in Microbiology. 1985, 39(1), pp.131-149. 
55. Dos Santos, J.-P., Iobbi-Nivol, C., Couillault, C., Giordano, G. and 
Méjean, V. Molecular analysis of the trimethylamine N-oxide (TMAO) 
reductase respiratory system from a Shewanella species. Journal of 
Molecular Biology. 1998, 284(2), pp.421-433. 
56. Czjzek, M., Dos Santos, J.-P., Pommier, J., Giordano, G., Méjean, V. 
and Haser, R. Crystal structure of oxidized trimethylamine N-oxide 
reductase from Shewanella massilia at 2.5 å resolution. Journal of 
Molecular Biology. 1998, 284(2), pp.435-447. 
57. Morris, C.J., Black, A., Pealing, S.L., Manson, F., Chapman, S.K., Reid, 
G., Gibson, D.M. and Ward, F.B. Purification and properties of a novel 
cytochrome: flavocytochrome c from Shewanella putrefaciens. 
Biochem. J. 1994, 302, pp.587-593. 
58. Leys, D., Tsapin, A.S., Nealson, K.H., Meyer, T.E., Cusanovich, M.A. 
and Van Beeumen, J.J. Structure and mechanism of the 
flavocytochrome c fumarate reductase of Shewanella putrefaciens MR-
1. Nature Structural & Molecular Biology. 1999, 6(12), pp.1113-1117. 
59. Taylor, P., Pealing, S.L., Reid, G.A., Chapman, S.K. and Walkinshaw, 
M.D. Structural and mechanistic mapping of a unique fumarate 
reductase. Nature Structural & Molecular Biology. 1999, 6(12), 
pp.1108-1112. 
60. Schwalb, C., Chapman, S.K. and Reid, G.A. The membrane-bound 
tetrahaem c-type cytochrome CymA interacts directly with the soluble 
fumarate reductase in Shewanella. Biochemical Society Transactions. 
2002, 30, pp.658-662. 
- 142 - 
61. Schuetz, B., Schicklberger, M., Kuermann, J., Spormann, A.M. and 
Gescher, J. Periplasmic Electron Transfer via the c-Type Cytochromes 
MtrA and FccA of Shewanella oneidensis MR-1. Applied and 
Environmental Microbiology. 2009, 75(24), pp.7789-7796. 
62. Beliaev, A.S., Thompson, D.K., Khare, T., Lim, H., Brandt, C.C., Li, G., 
Murray, A.E., Heidelberg, J.F., Giometti, C.S., Yates, J., III, Nealson, 
K.H., Tiedje, J.M. and Zhou, J. Gene and protein expression profiles of 
Shewanella oneidensis during anaerobic growth with different electron 
acceptors. OMICS A Journal of Integrative Biology. 2002, 6(1), pp.39-
60. 
63. Ross, D.E., Ruebush, S.S., Brantley, S.L., Hartshorne, R.S., Clarke, 
T.A., Richardson, D.J. and Tien, M. Characterization of protein-protein 
interactions involved in iron reduction by Shewanella oneidensis MR-
1. Applied and Environmental Microbiology. 2007, 73(18), pp.5797-
5808. 
64. Fonseca, B.M., Paquete, C.M., Neto, S.E., Pacheco, I., Soares, C.M. 
and Louro, R.O. Mind the gap: cytochrome interactions reveal electron 
pathways across the periplasm of Shewanella oneidensis MR-1. 
Biochemical Journal. 2013, 449, pp.101-108. 
65. Gordon, E.H., Pike, A.D., Hill, A.E., Cuthbertson, P.M., Chapman, S.K. 
and Reid, G.A. Identification and characterization of a novel 
cytochrome c(3) from Shewanella frigidimarina that is involved in Fe(III) 
respiration. Biochem J. 2000, 349(Pt 1), pp.153-158. 
66. Coursolle, D. and Gralnick, J.A. Modularity of the Mtr respiratory 
pathway of Shewanella oneidensis strain MR-1. Molecular 
Microbiology. 2010, 77(4), pp.995-1008. 
67. Leys, D., Meyer, T.E., Tsapin, A.S., Nealson, K.H., Cusanovich, M.A. 
and Van Beeumen, J.J. Crystal structures at atomic resolution reveal 
the novel concept of "electron-harvesting" as a role for the small 
tetraheme cytochrome c. Journal of Biological Chemistry. 2002, 
277(38), pp.35703-35711. 
68. Rosenbaum, M., Frawley, E.R., Lee, R.E., Angenent, L.T. and Kranz, 
R.G. Recombinant Engineering of Shewanella oneidensis MR-1 c-type 
- 143 - 
Cytochromes in Escherichia coli. Abstracts of the General Meeting of 
the American Society for Microbiology. 2008, 108, pp.621-621. 
69. Coursolle, D. and Gralnick, J.A. Reconstruction of Extracellular 
Respiratory Pathways for Iron(III) Reduction in Shewanella Oneidensis 
Strain MR-1. Frontiers in microbiology. 2012, 3, pp.56-56. 
70. Pitts, K.E., Dobbin, P.S., Reyes-Ramirez, F., Thomson, A.J., 
Richardson, D.J. and Seward, H.E. Characterization of the Shewanella 
oneidensis MR-1 decaheme cytochrome MtrA. Journal of Biological 
Chemistry. 2003, 278(30), pp.27758-27765. 
71. Hartshorne, R.S., Reardon, C.L., Ross, D., Nuester, J., Clarke, T.A., 
Gates, A.J., Mills, P.C., Fredrickson, J.K., Zachara, J.M., Shi, L., 
Beliaev, A.S., Marshall, M.J., Tien, M., Brantley, S., Butt, J.N. and 
Richardson, D.J. Characterization of an electron conduit between 
bacteria and the extracellular environment. Proceedings of the National 
Academy of Sciences. 2009. 
72. Firer-Sherwood, M.A., Ando, N., Drennan, C.L. and Elliott, S.J. 
Solution-based structural analysis of the decaheme cytochrome, MtrA, 
by small-angle X-ray scattering and analytical ultracentrifugation. The 
Journal of Physical Chemistry B. 2011, 115(38), pp.11208-11214. 
73. Vollmer, W. and Seligman, S.J. Architecture of peptidoglycan: more 
data and more models. Trends in microbiology. 2010, 18(2), pp.59-66. 
74. Matias, V.R., Al-Amoudi, A., Dubochet, J. and Beveridge, T.J. Cryo-
transmission electron microscopy of frozen-hydrated sections of 
Escherichia coli and Pseudomonas aeruginosa. Journal of 
Bacteriology. 2003, 185(20), pp.6112-6118. 
75. Beliaev, A.S. and Saffarini, D.A. Shewanella putrefaciens mtrB 
encodes an outer membrane protein required for Fe(III) and Mn(IV) 
reduction. Journal of Bacteriology. 1998, 180(23), pp.6292-6297. 
76. Baslé, A., Rummel, G., Storici, P., Rosenbusch, J.P. and Schirmer, T. 
Crystal Structure of Osmoporin OmpC from E. coli at 2.0 Å. Journal of 
Molecular Biology. 2006, 362(5), pp.933-942. 
77. Shi, L., Deng, S., Marshall, M.J., Wang, Z.M., Kennedy, D.W., 
Dohnalkova, A.C., Mottaz, H.M., Hill, E.A., Gorby, Y.A., Beliaev, A.S., 
Richardson, D.J., Zachara, J.M. and Fredrickson, J.K. Direct 
- 144 - 
involvement of type II secretion system in extracellular translocation of 
Shewanella oneidensis outer membrane cytochromes MtrC and 
OmcA. Journal of Bacteriology. 2008, 190(15), pp.5512-5516. 
78. Clarke, T.A., Edwards, M.J., Gates, A.J., Hall, A., White, G.F., Bradley, 
J., Reardon, C.L., Shi, L., Beliaev, A.S. and Marshall, M.J. Structure of 
a bacterial cell surface decaheme electron conduit. Proceedings of the 
National Academy of Sciences. 2011, 108(23), pp.9384-9389. 
79. Edwards, M., Fredrickson, J., Zachara, J., Richardson, D. and Clarke, 
T. Analysis of structural MtrC models based on homology with the 
crystal structure of MtrF. Biochemical Society Transactions. 2012, 
40(6), pp.1181-1185. 
80. Shi, L., Chen, B., Wang, Z., Elias, D.A., Mayer, M.U., Gorby, Y.A., Ni, 
S., Lower, B.H., Kennedy, D.W. and Wunschel, D.S. Isolation of a high-
affinity functional protein complex between OmcA and MtrC: two outer 
membrane decaheme c-type cytochromes of Shewanella oneidensis 
MR-1. Journal of Bacteriology. 2006, 188(13), pp.4705-4714. 
81. Lower, B.H., Shi, L., Yongsunthon, R., Droubay, T.C., McCready, D.E. 
and Lower, S.K. Specific bonds between an iron oxide surface and 
outer membrane cytochromes MtrC and OmcA from Shewanella 
oneidensis MR-1. Journal of Bacteriology. 2007, 189(13), pp.4944-
4952. 
82. Edwards, M.J., Baiden, N.A., Johs, A., Tomanicek, S.J., Liang, L., Shi, 
L., Fredrickson, J.K., Zachara, J.M., Gates, A.J. and Butt, J.N. The X-
ray crystal structure of Shewanella oneidensis OmcA reveals new 
insight at the microbe–mineral interface. Febs Letters. 2014, 588(10), 
pp.1886-1890. 
83. Stanley, N.R., Sargent, F., Buchanan, G., Shi, J.R., Stewart, V., 
Palmer, T. and Berks, B.C. Behaviour of topological marker proteins 
targeted to the Tat protein transport pathway. Molecular Microbiology. 
2002, 43(4), pp.1005-1021. 
84. McEWAN, A.G., Ferguson, S. and Jackson, J.B. Purification and 
properties of dimethyl sulphoxide reductase from Rhodobacter 
capsulatus. A periplasmic molybdoenzyme. Biochemical Journal. 
1991, 274(Pt 1), p.305. 
- 145 - 
85. Gralnick, J.A., Vali, H., Lies, D.P. and Newman, D.K. Extracellular 
respiration of dimethyl sulfoxide by Shewanella oneidensis strain MR-
1. Proceedings of the National Academy of Sciences of the United 
States of America. 2006, 103(12), pp.4669-4674. 
86. Bewley, K.D., Firer‐Sherwood, M.A., Mock, J.Y., Ando, N., Drennan, 
C.L. and Elliott, S.J. Mind the gap: diversity and reactivity relationships 
among multihaem cytochromes of the MtrA/DmsE family. 2012. 
87. Fonseca, B.M., Paquete, C.M., Neto, S.E., Pacheco, I., Soares, C.M. 
and Louro, R.O. Mind the gap: cytochrome interactions reveal electron 
pathways across the periplasm of Shewanella oneidensis MR-1. 
Biochem J. 2013, 449(1), pp.101-108. 
88. McMillan, D.G.G., Marritt, S.J., Firer-Sherwood, M.A., Shi, L., 
Richardson, D.J., Evans, S.D., Elliott, S.J., Butt, J.N. and Jeuken, 
L.J.C. Protein-Protein Interaction Regulates the Direction of Catalysis 
and Electron Transfer in a Redox Enzyme Complex. Journal of the 
American Chemical Society. 2013, 135(28), pp.10550-10556. 
89. Londer, Y.Y., Giuliani, S.E., Peppler, T. and Collart, F.R. Addressing 
Shewanella oneidensis "cytochromome": The first step towards high-
throughput expression of cytochromes c. Protein Expression and 
Purification. 2008, 62(1), pp.128-137. 
90. Dobbin, P., Butt, J., Powell, A., Reid, G. and Richardson, D. 
Characterization of a flavocytochrome that is induced during the 
anaerobic respiration of Fe3+ by Shewanella frigidimarina NCIMB400. 
Biochem. J. 1999, 342, pp.439-448. 
91. Myers, C.R. and Myers, J.M. Replication of plasmids with the p15A 
origin in Shewanella putrefaciens MR-1. Letters in Applied 
Microbiology. 1997, 24(3), pp.221-225. 
92. Meyer, T. and Lamberts, B. Use of coomassie brilliant blue R250 for 
the electrophoresis of microgram quantities of parotid saliva proteins 
on acrylamide-gel strips. Biochimica et Biophysica Acta (BBA)-General 
Subjects. 1965, 107(1), pp.144-145. 
93. Thomas, P.E., Ryan, D. and Levin, W. An improved staining procedure 
for the detection of the peroxidase activity of cytochrome P-450 on 
- 146 - 
sodium dodecyl sulfate polyacrylamide gels. Analytical biochemistry. 
1976, 75(1), pp.168-176. 
94. Carter, K. and Gennis, R.B. Reconstitution of the Ubiquinone-
dependent pyruvate oxidase system of Escherichia coli with the 
cytochrome o terminal oxidase complex. J Biol Chem. 1985, 260(20), 
pp.10986-10990. 
95. Jeuken, L.J., Connell, S.D., Henderson, P.J., Gennis, R.B., Evans, 
S.D. and Bushby, R.J. Redox enzymes in tethered membranes. 
Journal of the American Chemical Society. 2006, 128(5), pp.1711-
1716. 
96. Boden, N., Bushby, R.J., Clarkson, S., Evans, S.D., Knowles, P.F. and 
Marsh, A. The design and synthesis of simple molecular tethers for 
binding biomembranes to a gold surface. Tetrahedron. 1997, 53(31), 
pp.10939-10952. 
97. Jeuken, L.J.C., Daskalakis, N.N., Han, X.J., Sheikh, K., Erbe, A., 
Bushby, R.J. and Evans, S.D. Phase separation in mixed self-
assembled monolayers and its effect on biomimetic membranes. 
Sensors and Actuators B-Chemical. 2007, 124(2), pp.501-509. 
98. Cho, N.J., Frank, C.W., Kasemo, B. and Hook, F. Quartz crystal 
microbalance with dissipation monitoring of supported lipid bilayers on 
various substrates. Nat Protoc. 2010, 5(6), pp.1096-1106. 
99. Shi, L., Lin, J.T., Markillie, L.M., Squier, T.C. and Hooker, B.S. 
Overexpression of multi-heme C-type cytochromes. Biotechniques. 
2005, 38(2), pp.297-299. 
100. Di Tommaso, P., Moretti, S., Xenarios, I., Orobitg, M., Montanyola, A., 
Chang, J.M., Taly, J.F. and Notredame, C. T-Coffee: a web server for 
the multiple sequence alignment of protein and RNA sequences using 
structural information and homology extension. Nucleic Acids Res. 
2011, 39(Web Server issue), pp.W13-17. 
101. Notredame, C., Higgins, D.G. and Heringa, J. T-Coffee: A novel 
method for fast and accurate multiple sequence alignment. J Mol Biol. 
2000, 302(1), pp.205-217. 
- 147 - 
102. Arnold, K., Bordoli, L., Kopp, J. and Schwede, T. The SWISS-MODEL 
workspace: a web-based environment for protein structure homology 
modelling. Bioinformatics. 2006, 22(2), pp.195-201. 
103. Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., 
Schmidt, T., Kiefer, F., Gallo Cassarino, T., Bertoni, M., Bordoli, L. and 
Schwede, T. SWISS-MODEL: modelling protein tertiary and quaternary 
structure using evolutionary information. Nucleic Acids Res. 2014, 
42(Web Server issue), pp.W252-258. 
104. Hewitt, S.N., Choi, R., Kelley, A., Crowther, G.J., Napuli, A.J. and Van 
Voorhis, W.C. Expression of proteins in Escherichia coli as fusions with 
maltose-binding protein to rescue non-expressed targets in a high-
throughput protein-expression and purification pipeline. Acta 
Crystallographica Section F: Structural Biology and Crystallization 
Communications. 2011, 67(Pt 9), pp.1006-1009. 
105. Kertis, F., Khurshid, S., Okman, O., Kysar, J.W., Govada, L., Chayen, 
N. and Erlebacher, J. Heterogeneous nucleation of protein crystals 
using nanoporous gold nucleants. Journal of Materials Chemistry. 
2012, 22(41), pp.21928-21934. 
106. Griffin, L. and Lawson, A. Antibody fragments as tools in 
crystallography. Clinical and Experimental Immunology. 2011, 165(3), 
pp.285-291. 
107. Lim, H.-H., Fang, Y. and Williams, C. High-Efficiency Screening of 
Monoclonal Antibodies for Membrane Protein Crystallography. Plos 
One. 2011, 6(9), p.e24653. 
108. Clifton, M.C., Dranow, D.M., Leed, A., Fulroth, B., Fairman, J.W., 
Abendroth, J., Atkins, K.A., Wallace, E., Fan, D., Xu, G., Ni, Z.J., 
Daniels, D., Van Drie, J., Wei, G., Burgin, A.B., Golub, T.R., Hubbard, 
B.K. and Serrano-Wu, M.H. A Maltose-Binding Protein Fusion 
Construct Yields a Robust Crystallography Platform for MCL1. Plos 
One. 2015, 10(4), p.e0125010. 
109. Mintseris, J. and Weng, Z. Structure, function, and evolution of 
transient and obligate protein-protein interactions. Proc Natl Acad Sci 
U S A. 2005, 102(31), pp.10930-10935. 
- 148 - 
110. Choi, Y.S., Yang, J.S., Choi, Y., Ryu, S.H. and Kim, S. Evolutionary 
conservation in multiple faces of protein interaction. Proteins. 2009, 
77(1), pp.14-25. 
111. Jones, S. and Thornton, J.M. Principles of protein-protein interactions. 
Proc Natl Acad Sci U S A. 1996, 93(1), pp.13-20. 
112. Jones, S. and Thornton, J.M. Protein-protein interactions: a review of 
protein dimer structures. Prog Biophys Mol Biol. 1995, 63(1), pp.31-65. 
113. Tsai, C.J., Lin, S.L., Wolfson, H.J. and Nussinov, R. Studies of protein-
protein interfaces: a statistical analysis of the hydrophobic effect. 
Protein Sci. 1997, 6(1), pp.53-64. 
114. Block, P., Paern, J., Hüllermeier, E., Sanschagrin, P., Sotriffer, C.A. 
and Klebe, G. Physicochemical descriptors to discriminate protein–
protein interactions in permanent and transient complexes selected by 
means of machine learning algorithms. Proteins: Structure, Function, 
and Bioinformatics. 2006, 65(3), pp.607-622. 
115. Tjernberg, A., Markova, N., Griffiths, W.J. and Hallen, D. DMSO-related 
effects in protein characterization. J Biomol Screen. 2006, 11(2), 
pp.131-137. 
116. Arakawa, T., Kita, Y. and Timasheff, S.N. Protein precipitation and 
denaturation by dimethyl sulfoxide. Biophys Chem. 2007, 131(1-3), 
pp.62-70. 
117. Laftsoglou, T. and Jeuken, L.J.C. Supramolecular electrode 
assemblies for bioelectrochemistry. Chemical Communications 
(Cambridge, England). 2017, 53(27), pp.3801-3809. 
 
- 149 - 
Appendix A 
List of vendors  
[Purity or grade] as provided by the vendor. 
• Melford 
Yeast extract, tryptone, EDTA (disodium salt) dihydrate, sodium dodecyl 
sulfate micro-pellets, ammonium sulfate, urea [>99%], sodium acetate 
anhydrous [>99%], L(+) arabinose [>99%], glycine [>99.5%], Tris [molecular 
biology grade >99.9%], potassium phosphate monobasic [>98%], kanamycin 
monosulfate, TEMED, ammonium persulfate, 40% w/v acrylamide, 2% w/v 
bis-acrylamide, albumin bovine fraction V (BSA) [>98%], carbenicillin 
disodium, n-octyl-β-D-glycoside. 
• Fisher 
Sodium chloride, glycerol [molecular biology grade], methanol [analytical 
grade], isopropanol [analytical grade], calcium chloride dihydrate, hydrogen 
peroxide >30% w/v, Triton X-100 [electrophoresis grade]. 
• Sigma-Aldrich  
D-sorbitol, fumaric acid disodium salt, copper (II) sulfate pentahydrate, 
HEPES [≥99.5%], MOPS [≥99.5%], fumaric acid for cell culture, sodium 
sulfate [>99%], ethanol [≥99.8%], sodium dithionite [≥82%], brilliant blue R250 
coomassie, sodium-DL-lactate 60% w/v solution, tetramethylbenzidine 
dihydrochloride hydrate, lysozyme from chicken egg white [≥90%], DL-
dithiothreitol, tris(2-carboxyethyl) phosphine hydrochloride [≥98%], dimethyl-
sulfoxide [≥99.5%], TWEEN20, acetic acid [99-100%]. 
• OXOID 
Agar bacteriological (Agar No. 1). 
• Thermo Scientific 
BCA protein assay reagent A. 
• VMR chemicals 
Dipotassium hydrogen phosphate, chloroform [HPLC grade]. 
• ACROS organics 
Imidazole [99%], methyl viologen hydrate [98%], 2-mercaptoethanol [99%], 
magnesium chloride [pure]. 
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• Scientific Laboratory Supplies 
Bromophenol blue. 
• Alfa Aesor 
Chloramphenicol [99+%]. 
• Anatrace 
Anapoe-X-100 (10% w/v Triton X-100) [membrane grade], n-dodecyl-β-D-
maltopyranoside.  
• Generon 
Page ruler plus pre-stained protein ladder (10-250 kDa) (cat. No.: 26619), 
InstantBlue protein stain (cat. No.: ISB1L), isopropyl-β-D-
thiogalactopyranoside,  
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Appendix B 
Sequences of the Recombinant CymA 
1. 8xHisHRVCymA construct  
CCATGGCAAAACATCATCACCATCACCATCACCATCTGGAAGTTCTGTTCCAG
GGTCCGAACTGGCGTGCTTTATTCAAACCATCTGCTAAATACTCTATCTTAGCT
TTATTAGTTGTTGGTATCGTTATCGGTGTTGTTGGTTACTTCGCTACTCAACAA
ACTTTACACGCTACTTCTACTGATGCTTTCTGTATGTCTTGTCACTCTAACCACT
CTTTAAAAAACGAAGTTTTAGCTTCTGCTCACGGTGGTGGTAAAGCTGGTGTTA
CTGTTCAATGTCAAGATTGTCACTTACCACACGGTCCAGTTGATTACTTAATCA
AAAAAATCATCGTTTCTAAAGATTTATACGGTTTCTTAACTATCGATGGTTTCAA
CACTCAAGCGTGGTTAGATGAAAACCGTAAAGAACAAGCTGATAAAGCTCTCG
CTTACTTCCGTGGTAACGATTCTGCTAACTGTCAACACTGTCACACTCGTATCT
ACGAAAACCAACCAGAAACTATGAAACCAATGGCTGTTCGTATGCACACTAAC
AACTTCAAAAAAGATCCAGAAACTCGTAAAACTTGTGTTGATTGTCACAAAGGT
GTTGCTCACCCATACCCAAAAGGTTAAAAGCTT 
Key: Restriction sites are underlined (NcoI at the beginning of the construct, and 
HindIII at the end of the construct); start and stop codons are highlighted in green 
and red respectively; 8xHis-tag is highlighted in purple; and the HRV 3C proteolytic 
site is highlighted in light blue.  
 
2. Protein alignment of the translated construct and the wt CymA from S. 
oneidensis. 
 
SoCymA             1 ------------------MNWRALFKPSAKYSILALLVVGIVIGVVGYFA     32 
                                       .||||||||||||||||||||||||||||||| 
8xisHRVCymA        1 MAKHHHHHHHHLEVLFQGPNWRALFKPSAKYSILALLVVGIVIGVVGYFA     50 
 
SoCymA            33 TQQTLHATSTDAFCMSCHSNHSLKNEVLASAHGGGKAGVTVQCQDCHLPH     82 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
8xisHRVCymA       51 TQQTLHATSTDAFCMSCHSNHSLKNEVLASAHGGGKAGVTVQCQDCHLPH    100 
 
SoCymA            83 GPVDYLIKKIIVSKDLYGFLTIDGFNTQAWLDENRKEQADKALAYFRGND    132 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
8xisHRVCymA      101 GPVDYLIKKIIVSKDLYGFLTIDGFNTQAWLDENRKEQADKALAYFRGND    150 
 
SoCymA           133 SANCQHCHTRIYENQPETMKPMAVRMHTNNFKKDPETRKTCVDCHKGVAH    182 
                     |||||||||||||||||||||||||||||||||||||||||||||||||| 
8xisHRVCymA      151 SANCQHCHTRIYENQPETMKPMAVRMHTNNFKKDPETRKTCVDCHKGVAH    200 
 
SoCymA           183 PYPKG    187 
                     ||||| 
8xisHRVCymA      201 PYPKG    205 
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3. Cloning confirmation by Sanger sequencing; Sanger sequencing 
results aligned to the synthesized gene sequence by GenScript.  
 
 ....|....| ....|....| ....|....| ....|....| ....|....|  
                      10         20         30         40        50              
CL2_F_PBAD   NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNCTCTCTAC TGTTTCTCCN  
GenScript    ---------- ---------- ---------- ---------- ----------  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                      60         70         80         90       100             
CL2_F_PBAD   TNCCCGTTTT TTTGGGCNNG AANNNNNNNN NNNNNNCTTT AANAAGGAGA  
GenScript    ---------- ---------- ---------- ---------- ----------  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     110        120        130        140       150         
CL2_F_PBAD   TATACATACC CATGGCAAAA CATCATCACC ATCACCATCA CCATCTGGAA  
GenScript    ---------C CATGGCAAAA CATCATCACC ATCACCATCA CCATCTGGAA  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     160        170        180        190       200         
CL2_F_PBAD   GTTCTGTTCC AGGGTCCGAA CTGGCGTGCT TTATTCAAAC CATCTGCTAA  
GenScript    GTTCTGTTCC AGGGTCCGAA CTGGCGTGCT TTATTCAAAC CATCTGCTAA  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     210        220        230        240       250         
CL2_F_PBAD   ATACTCTATC TTAGCTTTAT TAGTTGTTGG TATCGTTATC GGTGTTGTTG  
GenScript    ATACTCTATC TTAGCTTTAT TAGTTGTTGG TATCGTTATC GGTGTTGTTG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     260        270        280        290       300         
CL2_F_PBAD   GTTACTTCGC TACTCAACAA ACTTTACACG CTACTTCTAC TGATGCTTTC  
GenScript    GTTACTTCGC TACTCAACAA ACTTTACACG CTACTTCTAC TGATGCTTTC  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     310        320        330        340       350         
CL2_F_PBAD   TGTATGTCTT GTCACTCTAA CCACTCTTTA AAAAACGAAG TTTTAGCTTC  
GenScript    TGTATGTCTT GTCACTCTAA CCACTCTTTA AAAAACGAAG TTTTAGCTTC  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     360        370        380        390       400         
CL2_F_PBAD   TGCTCACGGT GGTGGTAAAG CTGGTGTTAC TGTTCAATGT CAAGATTGNN  
GenScript    TGCTCACGGT GGTGGTAAAG CTGGTGTTAC TGTTCAATGT CAAGATTGTC  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     410        420        430        440       450         
CL2_F_PBAD   NNTTACCACA CGGTCCAGTT GATTACTTAA TCAAAAAAAT CATCGTTTCT  
GenScript    ACTTACCACA CGGTCCAGTT GATTACTTAA TCAAAAAAAT CATCGTTTCT  
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             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     460        470        480        490       500         
CL2_F_PBAD   AAAGATTTAT ACGGNTTCTT AACTATCGAT GGTTTCAACA CTCAAGCGTG  
GenScript    AAAGATTTAT ACGGTTTCTT AACTATCGAT GGTTTCAACA CTCAAGCGTG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     510        520        530        540       550         
CL2_F_PBAD   GTTAGATGAA AACCGTAAAG AACAAGCTGA TAAAGCTCTC GCTTACTTCC  
GenScript    GTTAGATGAA AACCGTAAAG AACAAGCTGA TAAAGCTCTC GCTTACTTCC  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     560        570        580        590       600         
CL2_F_PBAD   GTGGTAACGA TTCTGNNNNN NGTCAACACT GTCACACTCG TATCTACNAA  
GenScript    GTGGTAACGA TTCTGCTAAC TGTCAACACT GTCACACTCG TATCTACGAA  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     610        620        630        640       650         
CL2_F_PBAD   AACCAACCAN AAACTATGAA ACCAATGGCT GTTCNNNNGC ACACTAACNA  
GenScript    AACCAACCAG AAACTATGAA ACCAATGGCT GTTCGTATGC ACACTAACAA  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     660        670        680        690       700         
CL2_F_PBAD   CTTCAAAAAA GATCCANAAA CTCGTAAAAC TTGTGTTGAT TGTCACAAAG  
GenScript    CTTCAAAAAA GATCCAGAAA CTCGTAAAAC TTGTGTTGAT TGTCACAAAG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     710        720        730        740       750         
CL2_F_PBAD   GTGTTGCTCA CCCATACCCA AAAGGTTAAA AGCTTGAAGG TAAGCCTATC  
GenScript    GTGTTGCTCA CCCATACCCA AAAGGTTAAA AGCTT----- ----------  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     760        770        780        790       800         
CL2_F_PBAD   CCTAACCCTC TCCTCGGTCT CGANTCTACG CGTANCGGTC NNCNTCACCA  
GenScript    ---------- ---------- ---------- ---------- ----------  
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Appendix C  
Purification Profile of TEV protease 
The electrophoretic profile of TEV protease is shown in figure I as a reference 
from the in house purification of it, which was used for the removal of 
purification 6xHisMBP tags of the whole CymAsol construct.  
 
Figure I: The electrophoretic purification profile of TEV protease. 15% SDS-
PAGE. M: molecular mass protein markers, LD: load, FT: flowthrough, W: wash, TEV: 
final purified TEV protease.  
